Health food and beverage business Forbidden Foods (ASX: FFF) has clinched its largest purchase order from major retailer Costco Australia for the company’s Blue Dinosaur snack products, valued at $133,000.
🧃 Highlights the strong demand for Blue Dinosaur ‘Bites’ range which previously sold out across Costco stores
🧋 Builds on the company’s strategy to develop an expanded distribution footprint for its multi-brand portfolio
🥛 Continues sales momentum so far in 2025 after net sales for the first two months of the year jumped by 147% from the previous corresponding period
“The latest purchase order from Costco is another positive step in our strategy to establish Forbidden Foods as a leading multi-brand FMCG business, with a diversified distribution footprint and strong partnerships with major Australian retailers.” – Alex Aleksic, Forbidden Foods Chief Executive Officer

Health food and beverage business Forbidden Foods (ASX: FFF) has clinched its largest purchase order from major retailer Costco Australia for the company’s Blue Dinosaur snack products, valued at $133,000.
🧃 Highlights the strong demand for Blue Dinosaur ‘Bites’ range which previously sold out across Costco stores
🧋 Builds on the company’s strategy to develop an expanded distribution footprint for its multi-brand portfolio
🥛 Continues sales momentum so far in 2025 after net sales for the first two months of the year jumped by 147% from the previous corresponding period
“The latest purchase order from Costco is another positive step in our strategy to establish Forbidden Foods as a leading multi-brand FMCG business, with a diversified distribution footprint and strong partnerships with major Australian retailers.” – Alex Aleksic, Forbidden Foods Chief Executive Officer
MA Credit Income Trust (ASX:MA1) has listed on the ASX with a ticker code of MA1. This listed fund provides exposure to a portfolio of Australian, New Zealand and global credit investments covering three core private credit market segments: direct asset lending, asset backed lending, and direct corporate lending. It offers portfolio diversification for investors seeking income and capital preservation and aims to deliver consistent monthly distributions with a target return of the RBA Cash Rate plus 4.25% per annum.

MA Credit Income Trust (ASX:MA1) has listed on the ASX with a ticker code of MA1. This listed fund provides exposure to a portfolio of Australian, New Zealand and global credit investments covering three core private credit market segments: direct asset lending, asset backed lending, and direct corporate lending. It offers portfolio diversification for investors seeking income and capital preservation and aims to deliver consistent monthly distributions with a target return of the RBA Cash Rate plus 4.25% per annum.
Gold explorer James Bay Minerals (ASX: JBY) has joined the one million ounce club after unveiling a maiden 1.37 million ounce JORC compliant mineral resource estimate (MRE) for its Independence gold project in Nevada.
🌟 Reveals a deeper high-grade skarn component containing about 984,000 ounces of gold grading 6.67 grams per tonne
⚒️ The resource also includes a near-surface epithermal component taking in nearly 400,000 ounces of gold
💎 Identifies further exploration upside with known gold mineralisation sitting outside of the resource estimate
“Notably, significant mineralisation exists beyond both the skarn and near-surface epithermal models, remaining open in all directions. These factors strongly suggest a connection between the surface mineralisation and deeper skarn material, indicating substantial resource growth ahead.” – Matthew Hayes, James Bay Minerals Executive Director

Gold explorer James Bay Minerals (ASX: JBY) has joined the one million ounce club after unveiling a maiden 1.37 million ounce JORC compliant mineral resource estimate (MRE) for its Independence gold project in Nevada.
🌟 Reveals a deeper high-grade skarn component containing about 984,000 ounces of gold grading 6.67 grams per tonne
⚒️ The resource also includes a near-surface epithermal component taking in nearly 400,000 ounces of gold
💎 Identifies further exploration upside with known gold mineralisation sitting outside of the resource estimate
“Notably, significant mineralisation exists beyond both the skarn and near-surface epithermal models, remaining open in all directions. These factors strongly suggest a connection between the surface mineralisation and deeper skarn material, indicating substantial resource growth ahead.” – Matthew Hayes, James Bay Minerals Executive Director
Emerging gold producer Brightstar Resources (ASX: BTR) has delivered a series of significant gold hits from its maiden drilling campaign at the Lord Nelson deposit, located within the company’s 1.5 million ounce Sandstone gold project in WA.
🌟 Confirms continuity of high grade gold mineralisation within the optimised pit shell at Lord Nelson, as well as extensions of the mineralisation at depth
⚒️ Results bode well for potential upgrades of the mineral resource at Lord Nelson
💎 Ongoing drilling campaign seeks at upgrade and extend Sandstone’s existing mineral resource base with 80,000m of drilling planned for this year
“The results from our first drill program at the Lord Nelson deposit within our Sandstone Gold Project are significant, highlighting the continuity of the high-grade mineralisation and the robustness of the current mineral resource.” – Alex Rovira, Brightstar Resources Managing Director

Emerging gold producer Brightstar Resources (ASX: BTR) has delivered a series of significant gold hits from its maiden drilling campaign at the Lord Nelson deposit, located within the company’s 1.5 million ounce Sandstone gold project in WA.
🌟 Confirms continuity of high grade gold mineralisation within the optimised pit shell at Lord Nelson, as well as extensions of the mineralisation at depth
⚒️ Results bode well for potential upgrades of the mineral resource at Lord Nelson
💎 Ongoing drilling campaign seeks at upgrade and extend Sandstone’s existing mineral resource base with 80,000m of drilling planned for this year
“The results from our first drill program at the Lord Nelson deposit within our Sandstone Gold Project are significant, highlighting the continuity of the high-grade mineralisation and the robustness of the current mineral resource.” – Alex Rovira, Brightstar Resources Managing Director
Dominion Income Trust (ASX: DN1) has listed on the ASX with a ticker code of DN1. This Trust has invested in a Note with exposure to debt instruments such as loans and bank facilities issued by corporates, banks, and non-bank financial debt institutions with a demonstrated financial performance. The Note seeks to generate regular monthly interest income and to provide portfolio diversification with lower correlation to listed equity markets and a greater correlation to credit markets.
Directors: Michael J. O`Brien, Managing Director, CEO, Director
Andrew Godfrey, Director, Investor Relations
Mary O`Connor Director
Johanna Platt Director, CFO
David WarrenDirector
Media: The Stock Network @lelsmits

Dominion Income Trust (ASX: DN1) has listed on the ASX with a ticker code of DN1. This Trust has invested in a Note with exposure to debt instruments such as loans and bank facilities issued by corporates, banks, and non-bank financial debt institutions with a demonstrated financial performance. The Note seeks to generate regular monthly interest income and to provide portfolio diversification with lower correlation to listed equity markets and a greater correlation to credit markets.
Directors: Michael J. O`Brien, Managing Director, CEO, Director
Andrew Godfrey, Director, Investor Relations
Mary O`Connor Director
Johanna Platt Director, CFO
David WarrenDirector
Media: The Stock Network @lelsmits
Aquaculture business New Zealand King Salmon (ASX: NZK) has inked a five year funding partnership with the New Zealand government in the duo’s efforts to drive the future of the salmon farming industry in the country.
🐟 NZ government will invest up to NZ$11.7 million into a program designed to establish viability of open ocean farming for the King salmon species
🎣 The company is progressing New Zealand’s first open ocean salmon farm at its Blue Endeavour pilot project
🌊 The collaboration seeks to advance the technologies that will provide a blueprint for substantive and sustainable salmon farming growth in New Zealand
“Having the world’s first King salmon open ocean aquaculture site at Blue Endeavour is a big responsibility – while we are confident it will be successful, there will be some significant lessons learned along the way. This funding partnership will enable us to share these learnings and build industry and investor confidence.” – Carl Carrington, New Zealand King Salmon Chief Executive Officer

Aquaculture business New Zealand King Salmon (ASX: NZK) has inked a five year funding partnership with the New Zealand government in the duo’s efforts to drive the future of the salmon farming industry in the country.
🐟 NZ government will invest up to NZ$11.7 million into a program designed to establish viability of open ocean farming for the King salmon species
🎣 The company is progressing New Zealand’s first open ocean salmon farm at its Blue Endeavour pilot project
🌊 The collaboration seeks to advance the technologies that will provide a blueprint for substantive and sustainable salmon farming growth in New Zealand
“Having the world’s first King salmon open ocean aquaculture site at Blue Endeavour is a big responsibility – while we are confident it will be successful, there will be some significant lessons learned along the way. This funding partnership will enable us to share these learnings and build industry and investor confidence.” – Carl Carrington, New Zealand King Salmon Chief Executive Officer
The Stock Network is pleased to support the Sydney Mining Club and interview Auric Mining (ASX:AWJ) Managing Director Mark English, who will be presenting at the Sydney Mining Club Event. Hear about Auric Mining’s gold production plans for its Jeffreys Find and Munda gold projects located in the heart of Western Australia’s renowned Goldfields region.
🗓 Thursday 6 March 2025
🕛 5:15 PM
📍 The Establishment Rooms, 252 George Street, Sydney

The Stock Network is pleased to support the Sydney Mining Club and interview Auric Mining (ASX:AWJ) Managing Director Mark English, who will be presenting at the Sydney Mining Club Event. Hear about Auric Mining’s gold production plans for its Jeffreys Find and Munda gold projects located in the heart of Western Australia’s renowned Goldfields region.
🗓 Thursday 6 March 2025
🕛 5:15 PM
📍 The Establishment Rooms, 252 George Street, Sydney
Ahead of appearing at the Stocks On Track event, LTR Pharma (ASX:LTP) Executive Chairman, Lee Rodne speaks with The Stock Network`s Lel Smits and highlights:
🔹Market opportunity for SPONTAN nasal spray used to treat erectile dysfunction
🔹Advantages of SPONTAN over competitor products
🔹Commercialisation push for SPONTAN in Australia and the US

Ahead of appearing at the Stocks On Track event, LTR Pharma (ASX:LTP) Executive Chairman, Lee Rodne speaks with The Stock Network`s Lel Smits and highlights:
🔹Market opportunity for SPONTAN nasal spray used to treat erectile dysfunction
🔹Advantages of SPONTAN over competitor products
🔹Commercialisation push for SPONTAN in Australia and the US
Praemium Limited (ASX:PPS) provides technology and product solutions enabling advisers to deliver outcomes for their clients, including achieving their financial goals and having a positive wealth management experience. The company has just delivered a robust performance in the first half of the 2025 financial year (H1 FY25) showcased by a substantial jump in revenue, operating earnings, and profit. Praemium CEO Anthony Wamsteker speaks with The Stock Network`s Lel Smits.
🥁 Revenue and other income up by 32%
🧑💼 Industry acknowledgements
🗓️ Spectrum Growth plans
“This is an outstanding continuation of the momentum built through the 2024 financial year. We have greatly improved our organic growth, repriced our core SMA to reflect its top tier market position, rebounded from the impact of adviser exits, launched a market leading IDPS with Spectrum, restructured operations offshore and returned earnings to shareholders." - Praemium’s Chief Executive Officer, Mr. Anthony Wamsteker

Praemium Limited (ASX:PPS) provides technology and product solutions enabling advisers to deliver outcomes for their clients, including achieving their financial goals and having a positive wealth management experience. The company has just delivered a robust performance in the first half of the 2025 financial year (H1 FY25) showcased by a substantial jump in revenue, operating earnings, and profit. Praemium CEO Anthony Wamsteker speaks with The Stock Network`s Lel Smits.
🥁 Revenue and other income up by 32%
🧑💼 Industry acknowledgements
🗓️ Spectrum Growth plans
“This is an outstanding continuation of the momentum built through the 2024 financial year. We have greatly improved our organic growth, repriced our core SMA to reflect its top tier market position, rebounded from the impact of adviser exits, launched a market leading IDPS with Spectrum, restructured operations offshore and returned earnings to shareholders." - Praemium’s Chief Executive Officer, Mr. Anthony Wamsteker
Land and marine transport specialist Kelsian Group (ASX:KLS) has delivered healthy revenue growth in the first half of the 2025 financial year (H1 FY25), with the group now targeting a lift in free cash flow generation through reduced capital expenditure.
🚍 Revenue of $1.07 billion up by 9.1% from same time last year with the company on track to meet full-year earnings guidance
🛳️ Delivers a series of significant new and renewed contract wins including in key US growth market
🛣️ Majority of FY25 capital expenditure incurred in H1 FY25, positioning the company for higher free cash flow generation
“The result reflects the strength of our diversified, global business with a strong track record of growth, underpinned by a majority of highly defensive long-term service contracts with high quality counterparties as well as cost base protection in most contracts.” – Clint Feuerherdt, Kelsian Group Managing Director and Chief Executive Officer

Land and marine transport specialist Kelsian Group (ASX:KLS) has delivered healthy revenue growth in the first half of the 2025 financial year (H1 FY25), with the group now targeting a lift in free cash flow generation through reduced capital expenditure.
🚍 Revenue of $1.07 billion up by 9.1% from same time last year with the company on track to meet full-year earnings guidance
🛳️ Delivers a series of significant new and renewed contract wins including in key US growth market
🛣️ Majority of FY25 capital expenditure incurred in H1 FY25, positioning the company for higher free cash flow generation
“The result reflects the strength of our diversified, global business with a strong track record of growth, underpinned by a majority of highly defensive long-term service contracts with high quality counterparties as well as cost base protection in most contracts.” – Clint Feuerherdt, Kelsian Group Managing Director and Chief Executive Officer
The Stock Network is pleased to support the Sydney Mining Club and interview Barton Gold (ASX:BGD) Managing Director Alexander Scanlon, who will be presenting at the Sydney Mining Club Event. Hear Barton Gold accelerating gold development at Tunkillia project, Gawler Craton, South Australia. Joining The Stock Network’s Lel Smits ahead of appearing at Sydney Mining Club is Barton Gold (ASX:BGD), Managing Director Alexander Scanlon.
🗓 Thursday 6 March 2025
🕛 5:15 PM
📍 The Establishment Rooms, 252 George Street, Sydney

The Stock Network is pleased to support the Sydney Mining Club and interview Barton Gold (ASX:BGD) Managing Director Alexander Scanlon, who will be presenting at the Sydney Mining Club Event. Hear Barton Gold accelerating gold development at Tunkillia project, Gawler Craton, South Australia. Joining The Stock Network’s Lel Smits ahead of appearing at Sydney Mining Club is Barton Gold (ASX:BGD), Managing Director Alexander Scanlon.
🗓 Thursday 6 March 2025
🕛 5:15 PM
📍 The Establishment Rooms, 252 George Street, Sydney
Ahead of appearing at the Stocks On Track event, Amplia Therapeutics (ASX:ATX) CEO & Managing Director, Chris Burns speaks with The Stock Network`s Lel Smits and highlights:
🩻 Amplia’s role in improving cancer treatment
💉 The company’s upcoming clinical trial in pancreatic cancer
🩺 The global addressable market for pancreatic cancer treatment

Ahead of appearing at the Stocks On Track event, Amplia Therapeutics (ASX:ATX) CEO & Managing Director, Chris Burns speaks with The Stock Network`s Lel Smits and highlights:
🩻 Amplia’s role in improving cancer treatment
💉 The company’s upcoming clinical trial in pancreatic cancer
🩺 The global addressable market for pancreatic cancer treatment
Ahead of appearing at the Stocks On Track event, AdAlta (ASX:1AD) CEO & Managing Director, Tim Oldham speaks with The Stock Network`s Lel Smits and highlights:
🩺 Progress and potential of “East to West” strategy
💉 Strategy momentum and future goals

Ahead of appearing at the Stocks On Track event, AdAlta (ASX:1AD) CEO & Managing Director, Tim Oldham speaks with The Stock Network`s Lel Smits and highlights:
🩺 Progress and potential of “East to West” strategy
💉 Strategy momentum and future goals
3D metal printing specialist AML3D (ASX:AL3) has released its half yearly report for the first half of the 2025 financial year (H1 FY25), headlined by the commercialisation push of its patented Wire Additive Manufacturing technology known as ARCEMY.
Highlights for the half-year include:
🥁 Delivers $4.63 million in revenue in H1 FY25, up by 206% from the previous corresponding period
🏭 Opens US technology centre with immediate plans for expansion and an initial $2.27 million utilities contract
🔑 Seals $30 million in funding to facilitate expansion in the US and Europe
🚢 Strengthens partnership with BlueForge Alliance to support US Navy submarine program

3D metal printing specialist AML3D (ASX:AL3) has released its half yearly report for the first half of the 2025 financial year (H1 FY25), headlined by the commercialisation push of its patented Wire Additive Manufacturing technology known as ARCEMY.
Highlights for the half-year include:
🥁 Delivers $4.63 million in revenue in H1 FY25, up by 206% from the previous corresponding period
🏭 Opens US technology centre with immediate plans for expansion and an initial $2.27 million utilities contract
🔑 Seals $30 million in funding to facilitate expansion in the US and Europe
🚢 Strengthens partnership with BlueForge Alliance to support US Navy submarine program
Mexican restaurant business Guzman Y Gomez (ASX: GYG) has served up a strong set of numbers in the first half of the 2025 financial year (H1 FY25) headlined by a strong jump in global sales as its ongoing network expansion marches on.
🌮 Delivers 23% year-on-year improvement in global network sales as total number of restaurants rises to 239
🌶️ EBITDA of $32 million in the half-year up by 28% with NPAT of $7.3 million nearly doubling
🥑 Pipeline of more than 100 future restaurants to help drive growth

Mexican restaurant business Guzman Y Gomez (ASX: GYG) has served up a strong set of numbers in the first half of the 2025 financial year (H1 FY25) headlined by a strong jump in global sales as its ongoing network expansion marches on.
🌮 Delivers 23% year-on-year improvement in global network sales as total number of restaurants rises to 239
🌶️ EBITDA of $32 million in the half-year up by 28% with NPAT of $7.3 million nearly doubling
🥑 Pipeline of more than 100 future restaurants to help drive growth
Food and beverage business Retail Food Group (ASX: RFG) has delivered a strong set of numbers in the first half of the 2025 financial year whilst also announcing plans to introduce and expand American premium sandwich brand Firehouse Subs within Australia.
🍩 Underlying revenue of $66.5 million up by 24.7% from the previous corresponding period, driven by core brands such as Gloria Jean’s, Donut King, and Brumby’s
🍕 Statutory net profit after tax of $7.3 million up by nearly 74% year-on-year
🥪 Plans to open 165 Firehouse Subs outlets in Australia over the next decade
“Firehouse Subs is a key pillar of our ambitious growth strategy and we are confident consumers will be excited by the brand’s high-quality sandwich product together with an excellent guest experience.” – Matt Marshall, Retail Food Group Chief Executive Officer

Food and beverage business Retail Food Group (ASX: RFG) has delivered a strong set of numbers in the first half of the 2025 financial year whilst also announcing plans to introduce and expand American premium sandwich brand Firehouse Subs within Australia.
🍩 Underlying revenue of $66.5 million up by 24.7% from the previous corresponding period, driven by core brands such as Gloria Jean’s, Donut King, and Brumby’s
🍕 Statutory net profit after tax of $7.3 million up by nearly 74% year-on-year
🥪 Plans to open 165 Firehouse Subs outlets in Australia over the next decade
“Firehouse Subs is a key pillar of our ambitious growth strategy and we are confident consumers will be excited by the brand’s high-quality sandwich product together with an excellent guest experience.” – Matt Marshall, Retail Food Group Chief Executive Officer
Optiscan Imaging (ASX:OIL) has unveiled its next generation microscopic medical imaging device known as InForm, specifically designed to transform pathology workflows by delivering real-time digital insights at point of contact with a tissue sample.
🔹Improves efficiency and accuracy of analysis and diagnosis across all pathology workflows.
🔹Expands Optiscan’s product portfolio into the pathology market, marking a pivotal milestone in advancing the company`s strategic objectives.
🔹Enhances the entire pathology workflow across a range of settings, enabling efficiencies and on-the-spot digital decision making for pathologists to improve diagnostic capabilities.
“The reveal of our revolutionary InForm™ device, the latest addition to our ever-expanding suite of hardware products, represents a significant advancement in the evolution of digital pathology. InForm™ has the ability to enhance the entire pathology workflow from bedside to laboratory and beyond, by improving the speed, accuracy and flexibility of testing, analysis and diagnosis." - Optiscan CEO and Managing Director, Dr Camile Farah

Optiscan Imaging (ASX:OIL) has unveiled its next generation microscopic medical imaging device known as InForm, specifically designed to transform pathology workflows by delivering real-time digital insights at point of contact with a tissue sample.
🔹Improves efficiency and accuracy of analysis and diagnosis across all pathology workflows.
🔹Expands Optiscan’s product portfolio into the pathology market, marking a pivotal milestone in advancing the company`s strategic objectives.
🔹Enhances the entire pathology workflow across a range of settings, enabling efficiencies and on-the-spot digital decision making for pathologists to improve diagnostic capabilities.
“The reveal of our revolutionary InForm™ device, the latest addition to our ever-expanding suite of hardware products, represents a significant advancement in the evolution of digital pathology. InForm™ has the ability to enhance the entire pathology workflow from bedside to laboratory and beyond, by improving the speed, accuracy and flexibility of testing, analysis and diagnosis." - Optiscan CEO and Managing Director, Dr Camile Farah
Baby goods retailer Baby Bunting (ASX: BBN) has reported a boost in profitability in the first half of the 2025 financial year driven by an uptick in sales, a rise in new customer acquisitions, and gross margin expansion. The company is implementing a series of strategic initiatives to fuel further growth.
👶 Net profit after tax (NPAT) of $4.8 million on a pro-forma basis up by 37% from same time last year as new customer acquisitions rise by 12%
🍼 Gross margin expands by 260 basis points to 39.8 per cent with the company on track to meet its margin target for the full financial year
🧸 Progresses new store rollout and refurbishment of existing shops to fuel growth
“Our focus on driving sales through range innovation and new customer acquisition is delivering results. Newness in our ranges continues to resonate, with new customer acquisition up 12% on the prior period. Our exclusive branded products remain a key traffic driver and, with a strong pipeline of exclusive launches in the second half, we expect this momentum to continue.” – Mark Teperson, Baby Bunting Chief Executive Officer

Baby goods retailer Baby Bunting (ASX: BBN) has reported a boost in profitability in the first half of the 2025 financial year driven by an uptick in sales, a rise in new customer acquisitions, and gross margin expansion. The company is implementing a series of strategic initiatives to fuel further growth.
👶 Net profit after tax (NPAT) of $4.8 million on a pro-forma basis up by 37% from same time last year as new customer acquisitions rise by 12%
🍼 Gross margin expands by 260 basis points to 39.8 per cent with the company on track to meet its margin target for the full financial year
🧸 Progresses new store rollout and refurbishment of existing shops to fuel growth
“Our focus on driving sales through range innovation and new customer acquisition is delivering results. Newness in our ranges continues to resonate, with new customer acquisition up 12% on the prior period. Our exclusive branded products remain a key traffic driver and, with a strong pipeline of exclusive launches in the second half, we expect this momentum to continue.” – Mark Teperson, Baby Bunting Chief Executive Officer
Australian retailer Adore Beauty (ASX: ABY) has reported a sharp rise in profitability and margin growth in the first half of FY25 as its refreshed operational strategy focused on disciplined cost management and the expansion of its retail network begins to take shape.
💄 Operating earnings (EBIT) of $2.8 million in H1 FY25 up by 126% from same time last year
🧴 Delivers cash flow positive half-year and record gross margin of 36.2%
💅 Launches physical store roll out with opening of first shop in Victoria as it targets national retail network of 25 shops
“Our half-year results demonstrate the strength of the Adore Beauty brand and the early momentum of our strategy refresh focusing in the near-term on enhancing quality of earnings and optimising our operating model. I am delighted with the demonstrated gains in gross margin which delivered material improvement and the subsequent 126% growth in EBIT in the half.” – Sacha Laing, Adore Beauty Chief Executive Officer

Australian retailer Adore Beauty (ASX: ABY) has reported a sharp rise in profitability and margin growth in the first half of FY25 as its refreshed operational strategy focused on disciplined cost management and the expansion of its retail network begins to take shape.
💄 Operating earnings (EBIT) of $2.8 million in H1 FY25 up by 126% from same time last year
🧴 Delivers cash flow positive half-year and record gross margin of 36.2%
💅 Launches physical store roll out with opening of first shop in Victoria as it targets national retail network of 25 shops
“Our half-year results demonstrate the strength of the Adore Beauty brand and the early momentum of our strategy refresh focusing in the near-term on enhancing quality of earnings and optimising our operating model. I am delighted with the demonstrated gains in gross margin which delivered material improvement and the subsequent 126% growth in EBIT in the half.” – Sacha Laing, Adore Beauty Chief Executive Officer
Ahead of appearing at the Stocks On Track event, Kingston Resources (ASX:KSN) Managing Director Andrew Corbett speaks with The Stock Network`s Lel Smits and highlights:
⛏️ Rising gold price and operations
⚒️ Maiden underground Ore Reserve at Mineral Hill
⛰️ Mineral Hill upside

Ahead of appearing at the Stocks On Track event, Kingston Resources (ASX:KSN) Managing Director Andrew Corbett speaks with The Stock Network`s Lel Smits and highlights:
⛏️ Rising gold price and operations
⚒️ Maiden underground Ore Reserve at Mineral Hill
⛰️ Mineral Hill upside
Medical technology business Artrya (ASX: AYA) has pocketed $15 million from a placement as it looks to fast track the commercialisation of its patented Salix artificial intelligence (AI) platform used to detect heart disease.
⚕️ Proceeds will be used to accelerate regulatory approvals in the lucrative US market, as well as customer implementation, clinical studies, and regulatory costs
🧑⚕️ Clearance from the US Food and Drug Administration (FDA) expected soon
🏥 Adds to recent contract win with Australia’s second largest diagnostic imaging provider, Sonic Healthcare
“The Company continues the regulatory pathway to expand FDA approvals this year with a portion of Placement proceeds applied to accelerate regulatory applications for our SCP & SCF products, along with customer implementation costs including the Sonic Healthcare Australia Radiology commercial agreement announced on 12 February 2025.” – Mathew Regan, Artrya Chief Executive Officer

Medical technology business Artrya (ASX: AYA) has pocketed $15 million from a placement as it looks to fast track the commercialisation of its patented Salix artificial intelligence (AI) platform used to detect heart disease.
⚕️ Proceeds will be used to accelerate regulatory approvals in the lucrative US market, as well as customer implementation, clinical studies, and regulatory costs
🧑⚕️ Clearance from the US Food and Drug Administration (FDA) expected soon
🏥 Adds to recent contract win with Australia’s second largest diagnostic imaging provider, Sonic Healthcare
“The Company continues the regulatory pathway to expand FDA approvals this year with a portion of Placement proceeds applied to accelerate regulatory applications for our SCP & SCF products, along with customer implementation costs including the Sonic Healthcare Australia Radiology commercial agreement announced on 12 February 2025.” – Mathew Regan, Artrya Chief Executive Officer
Health and fitness club provider Viva Leisure (ASX: VVA) has delivered a strong set of numbers for the first half of the 2025 financial year with membership growth and network expansion propelling revenue and profitability to record levels.
🏋️ Revenue up by 25% from the same time last year as memberships soar by 72%
💪 Operating earnings (EBITDA) up by 26% year-on-year with net profit after tax up by 15%
🏃♀️ Prioritising free cash flow generation, network optimisation, and expansion of technology-driven offerings to drive further growth
“1H FY25 has been a phenomenal period for Viva Leisure, with record-breaking results reflecting the strength of our diversified strategy and the resilience of our business model. Our expanding corporate and franchise network, combined with our high-margin technology and payments division, continues to drive sustainable and profitable growth.” – Harry Konstantinou, Viva Leisure Chief Executive Officer and Managing Director

Health and fitness club provider Viva Leisure (ASX: VVA) has delivered a strong set of numbers for the first half of the 2025 financial year with membership growth and network expansion propelling revenue and profitability to record levels.
🏋️ Revenue up by 25% from the same time last year as memberships soar by 72%
💪 Operating earnings (EBITDA) up by 26% year-on-year with net profit after tax up by 15%
🏃♀️ Prioritising free cash flow generation, network optimisation, and expansion of technology-driven offerings to drive further growth
“1H FY25 has been a phenomenal period for Viva Leisure, with record-breaking results reflecting the strength of our diversified strategy and the resilience of our business model. Our expanding corporate and franchise network, combined with our high-margin technology and payments division, continues to drive sustainable and profitable growth.” – Harry Konstantinou, Viva Leisure Chief Executive Officer and Managing Director
If you like to buy at Chemist Warehouse you may be interested to know that from today, it today became part of a listed company. Sigma Healthcare is the listed company that merged with Chemist Warehouse, debuting today as a merged entity trading under the code SIG.

If you like to buy at Chemist Warehouse you may be interested to know that from today, it today became part of a listed company. Sigma Healthcare is the listed company that merged with Chemist Warehouse, debuting today as a merged entity trading under the code SIG.
Diversified digital health platform business Vitura Health (ASX: VIT) has sealed $5.1 million from a strategic placement to fund its new acquisition of leading Australian medicinal cannabis clinic business, Candor Medical.
🧑⚕️ Propels Vitura into one of Australia’s largest medicinal cannabis clinic providers by growing its consolidated consultation numbers to more than 100,000 each year
💊 Expands Vitura’s specialty healthcare division with the deal expected to deliver a material boost to revenue and operating earnings (EBITDA)
🥼 Backed by $5.1 million placement to an entity associated with renowned high-net-worth businessman, Professor Khalil Shahin
“We are very excited by the opportunities unlocked by this acquisition which we see as a great opportunity to bring together two leaders in the field, both of whom have a deep alignment on the commitment to providing patients with personalised care and which reinforces our goal to make specialty healthcare product and service verticals more accessible to millions of patients across Australia.” – Geoff Cockerill, Vitura Health Chief Executive Officer

Diversified digital health platform business Vitura Health (ASX: VIT) has sealed $5.1 million from a strategic placement to fund its new acquisition of leading Australian medicinal cannabis clinic business, Candor Medical.
🧑⚕️ Propels Vitura into one of Australia’s largest medicinal cannabis clinic providers by growing its consolidated consultation numbers to more than 100,000 each year
💊 Expands Vitura’s specialty healthcare division with the deal expected to deliver a material boost to revenue and operating earnings (EBITDA)
🥼 Backed by $5.1 million placement to an entity associated with renowned high-net-worth businessman, Professor Khalil Shahin
“We are very excited by the opportunities unlocked by this acquisition which we see as a great opportunity to bring together two leaders in the field, both of whom have a deep alignment on the commitment to providing patients with personalised care and which reinforces our goal to make specialty healthcare product and service verticals more accessible to millions of patients across Australia.” – Geoff Cockerill, Vitura Health Chief Executive Officer
BTC Health (ASX:BTC) has appointed Salesh Balak as Chief Financial Officer and Company Secretary, effective 17 March 2025. It has also appointed its current Head of Finance, Josh Kahanovitz, into the role of Chief Operating Officer.
🥼 Mr Balak joins BTC Health from Universal Biosensors Australia where he was the Chief Financial Officer and Company Secretary for more than 18 years
🩺 He is a member of the Institute of Chartered Accountants and Certified Practicing Accountants
💉 The appointment reflects the underlying expansion of the BTC Health business
“I am delighted to welcome Salesh to BTC. He brings significant international experience applicable to high-growth companies in the healthcare and medical sectors. He joins us at an exciting time in BTC’s growth journey and he will be a valuable addition to the leadership team.” - BTC Health Executive Chairman Dr Richard Treagus

BTC Health (ASX:BTC) has appointed Salesh Balak as Chief Financial Officer and Company Secretary, effective 17 March 2025. It has also appointed its current Head of Finance, Josh Kahanovitz, into the role of Chief Operating Officer.
🥼 Mr Balak joins BTC Health from Universal Biosensors Australia where he was the Chief Financial Officer and Company Secretary for more than 18 years
🩺 He is a member of the Institute of Chartered Accountants and Certified Practicing Accountants
💉 The appointment reflects the underlying expansion of the BTC Health business
“I am delighted to welcome Salesh to BTC. He brings significant international experience applicable to high-growth companies in the healthcare and medical sectors. He joins us at an exciting time in BTC’s growth journey and he will be a valuable addition to the leadership team.” - BTC Health Executive Chairman Dr Richard Treagus
Healthcare technology business Alcidion (ASX: ALC) has sealed a $5.5 million agreement with the Hywel Dda University Health Board in Wales for the provision of its Miya Precision Platform.
⚕️ Represents Alcidion’s first contract win with a Health Board in Wales
🧑⚕️ Hywel Dda provides primary, secondary and community and dental health services to about 380,000 people in Wales
🏥 Miya Precision Platform helps optimise resource allocation, provides clearer insights into vital signs in patients, and streamlines their journeys
“Introducing Alcidion’s Miya Precision Platform will support Hywel Dda to centralise and digitise essential patient information, optimising multiple inputs of clinical information and patient care metrics across its diverse service network to support improved patient flow and capacity management as well as clinical management of deteriorating patients.” – Kate Quirke, Alcidion Chief Executive Officer and Managing Director

Healthcare technology business Alcidion (ASX: ALC) has sealed a $5.5 million agreement with the Hywel Dda University Health Board in Wales for the provision of its Miya Precision Platform.
⚕️ Represents Alcidion’s first contract win with a Health Board in Wales
🧑⚕️ Hywel Dda provides primary, secondary and community and dental health services to about 380,000 people in Wales
🏥 Miya Precision Platform helps optimise resource allocation, provides clearer insights into vital signs in patients, and streamlines their journeys
“Introducing Alcidion’s Miya Precision Platform will support Hywel Dda to centralise and digitise essential patient information, optimising multiple inputs of clinical information and patient care metrics across its diverse service network to support improved patient flow and capacity management as well as clinical management of deteriorating patients.” – Kate Quirke, Alcidion Chief Executive Officer and Managing Director
Medication management specialist Careteq (ASX: CTQ) has entered a strategic partnership with MedicAlert Foundation Australia designed to improve medication safety for Australians living with complex health conditions.
⚕️ Enhances access to critical healthcare services offered by both organisations, including Careteq`s Home Medication Reviews (HMRs)
🧑⚕️ Careteq`s clients to benefit from MedicAlert`s life-saving medical identification products and around-the-clock emergency response hotline
💊 Addresses shortfall of more than 500,000 at-risk individuals who don’t receive the medication reviews they require
“Our partnership with MedicAlert aligns perfectly with our goal of preventing medication-related harm. By raising awareness of the benefits of HMRs, we hope to enhance health outcomes for all Australians.” – Mark Simari, Careteq Executive Chairman

Medication management specialist Careteq (ASX: CTQ) has entered a strategic partnership with MedicAlert Foundation Australia designed to improve medication safety for Australians living with complex health conditions.
⚕️ Enhances access to critical healthcare services offered by both organisations, including Careteq`s Home Medication Reviews (HMRs)
🧑⚕️ Careteq`s clients to benefit from MedicAlert`s life-saving medical identification products and around-the-clock emergency response hotline
💊 Addresses shortfall of more than 500,000 at-risk individuals who don’t receive the medication reviews they require
“Our partnership with MedicAlert aligns perfectly with our goal of preventing medication-related harm. By raising awareness of the benefits of HMRs, we hope to enhance health outcomes for all Australians.” – Mark Simari, Careteq Executive Chairman
PARKD (ASX: PKD) has sealed an exclusive licencing agreement with Fielders Steel Roofing - a division of BlueScope Steel - for the IP related to its innovative metal decking support bracket (MDSB) and metal deck support system (MDSS) used in the construction of car parks and other commercial structures.
🏗️ Grants Fielders an exclusive five year licence to manufacture, market, distribute, and sell the MDSB and MDSS within Australia
🧱 Creates confidence for immediate go-to-market strategy in Australia and expands PARKD’s addressable market and possible applications of its IP
🔨 Fielders has first right to negotiate additional licences for targeted international markets including the US, New Zealand, Indonesia, Japan, and India
“PARKD recognised the potential, its simple, yet ingenious connection system could present to the broader construction market. This small yet critical invention is the key to unlock the aspirations of the construction sector to meaningfully improve safety, productivity, costs and particularly sustainability goals of the government and private sectors.” – Peter McUtchen, PARKD Managing Director

PARKD (ASX: PKD) has sealed an exclusive licencing agreement with Fielders Steel Roofing - a division of BlueScope Steel - for the IP related to its innovative metal decking support bracket (MDSB) and metal deck support system (MDSS) used in the construction of car parks and other commercial structures.
🏗️ Grants Fielders an exclusive five year licence to manufacture, market, distribute, and sell the MDSB and MDSS within Australia
🧱 Creates confidence for immediate go-to-market strategy in Australia and expands PARKD’s addressable market and possible applications of its IP
🔨 Fielders has first right to negotiate additional licences for targeted international markets including the US, New Zealand, Indonesia, Japan, and India
“PARKD recognised the potential, its simple, yet ingenious connection system could present to the broader construction market. This small yet critical invention is the key to unlock the aspirations of the construction sector to meaningfully improve safety, productivity, costs and particularly sustainability goals of the government and private sectors.” – Peter McUtchen, PARKD Managing Director
Digital payments and financial services provider Findi Limited (ASX: FND) has locked in a seven year deal with Union Bank of India (UBI) for the deployment of an additional 900 ATMs across India.
🏧 Lifts the number of brown label ATMs operated by Findi in India to nearly 9,000
🏦Delivers more than $75 million in revenue and up to $38 million in operating earnings (EBITDA) for the company
💳 Findi will also hold close to 5,000 white label ATMs in India once its acquisition of Tata Communications Payment is concluded
“Findi is delighted to deepen the long-term relationship we have with Union Bank of India, and it is pleasing that we have again been entrusted by one of India’s largest banks to continue providing ATMs.” – Nicholas Smedley, Findi Limited Executive Chairman

Digital payments and financial services provider Findi Limited (ASX: FND) has locked in a seven year deal with Union Bank of India (UBI) for the deployment of an additional 900 ATMs across India.
🏧 Lifts the number of brown label ATMs operated by Findi in India to nearly 9,000
🏦Delivers more than $75 million in revenue and up to $38 million in operating earnings (EBITDA) for the company
💳 Findi will also hold close to 5,000 white label ATMs in India once its acquisition of Tata Communications Payment is concluded
“Findi is delighted to deepen the long-term relationship we have with Union Bank of India, and it is pleasing that we have again been entrusted by one of India’s largest banks to continue providing ATMs.” – Nicholas Smedley, Findi Limited Executive Chairman
Vection Technologies (ASX: VR1), a specialist in artificial intelligence (AI) and extended reality (XR) solutions, has sealed a $4 million contract extension with an existing defence sector client, adding to two other contract wins with the customer.
🥽 Highlights the group’s ability to enhance national security efforts by integrating cutting-edge AI capabilities
🤖 Enables real-time data processing and analysis for the client’s large-scale distributed infrastructure design projects
🧠 Builds momentum for Vection’s new AI capability and its partnership with global IT heavyweight Dell Technologies
“Our alignment with Dell Technologies further exemplifies the value of collaborative partnerships with industry leaders. Together, we are dedicated to pushing the boundaries of real-time data processing and driving meaningful innovation for high-performance intelligence and law enforcement operations.” – Gianmarco Biagi, Vection Technologies Managing Director
ASX announcement ⚡ https://announcements.asx.com.au/asxpdf/20250205/pdf/06f67yfwj74tzw.pdf

Vection Technologies (ASX: VR1), a specialist in artificial intelligence (AI) and extended reality (XR) solutions, has sealed a $4 million contract extension with an existing defence sector client, adding to two other contract wins with the customer.
🥽 Highlights the group’s ability to enhance national security efforts by integrating cutting-edge AI capabilities
🤖 Enables real-time data processing and analysis for the client’s large-scale distributed infrastructure design projects
🧠 Builds momentum for Vection’s new AI capability and its partnership with global IT heavyweight Dell Technologies
“Our alignment with Dell Technologies further exemplifies the value of collaborative partnerships with industry leaders. Together, we are dedicated to pushing the boundaries of real-time data processing and driving meaningful innovation for high-performance intelligence and law enforcement operations.” – Gianmarco Biagi, Vection Technologies Managing Director
ASX announcement ⚡ https://announcements.asx.com.au/asxpdf/20250205/pdf/06f67yfwj74tzw.pdf
A study testing the efficacy of Argenica Therapeutics’ (ASX: AGN) leading drug known as ARG-007 has displayed significant neuroprotection in traumatic brain injury (TBI). The broadened pre-clinical rat study measuring axonal injury and neuroinflammation has shown ARG-007 to significantly reduce brain cell damage.
💊 Results suggest ARG-007 reduces axonal injury and neuroinflammation following TBI to similar levels seen in non-injured animals
🧪 ARG-007 could be effective treatment strategy for preserving normal motor coordination and hold other benefits like restoring normal body weight in recipients
🧬 Argenica estimates the addressable market for treatment of TBI with ARG-007 could reach US$18.6 billion by 2031
“We are extremely pleased with the results from this larger preclinical study in a moderate TBI animal model. The study confirms previously generated data, indicating that ARG-007 consistently reduces axonal injury and neuroinflammation following TBI, and encouragingly to levels similar to non-injured animals.”
Dr Liz Dallimore, Argenica Therapeutics Managing Director

A study testing the efficacy of Argenica Therapeutics’ (ASX: AGN) leading drug known as ARG-007 has displayed significant neuroprotection in traumatic brain injury (TBI). The broadened pre-clinical rat study measuring axonal injury and neuroinflammation has shown ARG-007 to significantly reduce brain cell damage.
💊 Results suggest ARG-007 reduces axonal injury and neuroinflammation following TBI to similar levels seen in non-injured animals
🧪 ARG-007 could be effective treatment strategy for preserving normal motor coordination and hold other benefits like restoring normal body weight in recipients
🧬 Argenica estimates the addressable market for treatment of TBI with ARG-007 could reach US$18.6 billion by 2031
“We are extremely pleased with the results from this larger preclinical study in a moderate TBI animal model. The study confirms previously generated data, indicating that ARG-007 consistently reduces axonal injury and neuroinflammation following TBI, and encouragingly to levels similar to non-injured animals.”
Dr Liz Dallimore, Argenica Therapeutics Managing Director
Motion analysis device specialist @dorsavi (ASX: DVL) has entered a commercial research project with heralded American physician Dr Chiarg Patel to study athlete movement patterns using the company’s wearable sensor technology.
🏈 The study will assess patterns and traits that could increase the risk of foot and ankle injury in elite athletes
🦶 Dr Patel is regarded as a global authority in lower extremity sports medicine, specialising in injury prevention, performance optimisation, and athlete longevity
🏀 Expected to generate close to US$50,000 in revenue for the company, with potential for a broadened collaboration
🛡️ Integration of blockchain technology to enhance security and compliance could benefit data generated in the study

Motion analysis device specialist @dorsavi (ASX: DVL) has entered a commercial research project with heralded American physician Dr Chiarg Patel to study athlete movement patterns using the company’s wearable sensor technology.
🏈 The study will assess patterns and traits that could increase the risk of foot and ankle injury in elite athletes
🦶 Dr Patel is regarded as a global authority in lower extremity sports medicine, specialising in injury prevention, performance optimisation, and athlete longevity
🏀 Expected to generate close to US$50,000 in revenue for the company, with potential for a broadened collaboration
🛡️ Integration of blockchain technology to enhance security and compliance could benefit data generated in the study
Leading Australian home builder Simonds Group (ASX: SIO) has entered an agreement to acquire Dennis Family Homes in a $10 million deal from respected property development company owned by the Dennis family.
🏡 The deal is set to double Simonds Group’s existing product portfolio and significantly expand its market reach in Australia
🛠️ Expected to deliver $200 million in additional revenue for Simonds Group by FY26
🏗️ Could support future sales by expanding Simonds Group’s footprint across Victoria by about 40%
“In a time of increasing demand for accessible housing options, this acquisition enables us to scale up with a robust product line that meets the needs of first-time buyers, growing families, and downsizers alike.” – David McKeown, Simonds Group Chief Executive Officer

Leading Australian home builder Simonds Group (ASX: SIO) has entered an agreement to acquire Dennis Family Homes in a $10 million deal from respected property development company owned by the Dennis family.
🏡 The deal is set to double Simonds Group’s existing product portfolio and significantly expand its market reach in Australia
🛠️ Expected to deliver $200 million in additional revenue for Simonds Group by FY26
🏗️ Could support future sales by expanding Simonds Group’s footprint across Victoria by about 40%
“In a time of increasing demand for accessible housing options, this acquisition enables us to scale up with a robust product line that meets the needs of first-time buyers, growing families, and downsizers alike.” – David McKeown, Simonds Group Chief Executive Officer
Australia’s leading online pet ecosystem Mad Paws (ASX: MPA) has reported a strong lift in earnings in the second quarter of the 2025 financial year (FY25) as its recently launched promotional campaign in the mainstream media gathers traction.
🐶 Cash operating earnings (EBITDA) up by more than 300% from the same time last year as maiden brand campaign shifts up a gear
🐱 Operating cash flow up by 81 per cent from previous corresponding period
🐰 Retains healthy media budget to build awareness and accelerate growth for its wide array of pet services and products
“Our unwavering focus on profitability has delivered a Cash EBITDA of $0.3 million for the quarter — a 328% improvement compared to the prior corresponding period. This milestone also positions the Mad Paws Group as Cash EBITDA positive for the first half of FY25.” – Justus Hammer, Mad Paws Co-founder and Chief Executive Officer

Australia’s leading online pet ecosystem Mad Paws (ASX: MPA) has reported a strong lift in earnings in the second quarter of the 2025 financial year (FY25) as its recently launched promotional campaign in the mainstream media gathers traction.
🐶 Cash operating earnings (EBITDA) up by more than 300% from the same time last year as maiden brand campaign shifts up a gear
🐱 Operating cash flow up by 81 per cent from previous corresponding period
🐰 Retains healthy media budget to build awareness and accelerate growth for its wide array of pet services and products
“Our unwavering focus on profitability has delivered a Cash EBITDA of $0.3 million for the quarter — a 328% improvement compared to the prior corresponding period. This milestone also positions the Mad Paws Group as Cash EBITDA positive for the first half of FY25.” – Justus Hammer, Mad Paws Co-founder and Chief Executive Officer
AML3D (ASX: AL3), a leader in large scale Wire Additive Manufacturing technology and 3D metal printing solutions, has reported a series of key outcomes during the December quarter of the 2025 financial year (FY25) as its commercialisation push targeting the defence sector accelerates.
🏭 Opened US manufacturing facility for its advanced manufacturing technology solutions targeting the defence sector, with immediate plans for expansion
🔑 Locked in $30 million in funding to facilitate increased production of its specialist metal products and drive the company’s next growth phase
🚢 Nailed down a series of key US Navy and Australian defence contracts
🛡️ Initiated plans to enter European market targeting significant contract growth across defence, utility, oil & gas, marine and aerospace sectors

AML3D (ASX: AL3), a leader in large scale Wire Additive Manufacturing technology and 3D metal printing solutions, has reported a series of key outcomes during the December quarter of the 2025 financial year (FY25) as its commercialisation push targeting the defence sector accelerates.
🏭 Opened US manufacturing facility for its advanced manufacturing technology solutions targeting the defence sector, with immediate plans for expansion
🔑 Locked in $30 million in funding to facilitate increased production of its specialist metal products and drive the company’s next growth phase
🚢 Nailed down a series of key US Navy and Australian defence contracts
🛡️ Initiated plans to enter European market targeting significant contract growth across defence, utility, oil & gas, marine and aerospace sectors
Adventure tourism specialist Experience Co (ASX: EXP) has served up a strong set of numbers in Q2 FY25, showcased by robust revenue growth across both its operating segments and improved earnings stemming from cost optimisation initiatives.
🪂 Revenue for the quarter up by 14% from same time last year on the back of rising volumes for the company’s wide range of adventure experiences
🤿 Operating earnings (EBITDA) in Q2 FY25 up by 46% from a year ago as cost optimisation initiatives gain traction
✈️ EBITDA in the first half of FY25 up by 51 per cent, with the business free cash flow positive during the period
🏖️ Solid start to calendar year with recovery in international tourists to Australia expected to benefit volumes across the business

Adventure tourism specialist Experience Co (ASX: EXP) has served up a strong set of numbers in Q2 FY25, showcased by robust revenue growth across both its operating segments and improved earnings stemming from cost optimisation initiatives.
🪂 Revenue for the quarter up by 14% from same time last year on the back of rising volumes for the company’s wide range of adventure experiences
🤿 Operating earnings (EBITDA) in Q2 FY25 up by 46% from a year ago as cost optimisation initiatives gain traction
✈️ EBITDA in the first half of FY25 up by 51 per cent, with the business free cash flow positive during the period
🏖️ Solid start to calendar year with recovery in international tourists to Australia expected to benefit volumes across the business
Orthopedic imaging specialist CurveBeam AI (ASX: CVB) has locked in a commercial agreement with leading medical technology business Stryker Australia, designed to boost awareness and understanding of the company’s innovative weight bearing CT (WBCT) imaging equipment within its target markets.
🩻 Stryker to educate surgeons about benefits of WBCT scans and help to drive demand for the technology in Australia and New Zealand
🏥 Stryker also tasked with generating sales leads for CurveBeam’s flagship HiRise scanning equipment as part of initial three year deal
🦴 HiRise has unique ability to scan a patient’s hip, pelvis or foot in a weight bearing position, enabling medical professionals to gain detailed insight into bone and joint alignment under natural load conditions
“Stryker’s scale, resources and reach, along with the fact that the collaboration is very synergistic, will be all instrumental in driving surgeon demand for WBCT. We see this demand being met through placing HiRise WBCT scanners with imaging centres and hospitals.” – Greg Brown, CurveBeam AI Chief Executive Officer

Orthopedic imaging specialist CurveBeam AI (ASX: CVB) has locked in a commercial agreement with leading medical technology business Stryker Australia, designed to boost awareness and understanding of the company’s innovative weight bearing CT (WBCT) imaging equipment within its target markets.
🩻 Stryker to educate surgeons about benefits of WBCT scans and help to drive demand for the technology in Australia and New Zealand
🏥 Stryker also tasked with generating sales leads for CurveBeam’s flagship HiRise scanning equipment as part of initial three year deal
🦴 HiRise has unique ability to scan a patient’s hip, pelvis or foot in a weight bearing position, enabling medical professionals to gain detailed insight into bone and joint alignment under natural load conditions
“Stryker’s scale, resources and reach, along with the fact that the collaboration is very synergistic, will be all instrumental in driving surgeon demand for WBCT. We see this demand being met through placing HiRise WBCT scanners with imaging centres and hospitals.” – Greg Brown, CurveBeam AI Chief Executive Officer
4DMedical (ASX: 4DX) has sealed a significant commercial agreement for its respiratory care solutions with leading provider of diagnostic imaging services in Queensland, Qscan Radiology Clinics. The deal follows a successful pilot program.
🩻 Qscan will provide clinicians with access to 4DMedical’s lung function products in select Brisbane practices
🩺 Qscan is regarded as one of Australia’s leading medical imaging providers with 40 clinics across the nation
🧬 The deal adds to a series of other recent contract wins in Australia and the US
“Momentum continues to build with the commercialisation of our technology across the US and Australia. With the addition of Qscan to our network of providers in Australia, I am excited to see our footprint expand to ensure our cutting-edge technology is now becoming more readily available to all Australians.” – Andreas Fouras, 4DMedical Managing Director and Founder

4DMedical (ASX: 4DX) has sealed a significant commercial agreement for its respiratory care solutions with leading provider of diagnostic imaging services in Queensland, Qscan Radiology Clinics. The deal follows a successful pilot program.
🩻 Qscan will provide clinicians with access to 4DMedical’s lung function products in select Brisbane practices
🩺 Qscan is regarded as one of Australia’s leading medical imaging providers with 40 clinics across the nation
🧬 The deal adds to a series of other recent contract wins in Australia and the US
“Momentum continues to build with the commercialisation of our technology across the US and Australia. With the addition of Qscan to our network of providers in Australia, I am excited to see our footprint expand to ensure our cutting-edge technology is now becoming more readily available to all Australians.” – Andreas Fouras, 4DMedical Managing Director and Founder
Hearing health specialist Audeara (ASX: AUA) has launched its co-branded Clinico Sound Earbuds in Taiwan as the group’s strategy of penetrating international markets gathers momentum.
🎧 Successful launch of Clinico Sound Earbuds builds on Audeara`s strategic partnership with Taiwan`s largest hearing aid retailer Clinico
🎶 Clinico Sound Earbuds incorporate Audeara’s proprietary technology which provides tailored soundscapes that meet the unique needs of every individual
🔊 Lays the foundation for Audeara`s strategic expansion into other Asian markets including China
“As the largest hearing aid retailer in Taiwan, Clinico provides the Company with a unique distribution advantage which is expected to expand further now that the product is officially in-market. With this product launch, we have established a strong platform for growth in major Asian markets, further complementing our broader international momentum.” – Dr James Fielding, Audeara Chief Executive Officer and Founder

Hearing health specialist Audeara (ASX: AUA) has launched its co-branded Clinico Sound Earbuds in Taiwan as the group’s strategy of penetrating international markets gathers momentum.
🎧 Successful launch of Clinico Sound Earbuds builds on Audeara`s strategic partnership with Taiwan`s largest hearing aid retailer Clinico
🎶 Clinico Sound Earbuds incorporate Audeara’s proprietary technology which provides tailored soundscapes that meet the unique needs of every individual
🔊 Lays the foundation for Audeara`s strategic expansion into other Asian markets including China
“As the largest hearing aid retailer in Taiwan, Clinico provides the Company with a unique distribution advantage which is expected to expand further now that the product is officially in-market. With this product launch, we have established a strong platform for growth in major Asian markets, further complementing our broader international momentum.” – Dr James Fielding, Audeara Chief Executive Officer and Founder
Biotechnology business Zoono (ASX: ZNO) is advancing numerous significant sale prospects as the group continues to prioritise the development of commercial opportunities in its selected niche markets. More specifically, the company is reporting further strong interest in its technology designed to extend the shelf-life of fresh produce.
🍎 Eight additional supermarket groups and packaging companies joining shelf-life extensions trials being held across 12 countries, lifting the total to 21
🥒 Trials involve a diverse range of customers including supermarket chains, food producers, packaging companies and exporters
🫐 Zoono in discussions with more than 40 supermarket and packaging companies about the adoption of its shelf-life technology
🥦 Shelf-life technology could help reduce food waste globally

Biotechnology business Zoono (ASX: ZNO) is advancing numerous significant sale prospects as the group continues to prioritise the development of commercial opportunities in its selected niche markets. More specifically, the company is reporting further strong interest in its technology designed to extend the shelf-life of fresh produce.
🍎 Eight additional supermarket groups and packaging companies joining shelf-life extensions trials being held across 12 countries, lifting the total to 21
🥒 Trials involve a diverse range of customers including supermarket chains, food producers, packaging companies and exporters
🫐 Zoono in discussions with more than 40 supermarket and packaging companies about the adoption of its shelf-life technology
🥦 Shelf-life technology could help reduce food waste globally
Traffic Technologies (ASX: TTI), an Australian manufacturer of traffic related products and services, has locked in a five year contract with the City of Sydney Council for the provision of its innovative ‘Smart City IoT’ ready LED streetlights.
🚦 Five year deal worth up to $3 million with an option to extend to $5 million over nine years
💡 Traffic Technologies to replace existing streetlights along roads, parks, plazas, laneways, and footways in the City of Sydney
🏢 Agreement covers the Sydney CBD and surrounding inner suburbs of the greater metropolitan area which host more than 16,000 streetlights
“The award of this contract to one of the most prestigious local government areas in Australia is a fantastic vote of confidence in the Company’s state of the art LED streetlights. The length of the contract provides an opportunity for the Company to supply a range of additional products throughout the Sydney area.” – Con Liostas, Traffic Technologies Managing Director

Traffic Technologies (ASX: TTI), an Australian manufacturer of traffic related products and services, has locked in a five year contract with the City of Sydney Council for the provision of its innovative ‘Smart City IoT’ ready LED streetlights.
🚦 Five year deal worth up to $3 million with an option to extend to $5 million over nine years
💡 Traffic Technologies to replace existing streetlights along roads, parks, plazas, laneways, and footways in the City of Sydney
🏢 Agreement covers the Sydney CBD and surrounding inner suburbs of the greater metropolitan area which host more than 16,000 streetlights
“The award of this contract to one of the most prestigious local government areas in Australia is a fantastic vote of confidence in the Company’s state of the art LED streetlights. The length of the contract provides an opportunity for the Company to supply a range of additional products throughout the Sydney area.” – Con Liostas, Traffic Technologies Managing Director
Biopharmaceutical business Immuron (ASX:IMC) has served up a stellar set of numbers for the December quarter of the 2025 financial year, showcased by surging sales in Australia and North America for its Travelan product used to treat mild gastro-intestinal disorders.
📢 Total Travelan sales during the quarter up by nearly 250% from a year ago
⚕️Travelan sales in Australia up by more than 300% on the back of broadened product ranging in pharmacy chains
💊 Travelan sales in North America up by 130% following robust growth online and in physical retail stores
“We are achieving strong growth in both Australia and North America reflecting the core ranging we secured in another nine pharmacy banner groups in Australia, distribution in ten pharmacy/grocery retailers in Canada and sales growth on amazon.com in the US.” – Flavio Palumbo, Immuron Chief Commercial Officer
ASX announcement ⚡
https://announcements.asx.com.au/asxpdf/20250117/pdf/06dm5s0svt54n4.pdf

Biopharmaceutical business Immuron (ASX:IMC) has served up a stellar set of numbers for the December quarter of the 2025 financial year, showcased by surging sales in Australia and North America for its Travelan product used to treat mild gastro-intestinal disorders.
📢 Total Travelan sales during the quarter up by nearly 250% from a year ago
⚕️Travelan sales in Australia up by more than 300% on the back of broadened product ranging in pharmacy chains
💊 Travelan sales in North America up by 130% following robust growth online and in physical retail stores
“We are achieving strong growth in both Australia and North America reflecting the core ranging we secured in another nine pharmacy banner groups in Australia, distribution in ten pharmacy/grocery retailers in Canada and sales growth on amazon.com in the US.” – Flavio Palumbo, Immuron Chief Commercial Officer
ASX announcement ⚡
https://announcements.asx.com.au/asxpdf/20250117/pdf/06dm5s0svt54n4.pdf
Family safety and communication technology specialist Spacetalk (ASX:SPA) has continued its growth momentum with a sturdy increase in recurring revenue during the second quarter of the 2025 financial year, driven by a rising subscriber base for its paid mobile subscriber offering, Spacetalk Mobile.
🐄 Annual recurring revenue (ARR) up by 12% from the same time last year as Spacetalk Mobile subscriptions jump
🥁 Spacetalk Mobile subscriptions up by 21% from twelve months ago to nearly 40,000 subscribers
🍼 Targeting expansion in international markets and other emerging segments
“The increasing quality of our revenue reflects the strength and resilience of our business model and our ability to deliver consistent value to customers. This strong foundation not only enables us to scale further but also positions us for a capital-light expansion into international markets.” – Simon Crowther, Spacetalk Chief Executive Officer and Managing Director
ASX announcement ⚡
https://announcements.asx.com.au/asxpdf/20250116/pdf/06dl6dp2mpf3bq.pdf
@spacetalk.co

Family safety and communication technology specialist Spacetalk (ASX:SPA) has continued its growth momentum with a sturdy increase in recurring revenue during the second quarter of the 2025 financial year, driven by a rising subscriber base for its paid mobile subscriber offering, Spacetalk Mobile.
🐄 Annual recurring revenue (ARR) up by 12% from the same time last year as Spacetalk Mobile subscriptions jump
🥁 Spacetalk Mobile subscriptions up by 21% from twelve months ago to nearly 40,000 subscribers
🍼 Targeting expansion in international markets and other emerging segments
“The increasing quality of our revenue reflects the strength and resilience of our business model and our ability to deliver consistent value to customers. This strong foundation not only enables us to scale further but also positions us for a capital-light expansion into international markets.” – Simon Crowther, Spacetalk Chief Executive Officer and Managing Director
ASX announcement ⚡
https://announcements.asx.com.au/asxpdf/20250116/pdf/06dl6dp2mpf3bq.pdf
@spacetalk.co
Global medical device specialist Compumedics (ASX: CMP) has delivered record sale orders in the first half of the 2025 financial year driven by strong growth in its US sleep and Neuroscan brain analysis operations.
🛏 Total sale orders up by 55% from the same time last year as growth in US business continues to accelerate
🌙 Sale orders in America up by more than 200% as newly launched Somfit products gain market traction
💤 Global Somfit sale orders up by 70 per cent as penetration in Europe builds
🥁 Sales momentum expected to continue in second half of FY25 as growth initiatives kick into gear
ASX announcement ⚡
https://announcements.asx.com.au/asxpdf/20250115/pdf/06dk15drhpqzsj.pdf

Global medical device specialist Compumedics (ASX: CMP) has delivered record sale orders in the first half of the 2025 financial year driven by strong growth in its US sleep and Neuroscan brain analysis operations.
🛏 Total sale orders up by 55% from the same time last year as growth in US business continues to accelerate
🌙 Sale orders in America up by more than 200% as newly launched Somfit products gain market traction
💤 Global Somfit sale orders up by 70 per cent as penetration in Europe builds
🥁 Sales momentum expected to continue in second half of FY25 as growth initiatives kick into gear
ASX announcement ⚡
https://announcements.asx.com.au/asxpdf/20250115/pdf/06dk15drhpqzsj.pdf
Biopharmaceutical business Telix Pharmaceuticals (ASX: TLX) has reported a surge in revenue during the fourth quarter of the 2024 fiscal year with sales of its cancer diagnostic imaging agent known as Illuccix driving the group’s growth.
🥁 December quarter revenue up by 46% from the same time last year on the back of rising Illuccix sales
🔬 Revenue for the full 2024 financial year up by 55% as Illuccix sales continue to rocket
🧬 Targeting expansion in 2025 with planned launches of multiple new imaging products across key markets
“This has been another great quarter of commercial performance. Strong sales of Illuccix have led Telix to close out the year with revenue above guidance, while significantly progressing our strategic priorities.” – Dr Christian Behrenbruch, Telix Pharmaceuticals Managing Director and Group Chief Executive Officer
ASX announcement ⚡
https://announcements.asx.com.au/asxpdf/20250113/pdf/06dhcy5nm6xx7l.pdf

Biopharmaceutical business Telix Pharmaceuticals (ASX: TLX) has reported a surge in revenue during the fourth quarter of the 2024 fiscal year with sales of its cancer diagnostic imaging agent known as Illuccix driving the group’s growth.
🥁 December quarter revenue up by 46% from the same time last year on the back of rising Illuccix sales
🔬 Revenue for the full 2024 financial year up by 55% as Illuccix sales continue to rocket
🧬 Targeting expansion in 2025 with planned launches of multiple new imaging products across key markets
“This has been another great quarter of commercial performance. Strong sales of Illuccix have led Telix to close out the year with revenue above guidance, while significantly progressing our strategic priorities.” – Dr Christian Behrenbruch, Telix Pharmaceuticals Managing Director and Group Chief Executive Officer
ASX announcement ⚡
https://announcements.asx.com.au/asxpdf/20250113/pdf/06dhcy5nm6xx7l.pdf
MyEco Group (ASX: MCO), a leading developer and manufacturer of sustainable packaging materials, has reported a strong set of numbers in the second quarter of the 2025 financial year headlined by record quarterly sales for its namesake business unit.
🥁 Generated $4.1 million in total sales for the quarter, up by 32% from the same time last year
🌳Delivered $1.6 million in global sales for its MyEco branded products, up by 156% from twelve months prior
♻️ Produced $1.3 million in sales in it ‘Council and Waste Management’ division, up by 55% from a year ago
🌱 Total group sales expected to keep growing in the second half of FY25
ASX announcement ⚡
https://announcements.asx.com.au/asxpdf/20250113/pdf/06dgpfrpcf6qs0.pdf
@myeco_group

MyEco Group (ASX: MCO), a leading developer and manufacturer of sustainable packaging materials, has reported a strong set of numbers in the second quarter of the 2025 financial year headlined by record quarterly sales for its namesake business unit.
🥁 Generated $4.1 million in total sales for the quarter, up by 32% from the same time last year
🌳Delivered $1.6 million in global sales for its MyEco branded products, up by 156% from twelve months prior
♻️ Produced $1.3 million in sales in it ‘Council and Waste Management’ division, up by 55% from a year ago
🌱 Total group sales expected to keep growing in the second half of FY25
ASX announcement ⚡
https://announcements.asx.com.au/asxpdf/20250113/pdf/06dgpfrpcf6qs0.pdf
@myeco_group
Mineral explorer Sabre Resources (ASX: SBR) has unveiled results from a geochemical aircore drilling program testing a series of targets prospective for gold and nickel-copper-cobalt mineralisation at its Sherlock Bay project in the prolific northwest Pilbara region of WA.
⛏️ The drilling returned significant copper intersections with anomalous gold, cobalt, and nickel along an 800m strike length
🪨 New drill hits are located southwest of previous gold and nickel-copper-cobalt bearing sulphide intercepts, and in proximity to the company’s existing Sherlock Bay Ni-Cu-Co Mineral Resource
🚧 The results indicate potential for a broad copper bearing sulphide zone which remains open and appears to be increasing in grade to the west towards the company’s new tenement application at the project
ASX announcement ⚡ https://announcements.asx.com.au/asxpdf/20250109/pdf/06dd34lkk61ycb.pdf

Mineral explorer Sabre Resources (ASX: SBR) has unveiled results from a geochemical aircore drilling program testing a series of targets prospective for gold and nickel-copper-cobalt mineralisation at its Sherlock Bay project in the prolific northwest Pilbara region of WA.
⛏️ The drilling returned significant copper intersections with anomalous gold, cobalt, and nickel along an 800m strike length
🪨 New drill hits are located southwest of previous gold and nickel-copper-cobalt bearing sulphide intercepts, and in proximity to the company’s existing Sherlock Bay Ni-Cu-Co Mineral Resource
🚧 The results indicate potential for a broad copper bearing sulphide zone which remains open and appears to be increasing in grade to the west towards the company’s new tenement application at the project
ASX announcement ⚡ https://announcements.asx.com.au/asxpdf/20250109/pdf/06dd34lkk61ycb.pdf
Australian food and beverage company SPC Global (ASX: SPG) has locked in a 10-year exclusivity agreement with leading Asian retailer Dairy Farm Company through its international business division, Nature One Dairy (NOD). The deal will see NOD’s dairy products accessible in more than 320 outlets in Hong Kong and Macau.
🐄 NOD will supply dairy products across the Mannings retail network – Hong Kong’s largest health and beauty retail chain
🥁 Expected to generate $250 million in revenue during the term of the agreement
🍼 Marks a significant milestone for NOD`s functional powdered milk division
“This partnership highlights NOD`s dedication to delivering premium products worldwide, while further strengthening its position throughout Asia. With our recently announced merger and the exclusive partnership with Mannings now in place, NOD is set to play a central role in SPC Global`s vision of building a global food powerhouse.” – Robert Iervasi, SPC Global Managing Director
ASX announcement ⚡
https://announcements.asx.com.au/asxpdf/20250106/pdf/06d8r0g17cfvhj.pdf

Australian food and beverage company SPC Global (ASX: SPG) has locked in a 10-year exclusivity agreement with leading Asian retailer Dairy Farm Company through its international business division, Nature One Dairy (NOD). The deal will see NOD’s dairy products accessible in more than 320 outlets in Hong Kong and Macau.
🐄 NOD will supply dairy products across the Mannings retail network – Hong Kong’s largest health and beauty retail chain
🥁 Expected to generate $250 million in revenue during the term of the agreement
🍼 Marks a significant milestone for NOD`s functional powdered milk division
“This partnership highlights NOD`s dedication to delivering premium products worldwide, while further strengthening its position throughout Asia. With our recently announced merger and the exclusive partnership with Mannings now in place, NOD is set to play a central role in SPC Global`s vision of building a global food powerhouse.” – Robert Iervasi, SPC Global Managing Director
ASX announcement ⚡
https://announcements.asx.com.au/asxpdf/20250106/pdf/06d8r0g17cfvhj.pdf
Specialist metal technology business AML3D (ASX: AL3) has delivered a 3D-printed copper-nickel component order for the US Navy’s Virginia-Class nuclear submarine program, as part of the AUKUS trilateral defence agreement between Australia, the UK, and the US.
🏆 AML3D delivered the 3D-printed submarine components in less than five weeks, compared to an average 17-month period required in traditional manufacturing
🔩The components will now undergo testing prior to planned in-service installation onboard a conventionally armed nuclear-powered Virginia-Class submarine in 2025
🤝AML3D’s market-leading additive manufacturing technology is helping to establish a resilient trilateral AUKUS supply chain
“AML3D has been working with the U.S. Navy and its partners for close to two years. In that time, we have created a successful model that includes cross-continental coordination, information sharing, and the deployment of our ARCEMY advanced 3D metal printing technology across a network of U.S. defense industry and academic experts. We have also completed several alloy testing and characterisation programs including Copper-Nickel, which allows us to supply components to the U.S. Nuclear submarine program.” - CEO Sean Ebert
ASX announcement ⚡ https://announcements.asx.com.au/asxpdf/20250106/pdf/06d8mw4kf59wmg.pdf

Specialist metal technology business AML3D (ASX: AL3) has delivered a 3D-printed copper-nickel component order for the US Navy’s Virginia-Class nuclear submarine program, as part of the AUKUS trilateral defence agreement between Australia, the UK, and the US.
🏆 AML3D delivered the 3D-printed submarine components in less than five weeks, compared to an average 17-month period required in traditional manufacturing
🔩The components will now undergo testing prior to planned in-service installation onboard a conventionally armed nuclear-powered Virginia-Class submarine in 2025
🤝AML3D’s market-leading additive manufacturing technology is helping to establish a resilient trilateral AUKUS supply chain
“AML3D has been working with the U.S. Navy and its partners for close to two years. In that time, we have created a successful model that includes cross-continental coordination, information sharing, and the deployment of our ARCEMY advanced 3D metal printing technology across a network of U.S. defense industry and academic experts. We have also completed several alloy testing and characterisation programs including Copper-Nickel, which allows us to supply components to the U.S. Nuclear submarine program.” - CEO Sean Ebert
ASX announcement ⚡ https://announcements.asx.com.au/asxpdf/20250106/pdf/06d8mw4kf59wmg.pdf
Mount Hope Mining (ASX:MHM) has listed on the ASX with a ticker code of MHM. The company owns the NSW-based Mount Hope Project, located in the southern region of the Cobar Basin. The latter Basin has produced in excess of 3 million tonnes of copper metal and over 2 million ounces of gold plus significant volumes of lead, zinc and silver throughout the 140 years of various operations. With the tenure of the Mount Hope Project has seen limited modern exploration, the company’s initial objective is to conduct geophysical and geochemical surveys to confirm our historical results for the Project and prove up key target areas.

Mount Hope Mining (ASX:MHM) has listed on the ASX with a ticker code of MHM. The company owns the NSW-based Mount Hope Project, located in the southern region of the Cobar Basin. The latter Basin has produced in excess of 3 million tonnes of copper metal and over 2 million ounces of gold plus significant volumes of lead, zinc and silver throughout the 140 years of various operations. With the tenure of the Mount Hope Project has seen limited modern exploration, the company’s initial objective is to conduct geophysical and geochemical surveys to confirm our historical results for the Project and prove up key target areas.
Adacel Technologies (ASX: ADA), a specialist in Air Traffic Management (ATM) and Air Traffic Control (ATC) simulation and training solutions, has nailed down a US$3.6 million contract with a new client for its Aurora ATM system and another US$1 million contract from an existing customer for its MaxSim simulator systems.
🛫 Adacel will help modernise air traffic management operations of a UN member country by implementing new ATM automation and surveillance technologies through its Aurora system
🛡️ Aurora’s high level of automation reduces controller workload and allows for a significant increase in safety and airspace capacity
🛩️ Adacel will also help modernise the ATC Simulators of another UN member nation by expanding its collaboration with an existing client
“This award underscores our dedication to providing advanced air traffic management solutions that enhance safety, efficiency, and reliability. We look forward to contributing to the transformation of this nation’s air traffic infrastructure, helping to meet the evolving needs of their aviation sector.” – Daniel Verret, Adacel Technologies Chief Executive Officer

Adacel Technologies (ASX: ADA), a specialist in Air Traffic Management (ATM) and Air Traffic Control (ATC) simulation and training solutions, has nailed down a US$3.6 million contract with a new client for its Aurora ATM system and another US$1 million contract from an existing customer for its MaxSim simulator systems.
🛫 Adacel will help modernise air traffic management operations of a UN member country by implementing new ATM automation and surveillance technologies through its Aurora system
🛡️ Aurora’s high level of automation reduces controller workload and allows for a significant increase in safety and airspace capacity
🛩️ Adacel will also help modernise the ATC Simulators of another UN member nation by expanding its collaboration with an existing client
“This award underscores our dedication to providing advanced air traffic management solutions that enhance safety, efficiency, and reliability. We look forward to contributing to the transformation of this nation’s air traffic infrastructure, helping to meet the evolving needs of their aviation sector.” – Daniel Verret, Adacel Technologies Chief Executive Officer
Golden Horse Minerals (ASX:GHM) has listed on the ASX with a ticker code of GHM. The company is a gold explorer with a tenements package located in the WA-based Southern Cross region, one of Australia’s pre-eminent gold jurisdictions. These tenements, which extend across more than 130 kilometres, are sparsely drilled, and already contain several advanced brownfields projects, including the recently acquired Hopes Hill deposit located just 20 kilometres north of the Southern Cross township.
Directors: Chair - Graeme Sloan; Managing Director / CEO - Nicholas Anderson; Non-
Executive Director - Brett Dunnachie; Non-Executive Director - Jim Harris
Media: The Stock Network Lel Smits

Golden Horse Minerals (ASX:GHM) has listed on the ASX with a ticker code of GHM. The company is a gold explorer with a tenements package located in the WA-based Southern Cross region, one of Australia’s pre-eminent gold jurisdictions. These tenements, which extend across more than 130 kilometres, are sparsely drilled, and already contain several advanced brownfields projects, including the recently acquired Hopes Hill deposit located just 20 kilometres north of the Southern Cross township.
Directors: Chair - Graeme Sloan; Managing Director / CEO - Nicholas Anderson; Non-
Executive Director - Brett Dunnachie; Non-Executive Director - Jim Harris
Media: The Stock Network Lel Smits
Medical device specialist Control Bionics (ASX: CBL) has expanded into the high-growth US sports and Japanese rehabilitation markets with two strategic partnerships for its wearable physiological monitoring technology, NeuroStrip.
🏃♀️ Acquired 20% stake in Neuro Elite Athletics for US$250,000 — a US company behind the NeuroBounce program utilising cutting-edge technology to optimise motor neuron recruitment in muscles used for jumping
🏥 Entered agreement with Stroke Lab, a leading Tokyo-based rehabilitation facility, to localise NeuroStrip technology for the Japanese market
🥁 The partnerships are expected to generate material revenue for Control Bionics through new recurring subscription fees and hardware sales
“These collaborations underscore Control Bionics’ ability to enter and lead high-growth markets. With NeuroBounce’s proven success in sports and Stroke Lab’s rehabilitation expertise, we are driving innovation while delivering value for our shareholders.” – Jeremy Steele, Control Bionics Chief Executive Officer

Medical device specialist Control Bionics (ASX: CBL) has expanded into the high-growth US sports and Japanese rehabilitation markets with two strategic partnerships for its wearable physiological monitoring technology, NeuroStrip.
🏃♀️ Acquired 20% stake in Neuro Elite Athletics for US$250,000 — a US company behind the NeuroBounce program utilising cutting-edge technology to optimise motor neuron recruitment in muscles used for jumping
🏥 Entered agreement with Stroke Lab, a leading Tokyo-based rehabilitation facility, to localise NeuroStrip technology for the Japanese market
🥁 The partnerships are expected to generate material revenue for Control Bionics through new recurring subscription fees and hardware sales
“These collaborations underscore Control Bionics’ ability to enter and lead high-growth markets. With NeuroBounce’s proven success in sports and Stroke Lab’s rehabilitation expertise, we are driving innovation while delivering value for our shareholders.” – Jeremy Steele, Control Bionics Chief Executive Officer
Foresta Group (ASX: FGH), a natural and renewable pine chemical and biomass pellet manufacturing business, has entered an exclusive technology licensing agreement with German outfit E3 Carbon which will enable the company to produce high-quality torrefied wood pellets: a type of sustainable and efficient biomass fuel.
📜 Unconditional exclusive license for New Zealand and Australia until end of next year, and an exclusive conditional license for fifteen years in New Zealand
🌳 E3 Carbon’s torrefaction technology will facilitate the production of pellets that meet the stringent requirements of national and international markets
🏭 The strategic partnership will allow Foresta to produce the pellets at its flagship integrated manufacturing facility set to be developed in New Zealand
“We are excited to partner with E3 CARBON to bring this innovative and leading torrefaction technology to New Zealand. This partnership is a pivotal step for FORESTA in establishing our supply chain and developing our flagship manufacturing facility.” –Henry Cheng, Foresta Executive Chairman

Foresta Group (ASX: FGH), a natural and renewable pine chemical and biomass pellet manufacturing business, has entered an exclusive technology licensing agreement with German outfit E3 Carbon which will enable the company to produce high-quality torrefied wood pellets: a type of sustainable and efficient biomass fuel.
📜 Unconditional exclusive license for New Zealand and Australia until end of next year, and an exclusive conditional license for fifteen years in New Zealand
🌳 E3 Carbon’s torrefaction technology will facilitate the production of pellets that meet the stringent requirements of national and international markets
🏭 The strategic partnership will allow Foresta to produce the pellets at its flagship integrated manufacturing facility set to be developed in New Zealand
“We are excited to partner with E3 CARBON to bring this innovative and leading torrefaction technology to New Zealand. This partnership is a pivotal step for FORESTA in establishing our supply chain and developing our flagship manufacturing facility.” –Henry Cheng, Foresta Executive Chairman
HMC Capital`s DigiCo Infrastructure REIT (ASX:DGT) has listed on the ASX with a ticker code of DGT. The REIT’s strategy is to become a diversified owner, operator and developer of data centres that deliver superior risk-adjusted returns. To help achieve this goal, the REIT will target assets that deliver stable and growing income characteristics including via long leases, long-term customer contracts, rental escalations and a diversified customer base with high-quality credit counterparties. It will undertake greenfield and brownfield development of new data centre properties across different business models.
Website: https://www.hmccapital.com.au/insights/hmc-capital-today-announces-the-
establishment-of-a-new-asx-listed-digital-infrastructure-reit-asxdgt-digico-reit/
Board: Mr Michael O`Brien - Executive Chair; Mr Joseph Carrozzi - Non Exec. Chair; Mr Damon Reid - CEO; Mr Andrew Godfrey - Executive Director; Ms Mary O`Connor - Executive Director; Ms Johanna Platt - Executive Director; Mr David Warren - Executive Director; The Hon Mark Arbib - Non Exec. Director; Mr David Di Pilla - Non Exec. Director; Ms Rachel Grimes - Non Exec. Director; Ms Stephanie Lai - Non Exec. Director; Mr Chris Maher - Non Exec. Director; The Hon Kelly O`Dwyer - Non Exec. Director; Mr Simon Mitchell - CFO
Media: The Stock Network @lelsmits

HMC Capital`s DigiCo Infrastructure REIT (ASX:DGT) has listed on the ASX with a ticker code of DGT. The REIT’s strategy is to become a diversified owner, operator and developer of data centres that deliver superior risk-adjusted returns. To help achieve this goal, the REIT will target assets that deliver stable and growing income characteristics including via long leases, long-term customer contracts, rental escalations and a diversified customer base with high-quality credit counterparties. It will undertake greenfield and brownfield development of new data centre properties across different business models.
Website: https://www.hmccapital.com.au/insights/hmc-capital-today-announces-the-
establishment-of-a-new-asx-listed-digital-infrastructure-reit-asxdgt-digico-reit/
Board: Mr Michael O`Brien - Executive Chair; Mr Joseph Carrozzi - Non Exec. Chair; Mr Damon Reid - CEO; Mr Andrew Godfrey - Executive Director; Ms Mary O`Connor - Executive Director; Ms Johanna Platt - Executive Director; Mr David Warren - Executive Director; The Hon Mark Arbib - Non Exec. Director; Mr David Di Pilla - Non Exec. Director; Ms Rachel Grimes - Non Exec. Director; Ms Stephanie Lai - Non Exec. Director; Mr Chris Maher - Non Exec. Director; The Hon Kelly O`Dwyer - Non Exec. Director; Mr Simon Mitchell - CFO
Media: The Stock Network @lelsmits
AML3D’s (ASX:AL3) technology centre at Stow, Ohio has opened and is in production with one ARCEMY industrial metal 3D printing system on site and with plans to expand.
⚙️ Plans to more than double capacity at the Stow facility with the installation of up to 2 additional ARCEMY systems are progressing.
🔩 AML3D has already delivered ~A$16 million of US contracts ahead of an expected surge in US Defence spending on additive manufacturing.
🚀AML3D’s US manufacturing capability also supports new opportunities to expand into the US Energy and Defence Aerospace sectors.
“The opening of our US manufacturing hub and, just as importantly, our plans to more than double its capacity are important next steps in our US ‘Scale up’ strategy. The huge demand we have already experienced in the US has translated to over A$16 million of contracts, for the most part serviced from our Australian manufacturing hub." - CEO Sean Ebert

AML3D’s (ASX:AL3) technology centre at Stow, Ohio has opened and is in production with one ARCEMY industrial metal 3D printing system on site and with plans to expand.
⚙️ Plans to more than double capacity at the Stow facility with the installation of up to 2 additional ARCEMY systems are progressing.
🔩 AML3D has already delivered ~A$16 million of US contracts ahead of an expected surge in US Defence spending on additive manufacturing.
🚀AML3D’s US manufacturing capability also supports new opportunities to expand into the US Energy and Defence Aerospace sectors.
“The opening of our US manufacturing hub and, just as importantly, our plans to more than double its capacity are important next steps in our US ‘Scale up’ strategy. The huge demand we have already experienced in the US has translated to over A$16 million of contracts, for the most part serviced from our Australian manufacturing hub." - CEO Sean Ebert
PainChek (ASX: PCK), a developer of the world’s first smart phone-based pain assessment and monitoring application, continues to build momentum in the implementation of its innovative technology as well as its expansion push targeting new markets.
🥁 Generated a 10% jump in global implemented licences over the last two months, up from 61,705 at the end of September to 68,136 at the end of November
🩺 Agreement with the Western Australian government to develop a new PainChek App for children with disabilities now in place
⚕️ Royal Edinburgh Hospital in Scotland commenced a live trial using PainChek, which could potentially lead to a broader roll out across Edinburgh’s hospital network
“The Company is on track with its three focus business areas. This includes growing our core businesses in existing markets, entering new markets including specifically the USA, and market development of the large infant market where 150 million children are born each year and objective pain assessment is not currently available.” – Philip Daffas, PainChek Chief Executive Officer

PainChek (ASX: PCK), a developer of the world’s first smart phone-based pain assessment and monitoring application, continues to build momentum in the implementation of its innovative technology as well as its expansion push targeting new markets.
🥁 Generated a 10% jump in global implemented licences over the last two months, up from 61,705 at the end of September to 68,136 at the end of November
🩺 Agreement with the Western Australian government to develop a new PainChek App for children with disabilities now in place
⚕️ Royal Edinburgh Hospital in Scotland commenced a live trial using PainChek, which could potentially lead to a broader roll out across Edinburgh’s hospital network
“The Company is on track with its three focus business areas. This includes growing our core businesses in existing markets, entering new markets including specifically the USA, and market development of the large infant market where 150 million children are born each year and objective pain assessment is not currently available.” – Philip Daffas, PainChek Chief Executive Officer
Globe Metals & Mining (ASX:GBE) has now materially progressed the development of its Kanyika Niobium/Tantalum Project in Malawi, Africa.
Phase 1 of the Kanyika Niobium Project is expected to go into development in the March 2026 quarter, which would see it become only the second vertically integrated Niobium Oxide player globally.
Niobium Oxide is a critical metal that currently comprises just 9% of the total Niobium market, and is in demand by a wide range of growing high-tech industries.
Multiple Kanyika development milestones were realised in calendar 2024
📈 Delivery of an optimisation study covering the development of Kanyika, which included a host of robust financial and technical outcomes
💰 Including a 27-year mine life, an estimated pre-tax Net Present Value of US$1 billion and an internal rate of return of 47%
💸 A number of important funding and offtake agreements were progressed, all critical to Kanyika’s development and its economic case
🧑🤝🧑 The signing of a Community Development Agreement with representatives of communities surrounding the Kanyika Project
Key offtake agreement for 30% of production is at LOI level, with significant progress underway on more offtake agreements.
Project execution Owners Team has been put in place to take the project into execution.
And other important development milestones, including the release of an updated bankable feasibility study is expected in early Q2 2025.
Watch the full video on TSN⚡️ https://youtu.be/qq1O9pGGyD8

Globe Metals & Mining (ASX:GBE) has now materially progressed the development of its Kanyika Niobium/Tantalum Project in Malawi, Africa.
Phase 1 of the Kanyika Niobium Project is expected to go into development in the March 2026 quarter, which would see it become only the second vertically integrated Niobium Oxide player globally.
Niobium Oxide is a critical metal that currently comprises just 9% of the total Niobium market, and is in demand by a wide range of growing high-tech industries.
Multiple Kanyika development milestones were realised in calendar 2024
📈 Delivery of an optimisation study covering the development of Kanyika, which included a host of robust financial and technical outcomes
💰 Including a 27-year mine life, an estimated pre-tax Net Present Value of US$1 billion and an internal rate of return of 47%
💸 A number of important funding and offtake agreements were progressed, all critical to Kanyika’s development and its economic case
🧑🤝🧑 The signing of a Community Development Agreement with representatives of communities surrounding the Kanyika Project
Key offtake agreement for 30% of production is at LOI level, with significant progress underway on more offtake agreements.
Project execution Owners Team has been put in place to take the project into execution.
And other important development milestones, including the release of an updated bankable feasibility study is expected in early Q2 2025.
Watch the full video on TSN⚡️ https://youtu.be/qq1O9pGGyD8
Whitefield Income (ASX:WHI) has listed on the ASX with a ticker code of WHI. The company targets income generation inclusive of franking credits through actively managed investment in ASX 300 listed securities. Whitefield Income’s aim is to generate total returns similar to or in excess of the gross return of a specific S&P/ASX 300 benchmark index and then distribute some or all of its profit to shareholders.

Whitefield Income (ASX:WHI) has listed on the ASX with a ticker code of WHI. The company targets income generation inclusive of franking credits through actively managed investment in ASX 300 listed securities. Whitefield Income’s aim is to generate total returns similar to or in excess of the gross return of a specific S&P/ASX 300 benchmark index and then distribute some or all of its profit to shareholders.
Health club and fitness technology specialist Viva Leisure (ASX: VVA) has entered a deal to acquire a 25% strategic stake in World Gym Australia (WGA) for a $16.7 million consideration, coupled with three World Gym locations in Queensland.
🏋️ Expected to deliver substantial financial and strategic benefits for Viva, helping to further propel the group’s growth trajectory
💪 Could add nearly 170,000 WGA members to the Viva network, taking the total to more than 587,000 members
🏃♀️ Projected to contribute up to an additional $12.5 million in revenue and about $4m in operating earnings (EBITDA) for Viva
“With a pipeline of over 100 additional corporate and franchisee network locations already secured, the existing Viva network is expected to expand to over 583 locations, with a membership base exceeding 587,000 members, underscoring the scale and reach of our growing fitness community.” – Harry Konstantinou, Viva Leisure Chief Executive Officer and Managing Director

Health club and fitness technology specialist Viva Leisure (ASX: VVA) has entered a deal to acquire a 25% strategic stake in World Gym Australia (WGA) for a $16.7 million consideration, coupled with three World Gym locations in Queensland.
🏋️ Expected to deliver substantial financial and strategic benefits for Viva, helping to further propel the group’s growth trajectory
💪 Could add nearly 170,000 WGA members to the Viva network, taking the total to more than 587,000 members
🏃♀️ Projected to contribute up to an additional $12.5 million in revenue and about $4m in operating earnings (EBITDA) for Viva
“With a pipeline of over 100 additional corporate and franchisee network locations already secured, the existing Viva network is expected to expand to over 583 locations, with a membership base exceeding 587,000 members, underscoring the scale and reach of our growing fitness community.” – Harry Konstantinou, Viva Leisure Chief Executive Officer and Managing Director
Music technology specialist Vinyl Group (ASX: VNL) has wrapped up the acquisition of end-to-end events and brand activations business Funkified Entertainment in a $2.5 million deal.
🎈 Funkified has served as The Brag Media’s in-house events arm and as a brand activation agency for some of Australia’s leading advertising and creative houses
🥁 Funkified delivered about $4 million in revenue and more than $400,000 in operating earnings (EBITDA) in FY24
🎉 Vinyl Group expects the deal to help accelerate growth and improve margins by taking its events function in-house
“The Funkified acquisition presented an opportunity for the Company to deliver on its stated mission to improve margins across the board this financial year whilst also enjoying the benefits of working with a team who are already integrated and aligned. We look forward to reporting these results in the upcoming quarters where we expect the value of this deal to be realised.” – Josh Simons, Vinyl Group Chief Executive Officer

Music technology specialist Vinyl Group (ASX: VNL) has wrapped up the acquisition of end-to-end events and brand activations business Funkified Entertainment in a $2.5 million deal.
🎈 Funkified has served as The Brag Media’s in-house events arm and as a brand activation agency for some of Australia’s leading advertising and creative houses
🥁 Funkified delivered about $4 million in revenue and more than $400,000 in operating earnings (EBITDA) in FY24
🎉 Vinyl Group expects the deal to help accelerate growth and improve margins by taking its events function in-house
“The Funkified acquisition presented an opportunity for the Company to deliver on its stated mission to improve margins across the board this financial year whilst also enjoying the benefits of working with a team who are already integrated and aligned. We look forward to reporting these results in the upcoming quarters where we expect the value of this deal to be realised.” – Josh Simons, Vinyl Group Chief Executive Officer
AML3D (ASX:AL3) has won a $2.27 million ARCEMY® X contract which will enable it to expand into the US utilities sector. The contract has been awarded by the Tennessee Valley Authority (TVA) - the largest US public utility.
⚙️ AML3D’s ARCEMY® X system was selected to enhance the TVA’s power generation repair capabilities following a competitive tender process.
🔩 AML3D’s US Scale Up strategy includes building on the success supplying the Defence Sector to expand into additional industries.
“This ARCEMY® X order from the TVA is very much aligned with the US Scale Up growth strategy we have in place. When we launched the US Scale Up strategy, back in February 2023, our focus was on the Defence sector, in the first instance, and that has already delivered close to A$14 million of contract wins.
The next step in the strategy was always to expand beyond Defence, so it is very pleasing to see our ARCEMY® X system selected by the TVA. It demonstrates the relevance of ARCEMY® across US manufacturing and how our US strategy will continue to accelerate growth and value creation.
This entry into the US Utilities sector also supports our decision to further expand our US facilities, funded by the recent capital raising, to meet the continuing growth in demand and for our advanced manufacturing technology across the US." - CEO Sean Ebert

AML3D (ASX:AL3) has won a $2.27 million ARCEMY® X contract which will enable it to expand into the US utilities sector. The contract has been awarded by the Tennessee Valley Authority (TVA) - the largest US public utility.
⚙️ AML3D’s ARCEMY® X system was selected to enhance the TVA’s power generation repair capabilities following a competitive tender process.
🔩 AML3D’s US Scale Up strategy includes building on the success supplying the Defence Sector to expand into additional industries.
“This ARCEMY® X order from the TVA is very much aligned with the US Scale Up growth strategy we have in place. When we launched the US Scale Up strategy, back in February 2023, our focus was on the Defence sector, in the first instance, and that has already delivered close to A$14 million of contract wins.
The next step in the strategy was always to expand beyond Defence, so it is very pleasing to see our ARCEMY® X system selected by the TVA. It demonstrates the relevance of ARCEMY® across US manufacturing and how our US strategy will continue to accelerate growth and value creation.
This entry into the US Utilities sector also supports our decision to further expand our US facilities, funded by the recent capital raising, to meet the continuing growth in demand and for our advanced manufacturing technology across the US." - CEO Sean Ebert
Innovative industrial technology business Aurora Labs (ASX: A3D) has locked in a $319,000 contract with the Australian Department of Defence to develop a 3D-printed aircraft propulsion system.
🛡️ The new system is expected to support diverse applications, including defence operations utilising unmanned aerial system platforms
✈️ Marks a significant milestone for Aurora Labs as it builds a pathway to broaden the scope of propulsion systems offered to its customers
⚙️ Demonstrates the company’s growing role in enhancing sovereign capabilities through cutting-edge additive manufacturing technologies
“This contract signifies a major milestone in our commitment to defence innovation and underscores our capabilities in delivering high-performance, locally manufactured propulsion systems.” – Rebekah Letheby, Aurora Labs Chief Executive Officer

Innovative industrial technology business Aurora Labs (ASX: A3D) has locked in a $319,000 contract with the Australian Department of Defence to develop a 3D-printed aircraft propulsion system.
🛡️ The new system is expected to support diverse applications, including defence operations utilising unmanned aerial system platforms
✈️ Marks a significant milestone for Aurora Labs as it builds a pathway to broaden the scope of propulsion systems offered to its customers
⚙️ Demonstrates the company’s growing role in enhancing sovereign capabilities through cutting-edge additive manufacturing technologies
“This contract signifies a major milestone in our commitment to defence innovation and underscores our capabilities in delivering high-performance, locally manufactured propulsion systems.” – Rebekah Letheby, Aurora Labs Chief Executive Officer
Smart cycling accessories specialist Cycliq (ASX: CYQ) has delivered a boost to its key financial metrics during its 2024 Black Friday sales campaign, steered by the recent introduction of the company’s Fly6 Pro all-in-one light and camera safety system.
🚲 Introduction of Fly6 Pro has driven higher order values, with customers increasingly purchasing additional accessories
📹 Gross revenue of $1.28 million in November 2024, up by 6.7% from the same time last year
🚵♀️ 32% rise in average order value and a 12% increase in gross profit margin compared to November 2023
“We are proud of the strong 2024 Black Friday campaign, resulting in a 6.7% increase in our November revenue compared to last year. This is recognition of Cycliq’s technological innovation and our alignment to changing consumer preferences and reflects the work our team has undertaken to provide premium products and build trust in the Cycliq brand.” – Andrew Chapman, Cycliq Chairman

Smart cycling accessories specialist Cycliq (ASX: CYQ) has delivered a boost to its key financial metrics during its 2024 Black Friday sales campaign, steered by the recent introduction of the company’s Fly6 Pro all-in-one light and camera safety system.
🚲 Introduction of Fly6 Pro has driven higher order values, with customers increasingly purchasing additional accessories
📹 Gross revenue of $1.28 million in November 2024, up by 6.7% from the same time last year
🚵♀️ 32% rise in average order value and a 12% increase in gross profit margin compared to November 2023
“We are proud of the strong 2024 Black Friday campaign, resulting in a 6.7% increase in our November revenue compared to last year. This is recognition of Cycliq’s technological innovation and our alignment to changing consumer preferences and reflects the work our team has undertaken to provide premium products and build trust in the Cycliq brand.” – Andrew Chapman, Cycliq Chairman
Drone-based technology business RocketDNA (ASX: RKT) has notched up a first export of its xBot autonomous drone platform to an international mining customer, Kamoa Copper in the Democratic Republic of Congo.
⚒️ Kamoa Copper’s mining complex is one of the largest high-grade copper operations in the world
💎 The platform will support Kamoa Copper with critical services such emergency responses and the inspection of conveyors and smelters
⛏️ The deployment marks RocketDNA’s expansion into Africa’s vast resource sector and unlocks potential for significant growth in the global mining industry
“Partnering with Kamoa Copper demonstrates the versatility and robustness of our solutions, enabling us to deliver critical operational improvements and enhanced safety standards.” – Christopher Clark, RocketDNA Managing Director and Chief Executive Officer

Drone-based technology business RocketDNA (ASX: RKT) has notched up a first export of its xBot autonomous drone platform to an international mining customer, Kamoa Copper in the Democratic Republic of Congo.
⚒️ Kamoa Copper’s mining complex is one of the largest high-grade copper operations in the world
💎 The platform will support Kamoa Copper with critical services such emergency responses and the inspection of conveyors and smelters
⛏️ The deployment marks RocketDNA’s expansion into Africa’s vast resource sector and unlocks potential for significant growth in the global mining industry
“Partnering with Kamoa Copper demonstrates the versatility and robustness of our solutions, enabling us to deliver critical operational improvements and enhanced safety standards.” – Christopher Clark, RocketDNA Managing Director and Chief Executive Officer
4DMedical (ASX: 4DX), a global medical technology business specialising in respiratory imaging, has entered a commercial deal with leading Western Australian diagnostic imagining provider, Perth Radiological Clinic, to deliver its XV Technology enabled ventilation reports.
🩻 The agreement will see 4DMedical provide its innovative ventilation reports across 16 clinics operated by Perth Radiological Clinic (PRC)
🩺 The new partnership represents an important milestone in 4DMedical’s Australian expansion strategy
🧬 Builds on two recent commercial wins in the US with Imaging Partners of Orange County and UC San Diego Health
“We are delighted to partner with PRC, a leader in diagnostic imaging in Western Australia. This collaboration underscores the value and demand for XV Technology in enhancing respiratory diagnostics.” – Andreas Fouras, 4DMedical Managing Director and Founder

4DMedical (ASX: 4DX), a global medical technology business specialising in respiratory imaging, has entered a commercial deal with leading Western Australian diagnostic imagining provider, Perth Radiological Clinic, to deliver its XV Technology enabled ventilation reports.
🩻 The agreement will see 4DMedical provide its innovative ventilation reports across 16 clinics operated by Perth Radiological Clinic (PRC)
🩺 The new partnership represents an important milestone in 4DMedical’s Australian expansion strategy
🧬 Builds on two recent commercial wins in the US with Imaging Partners of Orange County and UC San Diego Health
“We are delighted to partner with PRC, a leader in diagnostic imaging in Western Australia. This collaboration underscores the value and demand for XV Technology in enhancing respiratory diagnostics.” – Andreas Fouras, 4DMedical Managing Director and Founder
ClearVue (ASX: CPV), a solar technology business specialising in energy generating glass, has entered a deal to acquire the intellectual property and assets of sustainable agricultural technology business, ROOTS.
🌽 The acquisition includes ROOTS’ leading ‘Root Zone Temperature Optimisation and Irrigation by Condensation’ technologies
🥦 ClearVue to integrate ROOTS’ solutions with its advanced solar greenhouse and solar glazing products to expand its presence in the agricultural technologies market
🥕 The complementary technologies combined could offer sustainable greenhouse and agricultural solutions globally
“ROOTS’ unique root temperature optimisation and irrigation technologies when combined with our advanced solar glazing solutions creates a comprehensive suite of agricultural solutions to enhance productivity and crop yields, optimise energy and water use, and address challenges in sustainable farming.” – Martin Deil, ClearVue Chief Executive Officer

ClearVue (ASX: CPV), a solar technology business specialising in energy generating glass, has entered a deal to acquire the intellectual property and assets of sustainable agricultural technology business, ROOTS.
🌽 The acquisition includes ROOTS’ leading ‘Root Zone Temperature Optimisation and Irrigation by Condensation’ technologies
🥦 ClearVue to integrate ROOTS’ solutions with its advanced solar greenhouse and solar glazing products to expand its presence in the agricultural technologies market
🥕 The complementary technologies combined could offer sustainable greenhouse and agricultural solutions globally
“ROOTS’ unique root temperature optimisation and irrigation technologies when combined with our advanced solar glazing solutions creates a comprehensive suite of agricultural solutions to enhance productivity and crop yields, optimise energy and water use, and address challenges in sustainable farming.” – Martin Deil, ClearVue Chief Executive Officer
Mount Hope Mining (ASX:MHM) has now closed its successful $5 million IPO raise and is set to list on Monday 9 December:
🏆The successful $5 million raise demonstrates strong market confidence in Mount Hope Mining’s exploration plans.
⛏️The IPO funds will be used to accelerate the company`s exploration programs, focusing on four advanced targets.
🚧The Mount Hope Mining CEO will soon conduct an on-the-ground orientation survey, as part of the company`s commitment to hands-on exploration

Mount Hope Mining (ASX:MHM) has now closed its successful $5 million IPO raise and is set to list on Monday 9 December:
🏆The successful $5 million raise demonstrates strong market confidence in Mount Hope Mining’s exploration plans.
⛏️The IPO funds will be used to accelerate the company`s exploration programs, focusing on four advanced targets.
🚧The Mount Hope Mining CEO will soon conduct an on-the-ground orientation survey, as part of the company`s commitment to hands-on exploration
SomnoMed (ASX: SOM), a leader in oral appliance treatment solutions for sleep-related breathing disorders, has lifted its guidance for the full financial year following a healthy start to its operations during the first quarter of FY25.
🛏️ Revenue of $25.3 million in Q1 FY25 jumped by 18% from the same time last year
⚕️ Strong growth in revenue across all key geographical segments driven by robust demand and improved production turnaround times
💤 Projecting revenue to reach $105 million in FY25, up from $91.7 million in FY24
🩺 Guiding for operating earnings (EBITDA) of more than $7 million in FY25, a substantial improvement on $600,000 in FY24

SomnoMed (ASX: SOM), a leader in oral appliance treatment solutions for sleep-related breathing disorders, has lifted its guidance for the full financial year following a healthy start to its operations during the first quarter of FY25.
🛏️ Revenue of $25.3 million in Q1 FY25 jumped by 18% from the same time last year
⚕️ Strong growth in revenue across all key geographical segments driven by robust demand and improved production turnaround times
💤 Projecting revenue to reach $105 million in FY25, up from $91.7 million in FY24
🩺 Guiding for operating earnings (EBITDA) of more than $7 million in FY25, a substantial improvement on $600,000 in FY24
Regenerative medicine specialist Aroa Biosurgery (ASX: ARX) has delivered a strong half yearly performance as it continues to build momentum in its US commercialisation push for its four product families used for soft tissue repair. The company is targeting a market opportunity totalling more than US$3 billion.
🩺 Product sales of NZ$39.1 million jumped by 25% from the same time last year, driven by robust growth in both the Myriad and Ovitex product families
🩹 Sales of the high-margin Myriad product family reached NZ$14.8 million in the first half of the fiscal year, up by 45% from twelve months prior
⚕️ Guiding for between NZ$80 million and NZ$87 million in total revenue for FY25, representing an increase of between 21% and 32% on FY24
“We’re pleased to see increased sales productivity drive strong growth in the Myriad portfolio. Sales to TELA Bio continue to perform well, tracking in line with their sales to customers. We expect total revenue of ~NZ$43-$50 million in the second half of this year, and to be cash flow positive.” – Brian Ward, Aroa Biosurgery Founder and Chief Executive Officer

Regenerative medicine specialist Aroa Biosurgery (ASX: ARX) has delivered a strong half yearly performance as it continues to build momentum in its US commercialisation push for its four product families used for soft tissue repair. The company is targeting a market opportunity totalling more than US$3 billion.
🩺 Product sales of NZ$39.1 million jumped by 25% from the same time last year, driven by robust growth in both the Myriad and Ovitex product families
🩹 Sales of the high-margin Myriad product family reached NZ$14.8 million in the first half of the fiscal year, up by 45% from twelve months prior
⚕️ Guiding for between NZ$80 million and NZ$87 million in total revenue for FY25, representing an increase of between 21% and 32% on FY24
“We’re pleased to see increased sales productivity drive strong growth in the Myriad portfolio. Sales to TELA Bio continue to perform well, tracking in line with their sales to customers. We expect total revenue of ~NZ$43-$50 million in the second half of this year, and to be cash flow positive.” – Brian Ward, Aroa Biosurgery Founder and Chief Executive Officer
Vitrafy Life Sciences has listed on the ASX with a ticker code of VFY. The company has designed and developed an innovative cryopreservation solution, which has application across many uses in animal and human health. Having proven its technology, Vitrafy is now pursuing additional product development initiatives and collaboration agreements.

Vitrafy Life Sciences has listed on the ASX with a ticker code of VFY. The company has designed and developed an innovative cryopreservation solution, which has application across many uses in animal and human health. Having proven its technology, Vitrafy is now pursuing additional product development initiatives and collaboration agreements.
ReNerve has listed on the ASX with a ticker code of RNV. The company is focussed on the development of bio-material based medical devices that deliver superior outcomes in the treatment of peripheral nerve injury and related applications. ReNerve’s first product, the NervAlign® Nerve Cuff, has received regulatory clearance from the FDA and launched in the US.

ReNerve has listed on the ASX with a ticker code of RNV. The company is focussed on the development of bio-material based medical devices that deliver superior outcomes in the treatment of peripheral nerve injury and related applications. ReNerve’s first product, the NervAlign® Nerve Cuff, has received regulatory clearance from the FDA and launched in the US.
Online gaming and eSports service provider Streamplay Studio (ASX: SP8) has entered a deal to acquire profitable Canadian-based indie gaming company Noodlecake Studios. The move is set to expand Streamplay’s global reach and its direct-to-consumer presence across North America’s gaming sector.
🎮 Noodlecake boasts a portfolio of more than 60 games which have achieved over 270 million downloads and generated some $42 million in revenue
💻 It has established partnerships with leading brands such as Apple, Google, Xbox, and PlayStation, with its games available in more than 45 countries
🕹️ Noodlecake’s lean and high-impact operating model consisting of a focused team and global collaborations could help maximise publishing reach
“The acquisition of Noodlecake marks an exciting milestone for Streamplay as we expand into North America and make further inroads into the highly lucrative global gaming market.”– Bert Mondello, Streamplay Studio Chairman

Online gaming and eSports service provider Streamplay Studio (ASX: SP8) has entered a deal to acquire profitable Canadian-based indie gaming company Noodlecake Studios. The move is set to expand Streamplay’s global reach and its direct-to-consumer presence across North America’s gaming sector.
🎮 Noodlecake boasts a portfolio of more than 60 games which have achieved over 270 million downloads and generated some $42 million in revenue
💻 It has established partnerships with leading brands such as Apple, Google, Xbox, and PlayStation, with its games available in more than 45 countries
🕹️ Noodlecake’s lean and high-impact operating model consisting of a focused team and global collaborations could help maximise publishing reach
“The acquisition of Noodlecake marks an exciting milestone for Streamplay as we expand into North America and make further inroads into the highly lucrative global gaming market.”– Bert Mondello, Streamplay Studio Chairman
Cuscal has listed on the ASX with a ticker code of CCL. The company is an authorised deposit taking institution, with the licences, connectivity and processing capability to support all payment types and regulated data services. The outlook for Cuscal is underpinned by strong competitive advantages; a predictable financial model and attractive growth fundamentals.

Cuscal has listed on the ASX with a ticker code of CCL. The company is an authorised deposit taking institution, with the licences, connectivity and processing capability to support all payment types and regulated data services. The outlook for Cuscal is underpinned by strong competitive advantages; a predictable financial model and attractive growth fundamentals.
AML3D (ASX:AL3) capital raising to fund doubling of US capacity
AML3D has developed a patented Wire Additive Manufacturing (WAM®) process. WAM® combines state-of-the-art welding science, robotics automation, materials engineering and proprietary software to lead metal additive manufacturing globally.
The $30m equity raise provides the funds required for AML3D to double capacity in the US, its core growth market
Where one of its key tier-1 clients is the US Department of Defense
The new capital will also finance the establishment of a Europe-based facility and ongoing investment in software and technology development projects
The raise was well supported by existing shareholders and also saw another 20 institutional funds join AML3D’s share register
AML3D’s Chief Executive Officer, Sean Ebert, commented: “The completion of this $30 million capital raising provides AML3D with the funds to scale up our US operations to maximise this opportunity. The Placement also allows us to accelerate development of our software and technology to maintain our market leading position in additive manufacturing, to maintain our competitive advantage and drive growth and value creation for our new and existing shareholders.”

AML3D (ASX:AL3) capital raising to fund doubling of US capacity
AML3D has developed a patented Wire Additive Manufacturing (WAM®) process. WAM® combines state-of-the-art welding science, robotics automation, materials engineering and proprietary software to lead metal additive manufacturing globally.
The $30m equity raise provides the funds required for AML3D to double capacity in the US, its core growth market
Where one of its key tier-1 clients is the US Department of Defense
The new capital will also finance the establishment of a Europe-based facility and ongoing investment in software and technology development projects
The raise was well supported by existing shareholders and also saw another 20 institutional funds join AML3D’s share register
AML3D’s Chief Executive Officer, Sean Ebert, commented: “The completion of this $30 million capital raising provides AML3D with the funds to scale up our US operations to maximise this opportunity. The Placement also allows us to accelerate development of our software and technology to maintain our market leading position in additive manufacturing, to maintain our competitive advantage and drive growth and value creation for our new and existing shareholders.”
Fulcrum Lithium has listed on the ASX with a ticker code of FUL. The company has a portfolio of lithium exploration projects in Nevada, USA, in the heart of that state’s “lithium belt”. Fulcrum’s three projects of Alkali Flats, Fairway and Summit together comprise one of the largest known portfolios of lode claims in Nevada focussed on the exploration for claystone hosted lithium deposits.

Fulcrum Lithium has listed on the ASX with a ticker code of FUL. The company has a portfolio of lithium exploration projects in Nevada, USA, in the heart of that state’s “lithium belt”. Fulcrum’s three projects of Alkali Flats, Fairway and Summit together comprise one of the largest known portfolios of lode claims in Nevada focussed on the exploration for claystone hosted lithium deposits.
Health food and beverage business Forbidden Foods (ASX: FFF) has expanded its presence at supermarket giant Woolworths with its Oat Milk Goodness coffee protein product hitting the shelves at 456 Woolworths supermarkets and metro stores across Australia.
🥛 Broadens the Oat Milk Goodness brand’s footprint by adding to the company’s Choc Oat milk products already stocked at Woolworths
🧃 Builds on recently announced ranging of Oat Milk Goodness across 130 Ampol Foodary stores
🧋 Could help drive future sales by building on positive demand trends for existing range of products across the company’s retail network partners
“Pleasingly, OMG now has three products in the broader Woolworths group and we are confident this will underpin sales growth over the coming months. Negotiations with a range of other stockists are very well advanced and we look forward to providing additional updates as our footprint grows.” – Alex Aleksic, Forbidden Foods Chief Executive Officer

Health food and beverage business Forbidden Foods (ASX: FFF) has expanded its presence at supermarket giant Woolworths with its Oat Milk Goodness coffee protein product hitting the shelves at 456 Woolworths supermarkets and metro stores across Australia.
🥛 Broadens the Oat Milk Goodness brand’s footprint by adding to the company’s Choc Oat milk products already stocked at Woolworths
🧃 Builds on recently announced ranging of Oat Milk Goodness across 130 Ampol Foodary stores
🧋 Could help drive future sales by building on positive demand trends for existing range of products across the company’s retail network partners
“Pleasingly, OMG now has three products in the broader Woolworths group and we are confident this will underpin sales growth over the coming months. Negotiations with a range of other stockists are very well advanced and we look forward to providing additional updates as our footprint grows.” – Alex Aleksic, Forbidden Foods Chief Executive Officer
Symal Group has listed on the ASX with a ticker code of SYL. It is an integrated Australian construction group focussed on civil construction, equipment hire, material sales, recycling and remediation, with diversified end market exposures. It provides an end-to-end solution across the entire construction project lifespan, with services delivered through its four brands: Symal Group, Sycle, Unyte and Wamarra.

Symal Group has listed on the ASX with a ticker code of SYL. It is an integrated Australian construction group focussed on civil construction, equipment hire, material sales, recycling and remediation, with diversified end market exposures. It provides an end-to-end solution across the entire construction project lifespan, with services delivered through its four brands: Symal Group, Sycle, Unyte and Wamarra.
4DMedical (ASX: 4DX), a global medical technology business specialising in respiratory imaging, has nailed down a three-year commercial contract with leading hospital for respiratory care in America, UC San Diego Health.
🩻 UC San Diego Health is ranked amongst the top 10 American hospitals for respiratory care
🧬 Will enable UC San Diego Health medical professionals to implement 4DMedical`s portfolio of advanced lung imaging products for clinical care
🧪 Demonstrates appeal of 4DMedical’s portfolio of structural and functional lung analysis tools for US clinicians and their patients
“Doing business with UCSD Health underscores the growing recognition of 4DMedical’s innovative technology in transforming respiratory care. Not only are they a great customer for us, but their status as one of the best respiratory hospitals in the country will undoubtedly boost our commercialisation efforts with the broader U.S healthcare system.” – Andreas Fouras, 4DMedical Managing Director and Founder

4DMedical (ASX: 4DX), a global medical technology business specialising in respiratory imaging, has nailed down a three-year commercial contract with leading hospital for respiratory care in America, UC San Diego Health.
🩻 UC San Diego Health is ranked amongst the top 10 American hospitals for respiratory care
🧬 Will enable UC San Diego Health medical professionals to implement 4DMedical`s portfolio of advanced lung imaging products for clinical care
🧪 Demonstrates appeal of 4DMedical’s portfolio of structural and functional lung analysis tools for US clinicians and their patients
“Doing business with UCSD Health underscores the growing recognition of 4DMedical’s innovative technology in transforming respiratory care. Not only are they a great customer for us, but their status as one of the best respiratory hospitals in the country will undoubtedly boost our commercialisation efforts with the broader U.S healthcare system.” – Andreas Fouras, 4DMedical Managing Director and Founder
Digital media and advertising business Motio (ASX: MXO) has delivered strong guidance for the full 2025 fiscal year following a robust performance across the group’s key financial metrics during the first quarter of the year.
🛒 First quarter sales up by 61% from the same time last year, with average contract value increasing by 66% during this period
💰 Guiding for revenue of between $9.45 million and $9.95 million in FY25, up from $8.37 million in FY24
☕ Guiding for operating earnings (EBITDA) of between $1 million and $1.2 million in FY25, up from $465,000 in FY24
“Motio has had four consecutive years of growth, is operating profitably and has continued its operational capabilities and efficiencies, including one of the most reliable digital display networks in the country. The team is ready, set up and capable of further expansion.” – Adam Cadwallader, Motio Chief Executive Officer and Managing Director

Digital media and advertising business Motio (ASX: MXO) has delivered strong guidance for the full 2025 fiscal year following a robust performance across the group’s key financial metrics during the first quarter of the year.
🛒 First quarter sales up by 61% from the same time last year, with average contract value increasing by 66% during this period
💰 Guiding for revenue of between $9.45 million and $9.95 million in FY25, up from $8.37 million in FY24
☕ Guiding for operating earnings (EBITDA) of between $1 million and $1.2 million in FY25, up from $465,000 in FY24
“Motio has had four consecutive years of growth, is operating profitably and has continued its operational capabilities and efficiencies, including one of the most reliable digital display networks in the country. The team is ready, set up and capable of further expansion.” – Adam Cadwallader, Motio Chief Executive Officer and Managing Director
Tennant Minerals (ASX:TMS) has announced the formation of a Strategic Alliance with CuFe and Emmerson Resources to collaborate on their copper, gold and critical metals development opportunities in the Tennant Creek Region of the Northern Territory.
⛏️ Creates a framework for collaboration on assessment of a shared facility
🪨 Establishes a committee made up of the CEO of each Company and technical teams to review data and outline a pathway to production with separate mines and a single processing facility
Tennant Minerals Managing Director Vincent Algar said: “The production history of Tennant Creek copper and gold supports the shared facility model we plan to investigate in this collaboration. The strategy will provide a shorter pathway to production and incentivise TMS to continue its exploration effort targeting further discoveries like Bluebird on our tenements.”

Tennant Minerals (ASX:TMS) has announced the formation of a Strategic Alliance with CuFe and Emmerson Resources to collaborate on their copper, gold and critical metals development opportunities in the Tennant Creek Region of the Northern Territory.
⛏️ Creates a framework for collaboration on assessment of a shared facility
🪨 Establishes a committee made up of the CEO of each Company and technical teams to review data and outline a pathway to production with separate mines and a single processing facility
Tennant Minerals Managing Director Vincent Algar said: “The production history of Tennant Creek copper and gold supports the shared facility model we plan to investigate in this collaboration. The strategy will provide a shorter pathway to production and incentivise TMS to continue its exploration effort targeting further discoveries like Bluebird on our tenements.”
Australian dental services business Pacific Smiles Group (ASX: PSQ) has provided solid guidance for the full 2025 financial year, driven by a jump in appointment volumes and price which have helped to boost patient fees since the start of July.
🦷 Patient fees of $115.7 million in FY25 so far, up by 9.6% from the same time last year
🪥 Growth seen across newer centres which continue to show uplift in both patient fees and profitability
😁 Guidance for patient fees of between $310 million and $318 million in FY25, representing a rise of between 6.2% and 9% on FY24
🩺 Guidance for underlying operating earnings (EBITDA) of between $31.2 million and $34.2 million in FY25, up by between 10.6% and 21.3% on FY24

Australian dental services business Pacific Smiles Group (ASX: PSQ) has provided solid guidance for the full 2025 financial year, driven by a jump in appointment volumes and price which have helped to boost patient fees since the start of July.
🦷 Patient fees of $115.7 million in FY25 so far, up by 9.6% from the same time last year
🪥 Growth seen across newer centres which continue to show uplift in both patient fees and profitability
😁 Guidance for patient fees of between $310 million and $318 million in FY25, representing a rise of between 6.2% and 9% on FY24
🩺 Guidance for underlying operating earnings (EBITDA) of between $31.2 million and $34.2 million in FY25, up by between 10.6% and 21.3% on FY24
ClearVue (ASX: CPV), a solar glass technology business specialising in energy generating windows, has entered its first manufacturing and distribution agreement in the United Kingdom with leading London-based glass fabrication business, My Glass Projects.
🪟 My Glass Projects granted non-exclusive rights in the UK market to manufacture and distribute products incorporating ClearVue’s technology
☀️ My Glass Projects attains exclusive rights to combine its heated glass technology with ClearVue’s solar glazing solution to create self-powered heating glass
🏢 Initial two year deal creates significant opportunity for ClearVue to expand into new markets and introduce its technology to a wider audience
“Combining My Glass Projects’ heated glass technology with our solar glazing solution has created another commercially viable smart façade solution that takes autonomous glazing systems to the next level.” – Martin Deil, ClearVue Global Chief Executive Officer

ClearVue (ASX: CPV), a solar glass technology business specialising in energy generating windows, has entered its first manufacturing and distribution agreement in the United Kingdom with leading London-based glass fabrication business, My Glass Projects.
🪟 My Glass Projects granted non-exclusive rights in the UK market to manufacture and distribute products incorporating ClearVue’s technology
☀️ My Glass Projects attains exclusive rights to combine its heated glass technology with ClearVue’s solar glazing solution to create self-powered heating glass
🏢 Initial two year deal creates significant opportunity for ClearVue to expand into new markets and introduce its technology to a wider audience
“Combining My Glass Projects’ heated glass technology with our solar glazing solution has created another commercially viable smart façade solution that takes autonomous glazing systems to the next level.” – Martin Deil, ClearVue Global Chief Executive Officer
Tennant Minerals (ASX:TMS) announces new drill targets to expand focus of copper and gold discovery potential within the 5km Bluebird ironstone corridor in the Tennant Creek Mineral Field.
⚒️ Tennant Minerals’ new drill program follows on from further thick, high-grade copper and gold zones including silver intersected in the June 2024 RC drilling program at the Bluebird discovery within Tennant Minerals’ 100%-owned Barkly Project in the Northern Territory,
🪨 The Company is expanding exploration across its tenements with the new drilling program focusing on Bluebird lookalike targets and high-grade gold occurrences in the 5km Bluebird-Perseverance Ironstone Corridor
⛏️ This new drilling program will commence on 15 November, with first results likely towards the end of the year.
Tennant Minerals CEO Vincent Algar commented: “The most recent drilling at Bluebird continued to confirm and expand the high gold and copper grades from previous drilling programs. Intersections continued to extend the mineralised zones to the east and down-plunge to the west. This new drilling program will continue our strategy of expanding Bluebird as one of the most important new discoveries in Tennant Creek for decades as well as starting follow up drilling on our list of high priority targets along strike. The newly acquired geophysics and geochemistry data will be used to generate more targets for follow up drilling in the 2025 field season."

Tennant Minerals (ASX:TMS) announces new drill targets to expand focus of copper and gold discovery potential within the 5km Bluebird ironstone corridor in the Tennant Creek Mineral Field.
⚒️ Tennant Minerals’ new drill program follows on from further thick, high-grade copper and gold zones including silver intersected in the June 2024 RC drilling program at the Bluebird discovery within Tennant Minerals’ 100%-owned Barkly Project in the Northern Territory,
🪨 The Company is expanding exploration across its tenements with the new drilling program focusing on Bluebird lookalike targets and high-grade gold occurrences in the 5km Bluebird-Perseverance Ironstone Corridor
⛏️ This new drilling program will commence on 15 November, with first results likely towards the end of the year.
Tennant Minerals CEO Vincent Algar commented: “The most recent drilling at Bluebird continued to confirm and expand the high gold and copper grades from previous drilling programs. Intersections continued to extend the mineralised zones to the east and down-plunge to the west. This new drilling program will continue our strategy of expanding Bluebird as one of the most important new discoveries in Tennant Creek for decades as well as starting follow up drilling on our list of high priority targets along strike. The newly acquired geophysics and geochemistry data will be used to generate more targets for follow up drilling in the 2025 field season."
Golden Deeps (ASX:GED) has received assay results from diamond drillhole HVD004 drilled at the Hazelbrook Prospect within the Company’s 100% owned Havilah Project in the Lachlan Fold Belt copper-gold province, located near Mudgee in central NSW.
🔹Assay results from diamond drillhole HVD004 at the Hazelbrook prospect confirm widespread copper bearing sulphide mineralisation at Golden Deeps’ 100% owned Havilah Project in the world-class Lachlan Fold Belt Copper-Gold Province in NSW.
🔹The results from HVD004 include a 30m zone grading 460ppm (0.05%) copper (Cu) from 86m, including results of up to 2m @ 1,260ppm (0.13%) Cu, within a highly anomalous 116m sulphide bearing zone from surface grading 224ppm Cu
🔹In addition, new mapping and rockchip sampling assay results from the Tuckers Hill high-grade gold prospect have confirmed the extensive zones of gold mineralised lode structures at this prospect.
Commenting on these exploration results, Golden Deeps CEO Jon Dugdale said: “The assay results for diamond drillhole HVD004 have confirmed the widespread highly anomalous copper mineralisation in the altered volcanic rocks at the Havilah Project. Further work programs will be developed based on the final results of the current program.”

Golden Deeps (ASX:GED) has received assay results from diamond drillhole HVD004 drilled at the Hazelbrook Prospect within the Company’s 100% owned Havilah Project in the Lachlan Fold Belt copper-gold province, located near Mudgee in central NSW.
🔹Assay results from diamond drillhole HVD004 at the Hazelbrook prospect confirm widespread copper bearing sulphide mineralisation at Golden Deeps’ 100% owned Havilah Project in the world-class Lachlan Fold Belt Copper-Gold Province in NSW.
🔹The results from HVD004 include a 30m zone grading 460ppm (0.05%) copper (Cu) from 86m, including results of up to 2m @ 1,260ppm (0.13%) Cu, within a highly anomalous 116m sulphide bearing zone from surface grading 224ppm Cu
🔹In addition, new mapping and rockchip sampling assay results from the Tuckers Hill high-grade gold prospect have confirmed the extensive zones of gold mineralised lode structures at this prospect.
Commenting on these exploration results, Golden Deeps CEO Jon Dugdale said: “The assay results for diamond drillhole HVD004 have confirmed the widespread highly anomalous copper mineralisation in the altered volcanic rocks at the Havilah Project. Further work programs will be developed based on the final results of the current program.”
Mount Hope Mining (ASX:MHM) is headed for the ASX and offering investors an opportunity to access copper and gold exploration assets through its flagship asset, the Mount Hope Project located in the southern Cobar region of New South Wales. Managing Director, Fergus Kiley speaks with Lel Smits about:
⚒️ Mount Hope Mining project portfolio and exploration
⛰️ Cobar region of New South Wales
👨🦱 Experienced team
🔔 Upcoming IPO

Mount Hope Mining (ASX:MHM) is headed for the ASX and offering investors an opportunity to access copper and gold exploration assets through its flagship asset, the Mount Hope Project located in the southern Cobar region of New South Wales. Managing Director, Fergus Kiley speaks with Lel Smits about:
⚒️ Mount Hope Mining project portfolio and exploration
⛰️ Cobar region of New South Wales
👨🦱 Experienced team
🔔 Upcoming IPO
Vection Technologies (ASX:VR1) has been awarded a $1.6 million artificial intelligence (AI) software licence contract for the Brexia Med healthcare project which uses technology developed by The Digital Box (TDB).
• $1.6m, three years, AI healthcare software licences sale.
• Option for an additional $1m for two further years.
• The contract includes recurring Algho AI licences and related AI-driven services.
• Algho AI is the proprietary artificial intelligence solution developed by TDB.
“This contract marks a significant milestone in showcasing the power of TDB’s AI capabilities. By providing AI-powered solutions, we are helping Brexia Med revolutionise its patient screening processes, creating a more efficient healthcare system.
The Algho AI platform is a game changer, demonstrating how AI can transform critical sectors like healthcare. This partnership highlights the potential of AI in driving innovation and opens doors to further opportunities in AI integration across the medical industry and beyond."
- Vection Managing Director, Gianmarco Biagi

Vection Technologies (ASX:VR1) has been awarded a $1.6 million artificial intelligence (AI) software licence contract for the Brexia Med healthcare project which uses technology developed by The Digital Box (TDB).
• $1.6m, three years, AI healthcare software licences sale.
• Option for an additional $1m for two further years.
• The contract includes recurring Algho AI licences and related AI-driven services.
• Algho AI is the proprietary artificial intelligence solution developed by TDB.
“This contract marks a significant milestone in showcasing the power of TDB’s AI capabilities. By providing AI-powered solutions, we are helping Brexia Med revolutionise its patient screening processes, creating a more efficient healthcare system.
The Algho AI platform is a game changer, demonstrating how AI can transform critical sectors like healthcare. This partnership highlights the potential of AI in driving innovation and opens doors to further opportunities in AI integration across the medical industry and beyond."
- Vection Managing Director, Gianmarco Biagi
Australian youth-focused fashion retailer Universal Store Holdings (ASX: UNI) delivered a strong update on its performance in the first 17 weeks of the current financial year, headlined by a 19.3% jump in direct-to-consumer sales when compared with the same time last year.
👖 Sales in the company’s Universal Store brand increased by 15.5% from twelve months prior, with strong growth across both women’s and men’s categories
👟 Sales in the Perfect Stanger brand rocketed by 111% year-on-year on the back of an expanding customer base
🧢 Three new stores opened in FY25 so far, with between 9 and 15 more stores on track for opening in the remainder of the financial year
“We’re pleased with the start of FY25 which has seen strong sales growth while maintaining the robust gross margins achieved in H2 FY24. The team continue to deliver a customer centric experience and product range with a focus on speed and nimbleness.” – Alice Barbery, Universal Store Holdings Chief Executive Officer

Australian youth-focused fashion retailer Universal Store Holdings (ASX: UNI) delivered a strong update on its performance in the first 17 weeks of the current financial year, headlined by a 19.3% jump in direct-to-consumer sales when compared with the same time last year.
👖 Sales in the company’s Universal Store brand increased by 15.5% from twelve months prior, with strong growth across both women’s and men’s categories
👟 Sales in the Perfect Stanger brand rocketed by 111% year-on-year on the back of an expanding customer base
🧢 Three new stores opened in FY25 so far, with between 9 and 15 more stores on track for opening in the remainder of the financial year
“We’re pleased with the start of FY25 which has seen strong sales growth while maintaining the robust gross margins achieved in H2 FY24. The team continue to deliver a customer centric experience and product range with a focus on speed and nimbleness.” – Alice Barbery, Universal Store Holdings Chief Executive Officer
Novatti (ASX:NOV) CEO, Mark Healy will present at The Stock Network`s ASX Gems investor event Tomorrow, 1 November 💡

Novatti (ASX:NOV) CEO, Mark Healy will present at The Stock Network`s ASX Gems investor event Tomorrow, 1 November 💡
AdAlta (ASX:1AD) CEO and Managing Director, Tim Oldham will present at The Stock Network`s ASX Gems investor event on Friday, 1 November 💡

AdAlta (ASX:1AD) CEO and Managing Director, Tim Oldham will present at The Stock Network`s ASX Gems investor event on Friday, 1 November 💡
Veris (ASX:VRS) Managing Director and CEO, Michael Shirley will present at The Stock Network`s ASX Gems investor event Tomorrow, 1 November 💡

Veris (ASX:VRS) Managing Director and CEO, Michael Shirley will present at The Stock Network`s ASX Gems investor event Tomorrow, 1 November 💡
Australian retailer Myer Holdings (ASX: MYR) has entered an agreement with fellow-ASX listed outfit Premier Investments to purchase a portfolio of popular clothing lines known as Apparel Brands, which consist of household names Just Jeans, Jay Jays, Portmans, Dotti, and Jacquie E.
👗 The all-share deal is anticipated to deliver significantly enhanced scale for Myer, providing operating leverage benefits and new capabilities to drive growth
👠 Expected to create a leading retail platform across Australia and New Zealand with close to 800 new stores for Myer
👜 Projected to generate combination benefits of at least $30 million per annum in earnings for Myer, as well as substantial growth in earnings per share
““The combination of Myer and Apparel Brands is transformational for our business. If approved by shareholders, it will create a leading retail group with more than 780 stores across Australia and New Zealand, with a large and highly engaged customer base and capital to fund future investment and growth.” – Olivia Wirth, Myer Executive Chair

Australian retailer Myer Holdings (ASX: MYR) has entered an agreement with fellow-ASX listed outfit Premier Investments to purchase a portfolio of popular clothing lines known as Apparel Brands, which consist of household names Just Jeans, Jay Jays, Portmans, Dotti, and Jacquie E.
👗 The all-share deal is anticipated to deliver significantly enhanced scale for Myer, providing operating leverage benefits and new capabilities to drive growth
👠 Expected to create a leading retail platform across Australia and New Zealand with close to 800 new stores for Myer
👜 Projected to generate combination benefits of at least $30 million per annum in earnings for Myer, as well as substantial growth in earnings per share
““The combination of Myer and Apparel Brands is transformational for our business. If approved by shareholders, it will create a leading retail group with more than 780 stores across Australia and New Zealand, with a large and highly engaged customer base and capital to fund future investment and growth.” – Olivia Wirth, Myer Executive Chair
AML3D (ASX:AL3) Managing Director, Sean Ebert will present at The Stock Network`s ASX Gems investor event on Tomorrow, 1 November 💡

AML3D (ASX:AL3) Managing Director, Sean Ebert will present at The Stock Network`s ASX Gems investor event on Tomorrow, 1 November 💡
Optiscan Imaging (ASX:OIL) CEO and Managing Director, Dr Camile Farah will present at The Stock Network`s ASX Gems investor event on Tomorrow, 1 November 💡

Optiscan Imaging (ASX:OIL) CEO and Managing Director, Dr Camile Farah will present at The Stock Network`s ASX Gems investor event on Tomorrow, 1 November 💡
Belararox (ASX:BRX) Managing Director, Arvind Misra will present at The Stock Network`s ASX Gems investor event on Tomorrow, 1 November 💡

Belararox (ASX:BRX) Managing Director, Arvind Misra will present at The Stock Network`s ASX Gems investor event on Tomorrow, 1 November 💡
Merino & Co (ASX:MNC) listed yesterday on the ASX with a ticker code of MNC. The merino wool company sells wool clothing and accessories in more than 600 points of sale across Australia. Merino & Co is a vertically integrated company involving the manufacture, marketing and sale of wool products, predominantly featuring fine Merino wool, to both Australian and international markets and it’s partners include the Australia Made label and Australian Wool Network certifications.

Merino & Co (ASX:MNC) listed yesterday on the ASX with a ticker code of MNC. The merino wool company sells wool clothing and accessories in more than 600 points of sale across Australia. Merino & Co is a vertically integrated company involving the manufacture, marketing and sale of wool products, predominantly featuring fine Merino wool, to both Australian and international markets and it’s partners include the Australia Made label and Australian Wool Network certifications.
Great Southern Mining (ASX:GSN), Managing Director Matthew Keane will present at The Stock Network`s ASX Gems investor event on Friday, 1 November 💡

Great Southern Mining (ASX:GSN), Managing Director Matthew Keane will present at The Stock Network`s ASX Gems investor event on Friday, 1 November 💡
Battery technology business Li-S Energy (ASX: LIS) has delivered a breakthrough for its innovative lithium-sulfur battery technology with testing at its automated pouch cell production facility achieving close to 500Wh/kg lithium-sulfur cell performance.
🔋 Manufactured full-size 10Ah semi-solid-state cells with energy density of 498Wh/kg on first discharge, marking a substantial improvement for the technology
💡 Higher energy density means a lighter battery, potentially helping to improve range, payload, and operating time for partner products
🔌 Targeting the rapidly growing drone, defence, and electric aviation markets where battery weight is critical
“Our partners in the aerospace, drone and defence industries have been clear that they need the highest possible energy density for their applications, plus reliable, high-quality cell production and a pathway to scale as demand grows. Our strategy has been to deliver to this requirement” – Dr Lee Finniear, Li-S Energy Chief Executive Officer

Battery technology business Li-S Energy (ASX: LIS) has delivered a breakthrough for its innovative lithium-sulfur battery technology with testing at its automated pouch cell production facility achieving close to 500Wh/kg lithium-sulfur cell performance.
🔋 Manufactured full-size 10Ah semi-solid-state cells with energy density of 498Wh/kg on first discharge, marking a substantial improvement for the technology
💡 Higher energy density means a lighter battery, potentially helping to improve range, payload, and operating time for partner products
🔌 Targeting the rapidly growing drone, defence, and electric aviation markets where battery weight is critical
“Our partners in the aerospace, drone and defence industries have been clear that they need the highest possible energy density for their applications, plus reliable, high-quality cell production and a pathway to scale as demand grows. Our strategy has been to deliver to this requirement” – Dr Lee Finniear, Li-S Energy Chief Executive Officer
Global Metals & Mining, CEO Paul Smith will present at The Stock Network`s ASX Gems investor event on Friday, 1 November💡

Global Metals & Mining, CEO Paul Smith will present at The Stock Network`s ASX Gems investor event on Friday, 1 November💡
chelon Resources (ASX:ECH)CEO & Managing Director, Andrew Jefferies will present at The Stock Network`s ASX Gems investor event on Friday, 1 November 💡

chelon Resources (ASX:ECH)CEO & Managing Director, Andrew Jefferies will present at The Stock Network`s ASX Gems investor event on Friday, 1 November 💡
RateMyAgent (ASX:RMY), Non-Executive Chairman David Williams will present at The Stock Network`s ASX Gems investor event on Friday, 1 November 💡

RateMyAgent (ASX:RMY), Non-Executive Chairman David Williams will present at The Stock Network`s ASX Gems investor event on Friday, 1 November 💡
Tennant Minerals (ASX:TMS) forms strategic copper and gold alliance
Tennant Minerals is collaborating with Emmerson Resources (ASX:ERM) and CuFe (ASX:CUF) to form a Strategic Alliance on their copper, gold and critical metals development opportunities in the Tennant Creek Region of the Northern Territory.
⛏️ Completing a Scoping Study on development options for the Emmerson Resources and Tennant Minerals 100%-owned deposits and the CuFe-operated JV deposits
🪨 On completion of the Scoping Study, a Pre-Feasibility Study to be undertaken premised on the preferred option(s) to develop the JV deposits
⚒️ Alliance to investigate potential synergies with other explorers and developers in the region
Tennant Minerals Managing Director Vincent Algar said: “The production history of Tennant Creek copper and gold supports the shared facility model we plan to investigate in this collaboration. The strategy will provide a shorter pathway to production and incentivise TMS to continue its exploration effort targeting further discoveries like Bluebird on our tenements.”

Tennant Minerals (ASX:TMS) forms strategic copper and gold alliance
Tennant Minerals is collaborating with Emmerson Resources (ASX:ERM) and CuFe (ASX:CUF) to form a Strategic Alliance on their copper, gold and critical metals development opportunities in the Tennant Creek Region of the Northern Territory.
⛏️ Completing a Scoping Study on development options for the Emmerson Resources and Tennant Minerals 100%-owned deposits and the CuFe-operated JV deposits
🪨 On completion of the Scoping Study, a Pre-Feasibility Study to be undertaken premised on the preferred option(s) to develop the JV deposits
⚒️ Alliance to investigate potential synergies with other explorers and developers in the region
Tennant Minerals Managing Director Vincent Algar said: “The production history of Tennant Creek copper and gold supports the shared facility model we plan to investigate in this collaboration. The strategy will provide a shorter pathway to production and incentivise TMS to continue its exploration effort targeting further discoveries like Bluebird on our tenements.”
The Stock Network is pleased to support the Sydney Mining Club and interview Nickel Industries (ASX:NIC) Managing Director Justin Werner, who will be presenting at the 294th Sydney Mining Club Lunchtime Event. Hear how Nickel Industries continued to grow and diversify its operations during a 12-month period of relative nickel price weakness, in the process reinforcing its position as a major global nickel miner and producer. Joining The Stock Network’s Lel Smits ahead of appearing at Sydney Mining Club is Nickel Industries (ASX:NIC) Managing Director Justin Werner.
🗓 7 November 2024
🕛 12:15 PM
📍 Ivy Ballroom, Sydney

The Stock Network is pleased to support the Sydney Mining Club and interview Nickel Industries (ASX:NIC) Managing Director Justin Werner, who will be presenting at the 294th Sydney Mining Club Lunchtime Event. Hear how Nickel Industries continued to grow and diversify its operations during a 12-month period of relative nickel price weakness, in the process reinforcing its position as a major global nickel miner and producer. Joining The Stock Network’s Lel Smits ahead of appearing at Sydney Mining Club is Nickel Industries (ASX:NIC) Managing Director Justin Werner.
🗓 7 November 2024
🕛 12:15 PM
📍 Ivy Ballroom, Sydney
Leading independent beverage company Good Drinks Australia (ASX: GDA) has delivered a solid set of numbers for the first quarter of FY25, headlined by its core beer business significantly outperforming the overall beer market. The group is Australia’s fastest growing manufacturer in the beer category.
🍺 Core beer business saw 9% volume growth from the same time last year, compared to decline in overall retail beer market of 4%
🥂Good Drink Australia’s own brands continued to outperform the beer market with 12% volume growth
🍷 Strong promotional programs in place for key summer trading period, expected to drive FY25 earnings
“"This has been another strong performance by Good Drinks, with excellent growth results being a validation of our Market Share Strategy. To continue to achieve substantial volume sales growth against a backdrop of overall market decline, demonstrates the effectiveness of this strategy and the strength of the Company`s brands.” – John Hoedemaker, Good Drinks Australia Managing Director

Leading independent beverage company Good Drinks Australia (ASX: GDA) has delivered a solid set of numbers for the first quarter of FY25, headlined by its core beer business significantly outperforming the overall beer market. The group is Australia’s fastest growing manufacturer in the beer category.
🍺 Core beer business saw 9% volume growth from the same time last year, compared to decline in overall retail beer market of 4%
🥂Good Drink Australia’s own brands continued to outperform the beer market with 12% volume growth
🍷 Strong promotional programs in place for key summer trading period, expected to drive FY25 earnings
“"This has been another strong performance by Good Drinks, with excellent growth results being a validation of our Market Share Strategy. To continue to achieve substantial volume sales growth against a backdrop of overall market decline, demonstrates the effectiveness of this strategy and the strength of the Company`s brands.” – John Hoedemaker, Good Drinks Australia Managing Director
Praemium (ASX:PPS) reports its funds and flows for the September 2024 quarter
🔹Total funds under administration (FUA) of $59.4 billion (30 September 2023: $44.6 billion, up 33%)
🔹Quarterly net inflows of $139 million (up $553m compared to the previous quarter)
🔹Net platform inflows for the September 2024 quarter were augmented by $837 million in positive market movement..
Commenting on the September 2024 quarter funds and flows data, Praemium CEO Anthony Wamsteker said: “The September quarter was extremely pleasing. We are well-placed for further growth with the launch of Spectrum, our next generation Investor Directed Portfolio Service (IDPS). Every service, and virtually every growth metric, has improved from the previous quarter."

Praemium (ASX:PPS) reports its funds and flows for the September 2024 quarter
🔹Total funds under administration (FUA) of $59.4 billion (30 September 2023: $44.6 billion, up 33%)
🔹Quarterly net inflows of $139 million (up $553m compared to the previous quarter)
🔹Net platform inflows for the September 2024 quarter were augmented by $837 million in positive market movement..
Commenting on the September 2024 quarter funds and flows data, Praemium CEO Anthony Wamsteker said: “The September quarter was extremely pleasing. We are well-placed for further growth with the launch of Spectrum, our next generation Investor Directed Portfolio Service (IDPS). Every service, and virtually every growth metric, has improved from the previous quarter."
Vection Technologies (ASX: VR1), a specialist in immersive and extended reality (XR) solutions for businesses, has partnered with global IT heavyweight Dell to launch its AI-based platform for use in spatial computing, known as Algho.
🥽 First sale of Algho to Dell valued at about $500,000, opening the door to wider market penetration and future sales opportunities
🤖 Collaboration with Dell strengthens Vection’s position in artificial intelligence and spatial computing, with Algho now available to Dell’s salesforce and partners
🎥 Algho builds on the company’s growing portfolio of spatial computing solutions, including its established VRONE product line used for virtual production in filmmaking
“This agreement showcases the power and potential of our solutions and opens incredible opportunities for us in the AI and Spatial Computing markets. We are excited about the future and confident this is just the beginning of a much larger journey.” – Gianmarco Biagi, Vection Technologies Chief Executive Officer

Vection Technologies (ASX: VR1), a specialist in immersive and extended reality (XR) solutions for businesses, has partnered with global IT heavyweight Dell to launch its AI-based platform for use in spatial computing, known as Algho.
🥽 First sale of Algho to Dell valued at about $500,000, opening the door to wider market penetration and future sales opportunities
🤖 Collaboration with Dell strengthens Vection’s position in artificial intelligence and spatial computing, with Algho now available to Dell’s salesforce and partners
🎥 Algho builds on the company’s growing portfolio of spatial computing solutions, including its established VRONE product line used for virtual production in filmmaking
“This agreement showcases the power and potential of our solutions and opens incredible opportunities for us in the AI and Spatial Computing markets. We are excited about the future and confident this is just the beginning of a much larger journey.” – Gianmarco Biagi, Vection Technologies Chief Executive Officer
Golden Deeps (ASX:GED) releases new Silver-Copper Mineral Resource model that highlights extension potential for high-grade Khusib Springs deposit in Namibia
⛏️ The Khusib Springs deposit is analogous to the world-class Tsumeb Cu-Pb-Zn-Ag deposit
⚒️ The Company’s previous drilling produced thick intersections of silver and copper, with zinc and antimony, associated with veins and blebs of the silver-copper bearing sulphide mineral, Tennantite.
Golden Deeps CEO Jon Dugdale commented: “The increasing silver price has triggered a review and new Mineral Resource modelling and targeting, based on the new mineralisation discovered below the very high-grade Khusib Springs deposit, which previously produced 300,000 tonnes at 584g/t silver and 10% copper."

Golden Deeps (ASX:GED) releases new Silver-Copper Mineral Resource model that highlights extension potential for high-grade Khusib Springs deposit in Namibia
⛏️ The Khusib Springs deposit is analogous to the world-class Tsumeb Cu-Pb-Zn-Ag deposit
⚒️ The Company’s previous drilling produced thick intersections of silver and copper, with zinc and antimony, associated with veins and blebs of the silver-copper bearing sulphide mineral, Tennantite.
Golden Deeps CEO Jon Dugdale commented: “The increasing silver price has triggered a review and new Mineral Resource modelling and targeting, based on the new mineralisation discovered below the very high-grade Khusib Springs deposit, which previously produced 300,000 tonnes at 584g/t silver and 10% copper."
Compumedics (ASX: CMP), a medical device business specialising in diagnostics technology for sleep, brain, and ultrasonic blood-flow monitoring applications, has delivered a 136% increase in US orders during the first quarter of FY25, when compared to the same time last year.
🩺 Momentum continuing to build in core US market as Compumedics targets accelerated growth in FY25 with new sales resources coming on board
💤 Sleep business is leading growth US, including sales of wearable device for collecting patients’ physiological data, Somfit, now closing in on $1m
🛌 Sales momentum also evident in Europe with new $800,000 sale to leading sleep customer in Poland against all major competitors
🧠 On track to deliver more than $55m in sales in FY25, and EBITDA of about $5m

Compumedics (ASX: CMP), a medical device business specialising in diagnostics technology for sleep, brain, and ultrasonic blood-flow monitoring applications, has delivered a 136% increase in US orders during the first quarter of FY25, when compared to the same time last year.
🩺 Momentum continuing to build in core US market as Compumedics targets accelerated growth in FY25 with new sales resources coming on board
💤 Sleep business is leading growth US, including sales of wearable device for collecting patients’ physiological data, Somfit, now closing in on $1m
🛌 Sales momentum also evident in Europe with new $800,000 sale to leading sleep customer in Poland against all major competitors
🧠 On track to deliver more than $55m in sales in FY25, and EBITDA of about $5m
Battery technology business Altech Batteries (ASX: ATC) has delivered a breakthrough for its proprietary Silumina Anodes technology with laboratory testing generating 55% higher energy capacity compared to graphite-only anode material traditionally utilised in lithium-ion batteries that are used to power electric vehicles.
🔋 Silumina Anodes uses a blend of alumina-coated silicon particles with battery-grade graphite to create a composite graphite-silicon anode for lithium-ion batteries
🚗 The new results represent a notable improvement from previous testing where a 30% increase in energy capacity was reported over traditional graphite-only anodes
🔌 Altech is in the process of commissioning a pilot plant as it looks to fast-track its Silumina Anodes technology to commercialisation
“Our breakthrough technology represents a major step forward in unlocking the full potential of silicon in lithium-ion batteries, and we believe it has the potential to revolutionise the battery industry.” – Iggy Tan, Altech’s Chief Executive Office and Managing Director

Battery technology business Altech Batteries (ASX: ATC) has delivered a breakthrough for its proprietary Silumina Anodes technology with laboratory testing generating 55% higher energy capacity compared to graphite-only anode material traditionally utilised in lithium-ion batteries that are used to power electric vehicles.
🔋 Silumina Anodes uses a blend of alumina-coated silicon particles with battery-grade graphite to create a composite graphite-silicon anode for lithium-ion batteries
🚗 The new results represent a notable improvement from previous testing where a 30% increase in energy capacity was reported over traditional graphite-only anodes
🔌 Altech is in the process of commissioning a pilot plant as it looks to fast-track its Silumina Anodes technology to commercialisation
“Our breakthrough technology represents a major step forward in unlocking the full potential of silicon in lithium-ion batteries, and we believe it has the potential to revolutionise the battery industry.” – Iggy Tan, Altech’s Chief Executive Office and Managing Director
Enlitic, Inc. (ASX:ENL) signs 3-year distribution contract with Bayer Healthcare for its ENDEX product for Radiation Dosimetry.
🩻 Bayer Healthcare is one of the largest pharmaceutical and biomedical companies in the world, offering products and services that empower radiologists to deliver high-quality contrast-enhanced imaging in CT and MR.
🩺 The contract is the third collaboration between Enlitic and Bayer, and will expand ENDEX into a new use case: Radiation Dosimetry for radiation dose monitoring
Michael Sistenich, CEO of Enlitic, said “We are incredibly excited to be working with the team at Bayer to support them with radiation dose monitoring to their customers. Ensuring patient radiation doses remain within safe limits is critical to providing high-quality care.”

Enlitic, Inc. (ASX:ENL) signs 3-year distribution contract with Bayer Healthcare for its ENDEX product for Radiation Dosimetry.
🩻 Bayer Healthcare is one of the largest pharmaceutical and biomedical companies in the world, offering products and services that empower radiologists to deliver high-quality contrast-enhanced imaging in CT and MR.
🩺 The contract is the third collaboration between Enlitic and Bayer, and will expand ENDEX into a new use case: Radiation Dosimetry for radiation dose monitoring
Michael Sistenich, CEO of Enlitic, said “We are incredibly excited to be working with the team at Bayer to support them with radiation dose monitoring to their customers. Ensuring patient radiation doses remain within safe limits is critical to providing high-quality care.”
Cutting-edge nanotechnology business Nanoveu (ASX: NVU) is set to acquire semiconductor design company EMASS – a specialist in advanced ‘System on a Chip’ technology which consolidates all essential components of a computer, like memory and network communications, into a single chip.
🖥️ Pivotal $5m deal will grant Nanoveu access to proprietary semiconductor System on a Chip technology and intellectual property held by EMASS
📱System on a Chip allows electronic devices to perform complex tasks such as AI acceleration, data processing, and wireless communication more effectively
📺 Expected to boost market reach for Nanoveu’s EyeFly3D platform to a greater range of electronic products, whilst also delivering glasses-free 3D experiences to new applications including medical devices and digital signage
“As recent market interest in our EyeFly3D technology has grown significantly, we embarked on a search for the best-in-class solution to further increase its commercialisation opportunities. The agreement to acquire EMASS marks a pivotal moment for Nanoveu, positioning us to deliver superior, glasses-free 3D experiences across a broader range of devices and industries.” – Alfred Chong, Nanoveu’s Managing Director and Chief Executive Officer

Cutting-edge nanotechnology business Nanoveu (ASX: NVU) is set to acquire semiconductor design company EMASS – a specialist in advanced ‘System on a Chip’ technology which consolidates all essential components of a computer, like memory and network communications, into a single chip.
🖥️ Pivotal $5m deal will grant Nanoveu access to proprietary semiconductor System on a Chip technology and intellectual property held by EMASS
📱System on a Chip allows electronic devices to perform complex tasks such as AI acceleration, data processing, and wireless communication more effectively
📺 Expected to boost market reach for Nanoveu’s EyeFly3D platform to a greater range of electronic products, whilst also delivering glasses-free 3D experiences to new applications including medical devices and digital signage
“As recent market interest in our EyeFly3D technology has grown significantly, we embarked on a search for the best-in-class solution to further increase its commercialisation opportunities. The agreement to acquire EMASS marks a pivotal moment for Nanoveu, positioning us to deliver superior, glasses-free 3D experiences across a broader range of devices and industries.” – Alfred Chong, Nanoveu’s Managing Director and Chief Executive Officer
Global HR technology platform Xref (ASX:XF1) has entered into an Exclusivity Deed with Seek (ASX:SEK)
🔹Following receipt of a non-binding indicative offer to acquire all of the ordinary Xref shares on issue for $0.2181 in cash per Xref share, by way of a scheme of arrangement
🔹Xref undertook a period of engagement and preliminary commercial due diligence with interested parties, including SEEK

Global HR technology platform Xref (ASX:XF1) has entered into an Exclusivity Deed with Seek (ASX:SEK)
🔹Following receipt of a non-binding indicative offer to acquire all of the ordinary Xref shares on issue for $0.2181 in cash per Xref share, by way of a scheme of arrangement
🔹Xref undertook a period of engagement and preliminary commercial due diligence with interested parties, including SEEK
James Bay Minerals (ASX:JBY) has entered a binding agreement pursuant to which the Company has the right to acquire up to 100% of the advanced Independence Gold Project located in Nevada, United States of America.
James Bay Minerals Executive Director, Andrew Dornan, said: “This is an exceptional opportunity for our shareholders and we are extremely fortunate to have secured this acquisition and earn-in at the Independence Gold Project. This gives us the opportunity to enhance our existing asset base in North America with a substantial high-grade gold asset with immediate growth potential.”

James Bay Minerals (ASX:JBY) has entered a binding agreement pursuant to which the Company has the right to acquire up to 100% of the advanced Independence Gold Project located in Nevada, United States of America.
James Bay Minerals Executive Director, Andrew Dornan, said: “This is an exceptional opportunity for our shareholders and we are extremely fortunate to have secured this acquisition and earn-in at the Independence Gold Project. This gives us the opportunity to enhance our existing asset base in North America with a substantial high-grade gold asset with immediate growth potential.”
Mexican inspired casual and fast-food restaurant business Guzman Y Gomez (ASX: GYG) has kept the momentum rolling since listing on the ASX in June this year by delivering $279 million in network sales during the first quarter of FY25, up 20.7 per cent from the same time last year.
🌮 Comparable sales in Australia above expectations on the back of strong delivery performance, successful execution of ‘Clean is the New Healthy’ campaign and demand for value menu items
🌶️ The US segment performed in line with expectations
🌯 Total number of corporate and franchised restaurants across Australia, Singapore, Japan and the US reached 226 during the quarter, up from 204 a year ago
🥑 On track to meet prospectus forecasts for FY25 with 31 new restaurants in Australia projected to open

Mexican inspired casual and fast-food restaurant business Guzman Y Gomez (ASX: GYG) has kept the momentum rolling since listing on the ASX in June this year by delivering $279 million in network sales during the first quarter of FY25, up 20.7 per cent from the same time last year.
🌮 Comparable sales in Australia above expectations on the back of strong delivery performance, successful execution of ‘Clean is the New Healthy’ campaign and demand for value menu items
🌶️ The US segment performed in line with expectations
🌯 Total number of corporate and franchised restaurants across Australia, Singapore, Japan and the US reached 226 during the quarter, up from 204 a year ago
🥑 On track to meet prospectus forecasts for FY25 with 31 new restaurants in Australia projected to open
Counter-drone defense business DroneShield (ASX:DRO) has nailed down a repeat $13.5 million order from a US Government customer for its dismounted C-UxS systems used to protect clients from hostile drone attacks.
🛰️ Full delivery and cash receipt from the new order expected in current quarter
🛡️ DroneShield is the only publicly listed company with pure-play exposure to the rapidly growing counter-drone/counter-UAS sector playing a key role in military, intelligence and law enforcement industries
🚀 New contract builds on a recently reported first-half record in revenue of $24.1 million and cash receipts of $21.4 million for H1FY24
“DroneShield’s ability to rapidly deliver high-performance, lifesaving technology at this scale sets us apart in the counter-UAS industry, empowering our clients with cutting-edge solutions precisely when they need it.” - Tom Branstetter, DroneShield’s Director of Business Development

Counter-drone defense business DroneShield (ASX:DRO) has nailed down a repeat $13.5 million order from a US Government customer for its dismounted C-UxS systems used to protect clients from hostile drone attacks.
🛰️ Full delivery and cash receipt from the new order expected in current quarter
🛡️ DroneShield is the only publicly listed company with pure-play exposure to the rapidly growing counter-drone/counter-UAS sector playing a key role in military, intelligence and law enforcement industries
🚀 New contract builds on a recently reported first-half record in revenue of $24.1 million and cash receipts of $21.4 million for H1FY24
“DroneShield’s ability to rapidly deliver high-performance, lifesaving technology at this scale sets us apart in the counter-UAS industry, empowering our clients with cutting-edge solutions precisely when they need it.” - Tom Branstetter, DroneShield’s Director of Business Development
Ahead of appearing at the Stocks On Track event, PolyNovo (ASX:PNV) Non-Executive Chairman David Williams speaks with The Stock Network`s Lel Smits and highlights:
⚙️ Unique technology
🏆 Competitive landscape
🤝 Collaborations & innovation
🖋️ Valuation

Ahead of appearing at the Stocks On Track event, PolyNovo (ASX:PNV) Non-Executive Chairman David Williams speaks with The Stock Network`s Lel Smits and highlights:
⚙️ Unique technology
🏆 Competitive landscape
🤝 Collaborations & innovation
🖋️ Valuation
Neuren Pharmaceuticals (ASX:NEU) has discussed proposals for the first ever pivotal clinical trial program in Phelan-McDermid syndrome (PMS) with the US Food and Drug Administration.
⚪️There are no medications approved for PMS, which has severe quality of life impacts on those living with it, as well as on parents and siblings
⚪️At the FDA meeting alignment was reached on key aspects of the NNZ-2591 Phase 3 program, with Neuren to submit further information to confirm endpoints for the primary efficacy assessment
“We are pleased with the outcomes of a very collaborative meeting with the FDA and are eager to move forward in our mission to develop NNZ-2591 as a first approved treatment for Phelan-McDermid syndrome, which has an overwhelming unmet need.” - Neuren CEO Jon Pilcher

Neuren Pharmaceuticals (ASX:NEU) has discussed proposals for the first ever pivotal clinical trial program in Phelan-McDermid syndrome (PMS) with the US Food and Drug Administration.
⚪️There are no medications approved for PMS, which has severe quality of life impacts on those living with it, as well as on parents and siblings
⚪️At the FDA meeting alignment was reached on key aspects of the NNZ-2591 Phase 3 program, with Neuren to submit further information to confirm endpoints for the primary efficacy assessment
“We are pleased with the outcomes of a very collaborative meeting with the FDA and are eager to move forward in our mission to develop NNZ-2591 as a first approved treatment for Phelan-McDermid syndrome, which has an overwhelming unmet need.” - Neuren CEO Jon Pilcher
Ahead of appearing at the Stocks On Track event, Praemium Limited (ASX:PPS) Chief Executive Officer, Anthony Wamsteker, speaks with The Stock Network`s Lel Smits and highlights:
🏆 Focus on earnings growth in FY24
⚙️ FY25 outlook

Ahead of appearing at the Stocks On Track event, Praemium Limited (ASX:PPS) Chief Executive Officer, Anthony Wamsteker, speaks with The Stock Network`s Lel Smits and highlights:
🏆 Focus on earnings growth in FY24
⚙️ FY25 outlook
PainChek (ASX:PCK), developer of the world’s first smart phone-based pain assessment and monitoring application, has provided an update on its progress with FDA de Novo submission for the PainChek Adult App.
- Majority of requirements for submission complete – Clinical Evaluation Report in final stages
- PainChek expects to provide a further update this month regarding the submission
- US Aged Care market is the world’s largest – 1.7 million people long-term aged care
- Potential FDA clearance for the Adult app would be a major milestone for the Company and provides a predicate for PainChek’s use with infants and in other market segments
Philip Daffas, CEO of PainChek, said “The US Aged Care market is the largest in the world where 1,700,000 people reside in these long-term care facilities, with a potential gross annual recurring revenue value of around $85,000,000 USD for PainChek based on our projected US pricing."

PainChek (ASX:PCK), developer of the world’s first smart phone-based pain assessment and monitoring application, has provided an update on its progress with FDA de Novo submission for the PainChek Adult App.
- Majority of requirements for submission complete – Clinical Evaluation Report in final stages
- PainChek expects to provide a further update this month regarding the submission
- US Aged Care market is the world’s largest – 1.7 million people long-term aged care
- Potential FDA clearance for the Adult app would be a major milestone for the Company and provides a predicate for PainChek’s use with infants and in other market segments
Philip Daffas, CEO of PainChek, said “The US Aged Care market is the largest in the world where 1,700,000 people reside in these long-term care facilities, with a potential gross annual recurring revenue value of around $85,000,000 USD for PainChek based on our projected US pricing."
The Original Juice Company (ASX:OJC) has merged with SPC Global and the powdered milk business owned by Nature One Dairy. The deal will deliver OJC with increased scale, diversification, significant operational synergies and a platform for further growth.
🍍 The deal is expected to create a market-leading Australian and global food and beverage company
🍊 SPC is a leader in the Australian food market and is one of the largest producers of packaged fruit, tomato-based products, baked beans, spaghetti and ready-made meals in Australia
🐮 Nature One Dairy is a Singaporean-registered, Australian-founded dairy business with powdered and baby formula milk products produced in Australia and sold extensively throughout Asia.
“SPC Global is excited to be joining with OJC and Nature One Dairy and come to market with a leading food and beverage platform.” - SPC’s incoming Managing Director, Robert Iervasi, who will lead the Combined Business

The Original Juice Company (ASX:OJC) has merged with SPC Global and the powdered milk business owned by Nature One Dairy. The deal will deliver OJC with increased scale, diversification, significant operational synergies and a platform for further growth.
🍍 The deal is expected to create a market-leading Australian and global food and beverage company
🍊 SPC is a leader in the Australian food market and is one of the largest producers of packaged fruit, tomato-based products, baked beans, spaghetti and ready-made meals in Australia
🐮 Nature One Dairy is a Singaporean-registered, Australian-founded dairy business with powdered and baby formula milk products produced in Australia and sold extensively throughout Asia.
“SPC Global is excited to be joining with OJC and Nature One Dairy and come to market with a leading food and beverage platform.” - SPC’s incoming Managing Director, Robert Iervasi, who will lead the Combined Business
Golden Deeps (ASX:GED) tenements in the Lachlan Fold Belt offer a unique opportunity for discovery. With a large landholding in a less explored area, they`ve identified a promising new sulphide zone containing copper and zinc. Jon Dugdale CEO speaks with The Stock Network`s Lel Smits about:
⚙️ Strategic tenement holding
🚧 Significant new sulphide zone
🪨 Potential for large sulphide system

Golden Deeps (ASX:GED) tenements in the Lachlan Fold Belt offer a unique opportunity for discovery. With a large landholding in a less explored area, they`ve identified a promising new sulphide zone containing copper and zinc. Jon Dugdale CEO speaks with The Stock Network`s Lel Smits about:
⚙️ Strategic tenement holding
🚧 Significant new sulphide zone
🪨 Potential for large sulphide system
Ahead of appearing at the Stocks On Track event, Magnetic Resource (ASX:MAU) Founder and Managing Director, George Sakalidis speaks with The Stock Network`s Lel Smits and highlights:
🚧 Resource expansion
⛏️ Production milestones
⚙️ Technical advancements

Ahead of appearing at the Stocks On Track event, Magnetic Resource (ASX:MAU) Founder and Managing Director, George Sakalidis speaks with The Stock Network`s Lel Smits and highlights:
🚧 Resource expansion
⛏️ Production milestones
⚙️ Technical advancements
Tennant Minerals (ASX:TMS) recent drill results have confirmed the presence of thick, high-grade copper and gold zones, including silver. Vincent Algar, CEO speaks with The Stock Network`s Lel Smits about:
🚧 Increased potential for further expansion
⛏️ Discovery of thick, high-grade zones

Tennant Minerals (ASX:TMS) recent drill results have confirmed the presence of thick, high-grade copper and gold zones, including silver. Vincent Algar, CEO speaks with The Stock Network`s Lel Smits about:
🚧 Increased potential for further expansion
⛏️ Discovery of thick, high-grade zones
Archer Materials (ASX:AXE), a semiconductor company advancing the quantum technology and medical diagnostics industries, has developed a highly manufacturable carbon film with attractive quantum properties including long room-temperature electron spin lifetimes.
Greg English, Executive Chair of Archer, said “Working on this new film, alongside CNOs or even in place of CNOs, will accelerate development of our quantum technology and provide a means of volume manufacturing of such devices. By observing quantum phenomena sooner, we can eventually develop quantum devices more rapidly.”

Archer Materials (ASX:AXE), a semiconductor company advancing the quantum technology and medical diagnostics industries, has developed a highly manufacturable carbon film with attractive quantum properties including long room-temperature electron spin lifetimes.
Greg English, Executive Chair of Archer, said “Working on this new film, alongside CNOs or even in place of CNOs, will accelerate development of our quantum technology and provide a means of volume manufacturing of such devices. By observing quantum phenomena sooner, we can eventually develop quantum devices more rapidly.”
Vinyl Group (ASX:VNL), Australia’s only ASX-listed music Company, has executed an agreement to acquire Funkified Entertainment Pty Ltd.
● Acquire Funkified Entertainment Pty Ltd for $2.5M
● Brings Vinyl Group events function and capabilities in-house; improves margins and accelerates growth
Vinyl Group CEO, Josh Simons, said: “The acquisition of Funkified completes our acquisition strategy aimed at fully realising the opportunities identified in The Brag Media business, while improving group company margins, revenue and driving growth."

Vinyl Group (ASX:VNL), Australia’s only ASX-listed music Company, has executed an agreement to acquire Funkified Entertainment Pty Ltd.
● Acquire Funkified Entertainment Pty Ltd for $2.5M
● Brings Vinyl Group events function and capabilities in-house; improves margins and accelerates growth
Vinyl Group CEO, Josh Simons, said: “The acquisition of Funkified completes our acquisition strategy aimed at fully realising the opportunities identified in The Brag Media business, while improving group company margins, revenue and driving growth."
South32 (ASX:S32) has received a US$166 million grant from the US Department of Energy for development of its Clark deposit.
💡 "Hermosa’s Clark deposit is currently the only advanced project in the United States with a clear pathway to produce battery-grade manganese from locally sourced ore for the North American electric vehicle battery market"
💡 The grant from the DOE’s Battery Materials Processing and Battery Manufacturing program will support the potential development of a commercial-scale manganese production facility

South32 (ASX:S32) has received a US$166 million grant from the US Department of Energy for development of its Clark deposit.
💡 "Hermosa’s Clark deposit is currently the only advanced project in the United States with a clear pathway to produce battery-grade manganese from locally sourced ore for the North American electric vehicle battery market"
💡 The grant from the DOE’s Battery Materials Processing and Battery Manufacturing program will support the potential development of a commercial-scale manganese production facility
Golden Deeps (ASX:GED) intersects 92m thick sulphide bearing zone, extending Hazelbrook zone
🔹Golden Deeps has intersected a 92m thick zone of disseminated sulphides, including silver-bearing pyrite and patches of the copper sulphide chalcopyrite, in diamond drillhole HVD004 at the Company’s Havilah Project in the world-class Lachlan Fold Belt Copper-Gold Province of NSW
🔹This latest sulphide intersection extends the Hazelbrook sulphide mineralisation a further 200m northeast of the 80m sulphide intersection in HVD003
🔹The 92m sulphide-mineralised intersection in HVD004, from 39m downhole, is predominantly disseminated sulphides and includes a 42m zone from 88.2m with patches of chalcopyrite which produced portable XRF readings ranging up to 3.6% Cu, with an average of detected readings of 1,010 ppm
“The widespread mineralisation at Havilah indicates we’re on top of a large porphyry-sulphide system with similar geological characteristics to major deposits in the Lachlan Fold Belt such as Cadia-Ridgeway." Golden Deeps CEO Jon Dugdale

Golden Deeps (ASX:GED) intersects 92m thick sulphide bearing zone, extending Hazelbrook zone
🔹Golden Deeps has intersected a 92m thick zone of disseminated sulphides, including silver-bearing pyrite and patches of the copper sulphide chalcopyrite, in diamond drillhole HVD004 at the Company’s Havilah Project in the world-class Lachlan Fold Belt Copper-Gold Province of NSW
🔹This latest sulphide intersection extends the Hazelbrook sulphide mineralisation a further 200m northeast of the 80m sulphide intersection in HVD003
🔹The 92m sulphide-mineralised intersection in HVD004, from 39m downhole, is predominantly disseminated sulphides and includes a 42m zone from 88.2m with patches of chalcopyrite which produced portable XRF readings ranging up to 3.6% Cu, with an average of detected readings of 1,010 ppm
“The widespread mineralisation at Havilah indicates we’re on top of a large porphyry-sulphide system with similar geological characteristics to major deposits in the Lachlan Fold Belt such as Cadia-Ridgeway." Golden Deeps CEO Jon Dugdale
Bindi Metals (ASX:BIM) has acquired the Lisa Antimony-Gold Project and the Mutnica Antimony-Copper Project in Serbia.
⚪️Both projects display classic geological characteristics of carbonate replacement or Carlin style deposits
⚪️ Strategically located near major European markets and with well-established modern infrastructure and a robust, skilled local mining workforce
Bindi Metals Chairman, Eddie King said: “We are excited to confirm the historical high-grade antimony mining within the Lisa permit and also high grades of antimony present at Mutnica. These historical antimony-rich regions, with evidence of shallow past production, is ideally situated to assist Europe as it faces growing supply chain vulnerabilities for critical metals."

Bindi Metals (ASX:BIM) has acquired the Lisa Antimony-Gold Project and the Mutnica Antimony-Copper Project in Serbia.
⚪️Both projects display classic geological characteristics of carbonate replacement or Carlin style deposits
⚪️ Strategically located near major European markets and with well-established modern infrastructure and a robust, skilled local mining workforce
Bindi Metals Chairman, Eddie King said: “We are excited to confirm the historical high-grade antimony mining within the Lisa permit and also high grades of antimony present at Mutnica. These historical antimony-rich regions, with evidence of shallow past production, is ideally situated to assist Europe as it faces growing supply chain vulnerabilities for critical metals."
Globe Metals & Mining (ASX:GBE) receives a 12-month extension for commencement of mine development at Kanyika Project in Malawi.
⛏️ Malawi Government agrees to an extension of the initial requirement for commencement of Kanyika mine development works.
⚒️ These development works must now commence by 27 September 2025, a full year later than the initial requirement.
🪨 This gives Globe time to successfully progress several significant processes critical to the Kanyika Project’s eventual delivery.
“Globe Metals & Mining is extremely grateful for the proactive and supportive relationship it enjoys with the Government of Malawi." Globe’s Chief Executive Officer, Paul Smith

Globe Metals & Mining (ASX:GBE) receives a 12-month extension for commencement of mine development at Kanyika Project in Malawi.
⛏️ Malawi Government agrees to an extension of the initial requirement for commencement of Kanyika mine development works.
⚒️ These development works must now commence by 27 September 2025, a full year later than the initial requirement.
🪨 This gives Globe time to successfully progress several significant processes critical to the Kanyika Project’s eventual delivery.
“Globe Metals & Mining is extremely grateful for the proactive and supportive relationship it enjoys with the Government of Malawi." Globe’s Chief Executive Officer, Paul Smith
Stormeur is the owner and operator of Cosmetique, Australia’s first accredited cosmetic clinic chain, which is now successfully penetrating the lucrative cosmetic and aesthetic healthcare sector, and approaching its ASX IPO in October. Chairman and Managing Director Vivek Eranki speaks with The Stock Network`s Lel Smits about:
✍️ The Cosmetique® business & expansion strategy
💄 Capitalising on the growing cosmetics market
🔔 Stormeur`s upcoming ASX IPO, proposed ticker code: STR
To learn more about the IPO, watch the full interview ⚡

Stormeur is the owner and operator of Cosmetique, Australia’s first accredited cosmetic clinic chain, which is now successfully penetrating the lucrative cosmetic and aesthetic healthcare sector, and approaching its ASX IPO in October. Chairman and Managing Director Vivek Eranki speaks with The Stock Network`s Lel Smits about:
✍️ The Cosmetique® business & expansion strategy
💄 Capitalising on the growing cosmetics market
🔔 Stormeur`s upcoming ASX IPO, proposed ticker code: STR
To learn more about the IPO, watch the full interview ⚡
Lepidico (ASX:LPD) has advised that the Trelavour Hard Rock Project in Cornwall, which will employ Lepidico’s proprietary hydrometallurgical lithium processing technologies under licence, has been designated as a Nationally Significant Infrastructure Project by the Secretary of State for Housing Communities and Local Government.
Lepidico’s Managing Director Joe Walsh said, “The directive from the UK Government’s Secretary of State that the Trelavour lithium mica project should be treated as a Nationally Significant Infrastructure Project represents a significant endorsement of Lepidico’s proprietary patented process technologies.

Lepidico (ASX:LPD) has advised that the Trelavour Hard Rock Project in Cornwall, which will employ Lepidico’s proprietary hydrometallurgical lithium processing technologies under licence, has been designated as a Nationally Significant Infrastructure Project by the Secretary of State for Housing Communities and Local Government.
Lepidico’s Managing Director Joe Walsh said, “The directive from the UK Government’s Secretary of State that the Trelavour lithium mica project should be treated as a Nationally Significant Infrastructure Project represents a significant endorsement of Lepidico’s proprietary patented process technologies.
Praemium is focussed on organic growth opportunities in the year ahead -
🌱 Praemium is targeting organic business growth over the coming 12 months
🖊️ Leveraging the value of its niche offering to more specialised financial advisors
📍 Including those servicing high net worth clients
Watch the full video on TSN with Praemium CEO Anthony Wamsteker ⚡

Praemium is focussed on organic growth opportunities in the year ahead -
🌱 Praemium is targeting organic business growth over the coming 12 months
🖊️ Leveraging the value of its niche offering to more specialised financial advisors
📍 Including those servicing high net worth clients
Watch the full video on TSN with Praemium CEO Anthony Wamsteker ⚡
Anson Resources (ASX:ASN) has received final approval by the State of Utah, Department of Natural Resources, Division of Water Rights, for its Green River Lithium Project.
• Final-approval from State of Utah, Department of Natural Resources, Division of Water Rights,
• First State of Utah approval related to large scale lithium production at Green River,
• The approval process confirms the water resources and surrounding areas will not be negatively affected by brine extraction.
Anson’s Executive Chairman and CEO Bruce Richardson commented, “Through detailed community engagement and employment of local staff, our Company has developed deep community ties and an understanding of local issues. The Company always believed we were fully compliant with the requirements for this approval and will continue to work with all levels of government and the community to advance the Project."

Anson Resources (ASX:ASN) has received final approval by the State of Utah, Department of Natural Resources, Division of Water Rights, for its Green River Lithium Project.
• Final-approval from State of Utah, Department of Natural Resources, Division of Water Rights,
• First State of Utah approval related to large scale lithium production at Green River,
• The approval process confirms the water resources and surrounding areas will not be negatively affected by brine extraction.
Anson’s Executive Chairman and CEO Bruce Richardson commented, “Through detailed community engagement and employment of local staff, our Company has developed deep community ties and an understanding of local issues. The Company always believed we were fully compliant with the requirements for this approval and will continue to work with all levels of government and the community to advance the Project."
For the first time in over 40 years, a cargo train has crossed the border from Mozambique, revitalizing Malawi`s railway system. This historic event marks a significant step towards:
🛤️ Seamless trade routes, connecting Malawi to the coastline
🚂 Enhanced logistics, boosting the capabilities of Malawi-based industries
⛏️ Supporting major projects like the Kanyika Niobium Project, owned by Globe Metals & Mining
"This new train route is a major milestone for Malawi, the global mining industry, and our project. It will enable safe, cost-effective, and efficient transport of niobium oxide to our customers." - Globe Metals & Mining`s Chief Financial Officer, Charles Altshuler

For the first time in over 40 years, a cargo train has crossed the border from Mozambique, revitalizing Malawi`s railway system. This historic event marks a significant step towards:
🛤️ Seamless trade routes, connecting Malawi to the coastline
🚂 Enhanced logistics, boosting the capabilities of Malawi-based industries
⛏️ Supporting major projects like the Kanyika Niobium Project, owned by Globe Metals & Mining
"This new train route is a major milestone for Malawi, the global mining industry, and our project. It will enable safe, cost-effective, and efficient transport of niobium oxide to our customers." - Globe Metals & Mining`s Chief Financial Officer, Charles Altshuler
Ahead of appearing at the Spark+ Australian Equities Day in Singapore, BlinkLab`s (ASX:BB1) Non-Executive Chairman Brian Leedman speaks with The Stock Network’s Lel Smits about:
📱 BlinkLab`s autism diagnostic test, technology development and near priorities
📱 Technology features and potential commercial outcomes

Ahead of appearing at the Spark+ Australian Equities Day in Singapore, BlinkLab`s (ASX:BB1) Non-Executive Chairman Brian Leedman speaks with The Stock Network’s Lel Smits about:
📱 BlinkLab`s autism diagnostic test, technology development and near priorities
📱 Technology features and potential commercial outcomes
Belararox (ASX:BRX) has just announced the acquisition of the Kalahari Copper Project in Botswana. Managing Director Arvind Misra joins Lel Smits on The Stock Network to discuss:
🇧🇼 Acquisition of Kalahari Copper Project, Botswana
⛏️ Kalahari Copper Project exploration plans
🚧 Toro–Malambo–Tambo Project update

Belararox (ASX:BRX) has just announced the acquisition of the Kalahari Copper Project in Botswana. Managing Director Arvind Misra joins Lel Smits on The Stock Network to discuss:
🇧🇼 Acquisition of Kalahari Copper Project, Botswana
⛏️ Kalahari Copper Project exploration plans
🚧 Toro–Malambo–Tambo Project update
Australian fixed wireless network provider Swoop Holdings (ASX:SWP) has completed a $2.45 million purchase of a 16.99% stake in telecommunications group Vonex (ASX:VN8).
📲 Swoop is a national provider of data and voice services to channel, business and residential customers with a focus on its own fibre and fixed wireless infrastructure
☎️ Vonex works in a range of industries, from the Sydney Harbour Trust to IGA’s across Australia
📞 Swoop has acquired its interest in Vonex for around $2.45 million which has been funded from existing cash resources
“Swoop is in a strong position to be able to acquire the Vonex business and integrate and extract material synergies” - Swoop Chair James Spenceley

Australian fixed wireless network provider Swoop Holdings (ASX:SWP) has completed a $2.45 million purchase of a 16.99% stake in telecommunications group Vonex (ASX:VN8).
📲 Swoop is a national provider of data and voice services to channel, business and residential customers with a focus on its own fibre and fixed wireless infrastructure
☎️ Vonex works in a range of industries, from the Sydney Harbour Trust to IGA’s across Australia
📞 Swoop has acquired its interest in Vonex for around $2.45 million which has been funded from existing cash resources
“Swoop is in a strong position to be able to acquire the Vonex business and integrate and extract material synergies” - Swoop Chair James Spenceley
AML3D Limited (ASX:AL3) has secured a Manufacturing License Agreement with US Navy intermediary - Blue Forge Alliance (“BFA”) - which will allow AML3D to substantially expand its access opportunities to manufacture parts for the US Navy.
⚓️ The MLA allows AML3D to work with key suppliers and internal teams within the US Navy submarine industrial base
⚓️ The MLA enables the exchange of technical assistance and data, facilitating an expansion of AML3D’s activities to support the US Navy
⚓️ The contract is open ended and has no fixed term
AML3D believes this is a major strategic development in its supply relationship with the US Navy: "This MLA creates opportunities for AML3D to print more parts for the US Navy... Today’s MLA agreement creates many opportunities to develop and deepen relationship that have the potential to further accelerate our US scale up strategy” - AML3D Managing Director Sean Ebert

AML3D Limited (ASX:AL3) has secured a Manufacturing License Agreement with US Navy intermediary - Blue Forge Alliance (“BFA”) - which will allow AML3D to substantially expand its access opportunities to manufacture parts for the US Navy.
⚓️ The MLA allows AML3D to work with key suppliers and internal teams within the US Navy submarine industrial base
⚓️ The MLA enables the exchange of technical assistance and data, facilitating an expansion of AML3D’s activities to support the US Navy
⚓️ The contract is open ended and has no fixed term
AML3D believes this is a major strategic development in its supply relationship with the US Navy: "This MLA creates opportunities for AML3D to print more parts for the US Navy... Today’s MLA agreement creates many opportunities to develop and deepen relationship that have the potential to further accelerate our US scale up strategy” - AML3D Managing Director Sean Ebert
Ahead of appearing at the Spark+ Australian Equities Day in Singapore GTI Energy (ASX:GTR) Executive Director Bruce Lane speaks with The Stock Network’s Lel Smits about:
⛏️ In Situ Recovery Mining explained
⛏️ Lo Herma In Situ Recovery uranium deposit in Wyoming
⛏️ Exploration programs and development of these assets
⛏️ Plans for GTI Energy`s uranium projects in the US

Ahead of appearing at the Spark+ Australian Equities Day in Singapore GTI Energy (ASX:GTR) Executive Director Bruce Lane speaks with The Stock Network’s Lel Smits about:
⛏️ In Situ Recovery Mining explained
⛏️ Lo Herma In Situ Recovery uranium deposit in Wyoming
⛏️ Exploration programs and development of these assets
⛏️ Plans for GTI Energy`s uranium projects in the US
Globe Metals & Mining (ASX:GBE) is progressing its Kanyika niobium project in Malawi towards production having already proved up a robust economic profile for its potential development
🌍 Full government, environmental, and land access approvals
⛏️ Production-ready from a regulatory perspective
🇲🇼Focused on updating the existing definitive feasibility study (DFS) and metallurgical test-work to optimise refining

Globe Metals & Mining (ASX:GBE) is progressing its Kanyika niobium project in Malawi towards production having already proved up a robust economic profile for its potential development
🌍 Full government, environmental, and land access approvals
⛏️ Production-ready from a regulatory perspective
🇲🇼Focused on updating the existing definitive feasibility study (DFS) and metallurgical test-work to optimise refining
Ahead of appearing at the Spark+ Australian Equities Day in Singapore, Airtasker`s (ASX:ART) Founder & CEO Tim Fung speaks with The Stock Network’s Lel Smits about:
⚙️ Marketplace function
📱 Revenue model
🗺️ International expansion

Ahead of appearing at the Spark+ Australian Equities Day in Singapore, Airtasker`s (ASX:ART) Founder & CEO Tim Fung speaks with The Stock Network’s Lel Smits about:
⚙️ Marketplace function
📱 Revenue model
🗺️ International expansion
Omega Oil and Gas (ASX:OMA) is aiming to unlock new gas reserves for the eastern states market.
• Mobilisation of Ensign rig #965 to Omega’s Canyon-1H Project has commenced
• The Canyon-1H well is expected to spud on approximately 20 September 2024
• The Canyon-1H well consists of re-entry into the existing, vertical Canyon-1 well, then drilling a horizontal well section up to 1,100m long into the Canyon Sandstone
Omega’s CEO and Managing Director, Trevor Brown, said: "Our dedicated and skilled team of professionals are very well-prepared for the program and are pleased to commence this important operational phase of the Canyon Gas Project."

Omega Oil and Gas (ASX:OMA) is aiming to unlock new gas reserves for the eastern states market.
• Mobilisation of Ensign rig #965 to Omega’s Canyon-1H Project has commenced
• The Canyon-1H well is expected to spud on approximately 20 September 2024
• The Canyon-1H well consists of re-entry into the existing, vertical Canyon-1 well, then drilling a horizontal well section up to 1,100m long into the Canyon Sandstone
Omega’s CEO and Managing Director, Trevor Brown, said: "Our dedicated and skilled team of professionals are very well-prepared for the program and are pleased to commence this important operational phase of the Canyon Gas Project."
Ahead of appearing at the Spark+ Australian Equities Day in Singapore, ActivePort Group (ASX:ATV) Group Chairman & CEO Peter Christie speaks with The Stock Network’s Lel Smits about:
📳 ActivePort`s software-designed networking solutions enabling customers to create network connections, deliver cloud services, and manage data at a local, national or global scale
📳 ActivePort`s market opportunity for telecommunications and other sectors

Ahead of appearing at the Spark+ Australian Equities Day in Singapore, ActivePort Group (ASX:ATV) Group Chairman & CEO Peter Christie speaks with The Stock Network’s Lel Smits about:
📳 ActivePort`s software-designed networking solutions enabling customers to create network connections, deliver cloud services, and manage data at a local, national or global scale
📳 ActivePort`s market opportunity for telecommunications and other sectors
Control Bionics (ASX:CBL) expands global reach with exclusive UK and Ireland distribution agreement.
• Exclusive distribution of NeuroNode® by Smart Box in the UK and Ireland.
• Access to Smart Box’s established network of healthcare professionals and end-users.
• Strengthening Control Bionics’ presence in the European market.
Jeremy Steele, CEO of Control Bionics, commented: "The NeuroNode® has already been paired with hundreds of Smart Box
devices and devices with Smart Box software around the world."

Control Bionics (ASX:CBL) expands global reach with exclusive UK and Ireland distribution agreement.
• Exclusive distribution of NeuroNode® by Smart Box in the UK and Ireland.
• Access to Smart Box’s established network of healthcare professionals and end-users.
• Strengthening Control Bionics’ presence in the European market.
Jeremy Steele, CEO of Control Bionics, commented: "The NeuroNode® has already been paired with hundreds of Smart Box
devices and devices with Smart Box software around the world."
Ahead of appearing at the Spark+ Australian Equities Day in Singapore, Altech Batteries (ASX:ATC) Chief Financial Officer, Martin Stein speaks with The Stock Network’s Lel Smits about:
🔋 Benefits of CERENERGY batteries, an innovative battery technology that could revolutionise energy grid storage worldwide
🔋 Commercialising the CERENERGY® battery technology through joint venture agreement with Fraunhofer IKTS
🔋 Novel grid storage solutions to help the world’s transition to a renewable energy economy

Ahead of appearing at the Spark+ Australian Equities Day in Singapore, Altech Batteries (ASX:ATC) Chief Financial Officer, Martin Stein speaks with The Stock Network’s Lel Smits about:
🔋 Benefits of CERENERGY batteries, an innovative battery technology that could revolutionise energy grid storage worldwide
🔋 Commercialising the CERENERGY® battery technology through joint venture agreement with Fraunhofer IKTS
🔋 Novel grid storage solutions to help the world’s transition to a renewable energy economy
Golden Deeps (ASX: GED) has raised $1.78 million from investors through a fully subscribed Placement managed by PAC Partners Securities and Peak Asset Management, together Joint Lead Managers.
🏆 $1.78 million raised through a placement
⛏️ Funds will be used to explore the Havilah Project in New South Wales where copper and zinc mineralisation has been discovered
“This new funding will allow us to carry out further drilling of key copper-zinc sulphide and gold targets on our Havilah Project, where we have intersected thick zones of copper and zinc sulphide mineralisation in HVD003, which indicates we’re on top of a large porphyry-sulphide system with similar characteristics to other major discoveries in the Lachlan Fold Belt.
We also plan further drill-testing to extend copper-silver sulphide zones intersected at the Nosib and Khusib Springs in Namibia, as well as testing other copper and gold targets in the Lachlan Fold Belt on the new JV area.”
- Golden Deeps CEO Jon Dugdale

Golden Deeps (ASX: GED) has raised $1.78 million from investors through a fully subscribed Placement managed by PAC Partners Securities and Peak Asset Management, together Joint Lead Managers.
🏆 $1.78 million raised through a placement
⛏️ Funds will be used to explore the Havilah Project in New South Wales where copper and zinc mineralisation has been discovered
“This new funding will allow us to carry out further drilling of key copper-zinc sulphide and gold targets on our Havilah Project, where we have intersected thick zones of copper and zinc sulphide mineralisation in HVD003, which indicates we’re on top of a large porphyry-sulphide system with similar characteristics to other major discoveries in the Lachlan Fold Belt.
We also plan further drill-testing to extend copper-silver sulphide zones intersected at the Nosib and Khusib Springs in Namibia, as well as testing other copper and gold targets in the Lachlan Fold Belt on the new JV area.”
- Golden Deeps CEO Jon Dugdale
head of appearing at the Spark+ Australian Equities Day in Singapore, Lithium Universe (ASX:LU7) Executive Chair Iggy Tan speaks with The Stock Network’s Lel Smits about:
🔋 Progress at Lithium Universe’s Bécancour Lithium Refinery
🔋 Design, environmental and procurement strategy milestones
🔋 Planned work and catalysts in the pipeline

head of appearing at the Spark+ Australian Equities Day in Singapore, Lithium Universe (ASX:LU7) Executive Chair Iggy Tan speaks with The Stock Network’s Lel Smits about:
🔋 Progress at Lithium Universe’s Bécancour Lithium Refinery
🔋 Design, environmental and procurement strategy milestones
🔋 Planned work and catalysts in the pipeline
Lithium Australia (ASX:LIT) announces that its wholly owned subsidiary, Envirostream Australia, has signed an exclusive 3-year recycling agreement with BYD Auto Industry Company.
♻️ The Agreement is to provide battery recycling services for all New Energy vehicles end-of life batteries in Australia
♻️ Envirostream Australia is a battery recycling company
♻️BYD Auto Industry Company is a "global leader in New Energy vehicles"

Lithium Australia (ASX:LIT) announces that its wholly owned subsidiary, Envirostream Australia, has signed an exclusive 3-year recycling agreement with BYD Auto Industry Company.
♻️ The Agreement is to provide battery recycling services for all New Energy vehicles end-of life batteries in Australia
♻️ Envirostream Australia is a battery recycling company
♻️BYD Auto Industry Company is a "global leader in New Energy vehicles"
Globe Metals & Mining (ASX:GBE) has signed a letter of intent with Affilips N.V. for up to 100 tonnes of refined high purity Niobium Pentoxide. The letter of intent outlines the framework for both parties to negotiate a binding offtake agreement for 32% of Phase 1 niobium production from the now under development Kanyika Niobium Project, located in Malawi, Africa. Such agreements are a critical component of the Project’s development and the subsequent generation of sustainable cash flows. Globe Metals & Mining Chief Executive Officer Paul Smith joins The Stock Network`s Lel Smits.
🖊️ Signed a letter of intent with Affilips N.V.
⛏️ Niobium buyers Globe will gain access to via the Affilips relationship

Globe Metals & Mining (ASX:GBE) has signed a letter of intent with Affilips N.V. for up to 100 tonnes of refined high purity Niobium Pentoxide. The letter of intent outlines the framework for both parties to negotiate a binding offtake agreement for 32% of Phase 1 niobium production from the now under development Kanyika Niobium Project, located in Malawi, Africa. Such agreements are a critical component of the Project’s development and the subsequent generation of sustainable cash flows. Globe Metals & Mining Chief Executive Officer Paul Smith joins The Stock Network`s Lel Smits.
🖊️ Signed a letter of intent with Affilips N.V.
⛏️ Niobium buyers Globe will gain access to via the Affilips relationship
Ahead of appearing at the Spark+ Australian Equities Day in Singapore, EZZ Life Science Holdings (ASX:EZZ) Chairman, Glenn Cross speaks with The Stock Network’s Lel Smits about:
🧬 Health supplements product range
🧬 Identifying and creating new product opportunities
🧬 Direct-to-consumer and e-commerce market place distribution strategies

Ahead of appearing at the Spark+ Australian Equities Day in Singapore, EZZ Life Science Holdings (ASX:EZZ) Chairman, Glenn Cross speaks with The Stock Network’s Lel Smits about:
🧬 Health supplements product range
🧬 Identifying and creating new product opportunities
🧬 Direct-to-consumer and e-commerce market place distribution strategies
Ahead of appearing at the Spark+ Australian Equities Day in Singapore, FBR`s (ASX:FBR) Mike Pivac speaks with The Stock Network’s Lel Smits about:
🧱 FBR’s robotic brick-laying construction technology
🧱 Highlights from Hadrian X`s structural wall bricklaying robot
🧱 Potential deliverables from US demonstration and revenue outlook

Ahead of appearing at the Spark+ Australian Equities Day in Singapore, FBR`s (ASX:FBR) Mike Pivac speaks with The Stock Network’s Lel Smits about:
🧱 FBR’s robotic brick-laying construction technology
🧱 Highlights from Hadrian X`s structural wall bricklaying robot
🧱 Potential deliverables from US demonstration and revenue outlook
Emyria (ASX:EMD) announces interim clinical results from analysis of its MDMA-assisted therapy for Post-Traumatic Stress Disorder program which commenced in October 2023.
🧠 Interim analysis of the first eight patients completing Emyria`s MDMA-assisted therapy program for Post-Traumatic Stress Disorder (PTSD) has demonstrated all patients achieved substantial improvement in PTSD symptoms
🧠 With a clinically and statistically significant average reduction of 33 points in PCL-5 scores
Michael Winlo, CEO, commented: “Emyria is uniquely positioned to lead the global development and refinement of this treatment as Australia is currently the only jurisdiction permitting these therapies under stringent oversight."

Emyria (ASX:EMD) announces interim clinical results from analysis of its MDMA-assisted therapy for Post-Traumatic Stress Disorder program which commenced in October 2023.
🧠 Interim analysis of the first eight patients completing Emyria`s MDMA-assisted therapy program for Post-Traumatic Stress Disorder (PTSD) has demonstrated all patients achieved substantial improvement in PTSD symptoms
🧠 With a clinically and statistically significant average reduction of 33 points in PCL-5 scores
Michael Winlo, CEO, commented: “Emyria is uniquely positioned to lead the global development and refinement of this treatment as Australia is currently the only jurisdiction permitting these therapies under stringent oversight."
Golden Deeps (ASX:GED) has reported the intersection of significant sulphide mineralisation in all three completed diamond drillholes at its 100% owned Havilah Project in the Lachlan Fold Belt Copper-Gold Province of central NSW.
⛏️Copper and zinc sulfide mineralization found in diamond drilling at Havilah Project in NSW, Lachlan Fold Belt
💎Diamond drillhole HVD003 intersected copper and zinc sulfides (chalcopyrite, sphalerite) in patches, veins, and disseminated forms across an 80m zone in the Sofala Volcanics. This is within the Hazelbrook copper anomaly

Golden Deeps (ASX:GED) has reported the intersection of significant sulphide mineralisation in all three completed diamond drillholes at its 100% owned Havilah Project in the Lachlan Fold Belt Copper-Gold Province of central NSW.
⛏️Copper and zinc sulfide mineralization found in diamond drilling at Havilah Project in NSW, Lachlan Fold Belt
💎Diamond drillhole HVD003 intersected copper and zinc sulfides (chalcopyrite, sphalerite) in patches, veins, and disseminated forms across an 80m zone in the Sofala Volcanics. This is within the Hazelbrook copper anomaly
Ahead of appearing at the Spark+ Australian Equities Day in Singapore, PharmAust`s (ASX:PAA) Managing Director Dr Michael Thurn speaks with The Stock Network’s Lel Smits about:
🧬 A re-prioritised commercialisation strategy: PharmAust focus on neurodegenerative diseases, including Alzheimer’s, Parkinson’s and Huntington’s disease
🧬 Monepantel gets US FDA Orphan Drug Designation for treatment of ALS:
Next steps following PharmAust’s Monepantel recently granted Orphan Drug Designation for the treatment of ALS by the US FDA

Ahead of appearing at the Spark+ Australian Equities Day in Singapore, PharmAust`s (ASX:PAA) Managing Director Dr Michael Thurn speaks with The Stock Network’s Lel Smits about:
🧬 A re-prioritised commercialisation strategy: PharmAust focus on neurodegenerative diseases, including Alzheimer’s, Parkinson’s and Huntington’s disease
🧬 Monepantel gets US FDA Orphan Drug Designation for treatment of ALS:
Next steps following PharmAust’s Monepantel recently granted Orphan Drug Designation for the treatment of ALS by the US FDA
Globe Metals & Mining (ASX: GBE) has signed a letter of intent with Affilips N.V. for up to 100 tonnes of refined high purity Niobium Pentoxide.
⛏️ Affilips would take up to 32% (approximately 100 tonnes) of expected annual highpurity Niobium Pentoxide production from the Kanyika Project
🖊️ The agreement will initially be for 3 years, starting in May 2026
🚧 Development of the Kanyika Project will see Globe Metals & Mining become a reliable supplier of in demand Niobium Oxide for specialised industries based in Europe
📍Affilips exports approximately 50,000 tonnes of master alloys annually to 80 countries

Globe Metals & Mining (ASX: GBE) has signed a letter of intent with Affilips N.V. for up to 100 tonnes of refined high purity Niobium Pentoxide.
⛏️ Affilips would take up to 32% (approximately 100 tonnes) of expected annual highpurity Niobium Pentoxide production from the Kanyika Project
🖊️ The agreement will initially be for 3 years, starting in May 2026
🚧 Development of the Kanyika Project will see Globe Metals & Mining become a reliable supplier of in demand Niobium Oxide for specialised industries based in Europe
📍Affilips exports approximately 50,000 tonnes of master alloys annually to 80 countries
Ahead of appearing at the Spark+ Australian Equities Day in Singapore, Arovella`s (ASX:ALA) CEO & Managing Director Dr Michael Baker speaks with The Stock Network’s Lel Smits about:
🩸 The current lead product coming out of Arovella Therapeutics’ cell therapy platform - ALA-101 - iNKT cells create receptors that target antigens
🩸 How ALA-101 targets cancers and tumours
🩸 Timing of Phase 1 trials for ALA-101

Ahead of appearing at the Spark+ Australian Equities Day in Singapore, Arovella`s (ASX:ALA) CEO & Managing Director Dr Michael Baker speaks with The Stock Network’s Lel Smits about:
🩸 The current lead product coming out of Arovella Therapeutics’ cell therapy platform - ALA-101 - iNKT cells create receptors that target antigens
🩸 How ALA-101 targets cancers and tumours
🩸 Timing of Phase 1 trials for ALA-101
EBR Systems (ASX:EBR) has submitted the final Premarket Approval (PMA) application module for its WiSE CRT System to the U.S. FDA.
🫀 EBR Systems is developing the world’s only wireless cardiac pacing device for heart failure
🫀The PMA application is subject to an initial filing review period to ensure all necessary information has been completed for the FDA to conduct a substantive review
John McCutcheon, EBR Systems` President & CEO said: "The submission is the result of years of effort and collaboration between our clinical, regulatory, and engineering teams."

EBR Systems (ASX:EBR) has submitted the final Premarket Approval (PMA) application module for its WiSE CRT System to the U.S. FDA.
🫀 EBR Systems is developing the world’s only wireless cardiac pacing device for heart failure
🫀The PMA application is subject to an initial filing review period to ensure all necessary information has been completed for the FDA to conduct a substantive review
John McCutcheon, EBR Systems` President & CEO said: "The submission is the result of years of effort and collaboration between our clinical, regulatory, and engineering teams."
White Cliff Minerals (ASX:WCN) has uncovered silver grades from epithermal structures and polymetallic results from skarn-style mineralisation.
⚪ The company announced it has received the final batch of assay results from rock chip samples
⚪ Taken during the maiden field program at the Great Bear Project, Northern Canada
"It’s remarkable that the team has now delineated a total of six high grade Copper, Gold and Silver mineralised districts at Great Bear." - Troy Whittaker, Managing Director

White Cliff Minerals (ASX:WCN) has uncovered silver grades from epithermal structures and polymetallic results from skarn-style mineralisation.
⚪ The company announced it has received the final batch of assay results from rock chip samples
⚪ Taken during the maiden field program at the Great Bear Project, Northern Canada
"It’s remarkable that the team has now delineated a total of six high grade Copper, Gold and Silver mineralised districts at Great Bear." - Troy Whittaker, Managing Director
Globe Metals & Mining (ASX:GBE) is an African-focused resources company advancing its Kanyika niobium and tantalum project in Malawi towards production
🌍 Established JORC-compliant resource and reserve estimate
⛏️ Completed definitive feasibility study (DFS)
Net present value (NPV) of US$1 billion with internal rate of return (IRR) of 47%
Watch the full video on The Stock Network youtube channel⚡️

Globe Metals & Mining (ASX:GBE) is an African-focused resources company advancing its Kanyika niobium and tantalum project in Malawi towards production
🌍 Established JORC-compliant resource and reserve estimate
⛏️ Completed definitive feasibility study (DFS)
Net present value (NPV) of US$1 billion with internal rate of return (IRR) of 47%
Watch the full video on The Stock Network youtube channel⚡️
AML3D (ASX:AL3) has released its Annual Report, highlighting 1005% revenue growth over a period in which the company focussed on the continued delivery of its “US Scale-up” strategy and achieved its most successful year on record.
🔹 The “US Scaleup” strategy is focused on supplying the AML3D’s proprietary ARCEMY® metal 3D printing systems and contract manufacturing services to industrial manufacturers in and supporting the US Defence, marine and aerospace industries.
🔹 The “US Scale-up” strategy underpinned a more than ten-fold increase in AML3D’s revenues during the financial year, when compared to the prior year.
🔹 Looking ahead AML3D is confident the demand from the US Defence market will remain strong and convert into continued US ARCEMY® sales and contract manufacturing orders during FY25 and says its contract manufacturing facility continues to deliver on the its current order book and retains the capacity to support additional contract manufacturing orders

AML3D (ASX:AL3) has released its Annual Report, highlighting 1005% revenue growth over a period in which the company focussed on the continued delivery of its “US Scale-up” strategy and achieved its most successful year on record.
🔹 The “US Scaleup” strategy is focused on supplying the AML3D’s proprietary ARCEMY® metal 3D printing systems and contract manufacturing services to industrial manufacturers in and supporting the US Defence, marine and aerospace industries.
🔹 The “US Scale-up” strategy underpinned a more than ten-fold increase in AML3D’s revenues during the financial year, when compared to the prior year.
🔹 Looking ahead AML3D is confident the demand from the US Defence market will remain strong and convert into continued US ARCEMY® sales and contract manufacturing orders during FY25 and says its contract manufacturing facility continues to deliver on the its current order book and retains the capacity to support additional contract manufacturing orders
Praemium Limited (ASX:PPS) provides technology and product solutions enabling advisers to deliver outcomes for their clients, including achieving their financial goals and having a positive wealth management experience. The Praemium platform is designed to bring innovations to transform advice services and the Company has just released its full year results and declared a maiden dividend. Praemium CEO Anthony Wamsteker speaks with The Stock Network`s Lel Smits.
🏆 Results highlights - Declared 1 cent per share fully franked dividend
🖥️ Results details - Revenue and other income of up 12%
🗓️ Outlook - “Praemium enters 2025 with optimism and positive momentum. The SMA platform’s premium offer is priced at competitive levels consistent with the market we serve. We will look to that experience as a model for ensuring the same rigorous review is applied to our VMA and VMAAS offers in 2025. Our investments in capability and resilience have set us up for long-term success.
We are also on the cusp of launching our next generation IDPS. We have listened to our stakeholders and deployed our best operational, technology and product experts to ensure this service will meet the needs of a significant portion of our target market. We already have active portfolios in this IDPS and will launch fully in October 2024." - CEO Anthony Wamsteker & CFO David Coulter

Praemium Limited (ASX:PPS) provides technology and product solutions enabling advisers to deliver outcomes for their clients, including achieving their financial goals and having a positive wealth management experience. The Praemium platform is designed to bring innovations to transform advice services and the Company has just released its full year results and declared a maiden dividend. Praemium CEO Anthony Wamsteker speaks with The Stock Network`s Lel Smits.
🏆 Results highlights - Declared 1 cent per share fully franked dividend
🖥️ Results details - Revenue and other income of up 12%
🗓️ Outlook - “Praemium enters 2025 with optimism and positive momentum. The SMA platform’s premium offer is priced at competitive levels consistent with the market we serve. We will look to that experience as a model for ensuring the same rigorous review is applied to our VMA and VMAAS offers in 2025. Our investments in capability and resilience have set us up for long-term success.
We are also on the cusp of launching our next generation IDPS. We have listened to our stakeholders and deployed our best operational, technology and product experts to ensure this service will meet the needs of a significant portion of our target market. We already have active portfolios in this IDPS and will launch fully in October 2024." - CEO Anthony Wamsteker & CFO David Coulter
Belararox (ASX:BRX) is a mineral explorer focused on securing and developing resources to meet the surge in demand from the technology, battery and renewable energy markets. Its projects include the potential for zinc, copper, gold, silver, nickel and lead resources and the Company has just raised $7.7 million, enabling it to kick off the initial stages of our extensive drilling program.
⛏️ Near term catalysts after raising $7.7 million
🪨 Toro–Malambo–Tambo Project drilling program
🚧 Priorities for TMT Project

Belararox (ASX:BRX) is a mineral explorer focused on securing and developing resources to meet the surge in demand from the technology, battery and renewable energy markets. Its projects include the potential for zinc, copper, gold, silver, nickel and lead resources and the Company has just raised $7.7 million, enabling it to kick off the initial stages of our extensive drilling program.
⛏️ Near term catalysts after raising $7.7 million
🪨 Toro–Malambo–Tambo Project drilling program
🚧 Priorities for TMT Project
Aurora Labs (ASX:A3D) has launched the AL250 3D Metal Printer, designed, engineered and built in Australia by Aurora Labs is now available for printing in the Company’s industrial printing services facility based in Perth.
🖨️ AL250 Printer production ready for commercial printing in A3D’s Industrial Print Services Business
🖨️ Printer will bolster print capability in the Print Bureau and show A3D’s Print technology capability for future printer sales
Rebekah Letheby, CEO, commented “The AL250 3D printer is a significant advancement for our industrial printing service and machine building capabilities. It will meet the increasing demand for specialised materials as we expand our capabilities and scale up production for the Defence industry, reinforcing our commitment to developing machines tailored for practical industrial printing applications.

Aurora Labs (ASX:A3D) has launched the AL250 3D Metal Printer, designed, engineered and built in Australia by Aurora Labs is now available for printing in the Company’s industrial printing services facility based in Perth.
🖨️ AL250 Printer production ready for commercial printing in A3D’s Industrial Print Services Business
🖨️ Printer will bolster print capability in the Print Bureau and show A3D’s Print technology capability for future printer sales
Rebekah Letheby, CEO, commented “The AL250 3D printer is a significant advancement for our industrial printing service and machine building capabilities. It will meet the increasing demand for specialised materials as we expand our capabilities and scale up production for the Defence industry, reinforcing our commitment to developing machines tailored for practical industrial printing applications.
HITIQ Limited (ASX:HIQ) has been approved its second US Patent relating to an innovative design feature for its Nexus™ technology.
👄 HITIQ`s "technology enables data driven decisions for thousands of professional and amateur sports players who experience brain impacts, empowers clinicians who care for their brains and enhance concussion management policies for progressive leagues around the globe"
👄 US Patent Application US 17/427,869 approved
👄 IP portfolio bolstered by second US patent
👄 Flexible PCB design to ensure a "one size fits all" functionality
"A key part of HITIQ`s patent strategy, including in relation to this patent, is to seek coverage over technologies which allow for instrumented mouthguard technology to transition from bespoke research tools, and into commercial use devices for sports participants at all levels" - HITIQ Chief Executive, Mike Vegar

HITIQ Limited (ASX:HIQ) has been approved its second US Patent relating to an innovative design feature for its Nexus™ technology.
👄 HITIQ`s "technology enables data driven decisions for thousands of professional and amateur sports players who experience brain impacts, empowers clinicians who care for their brains and enhance concussion management policies for progressive leagues around the globe"
👄 US Patent Application US 17/427,869 approved
👄 IP portfolio bolstered by second US patent
👄 Flexible PCB design to ensure a "one size fits all" functionality
"A key part of HITIQ`s patent strategy, including in relation to this patent, is to seek coverage over technologies which allow for instrumented mouthguard technology to transition from bespoke research tools, and into commercial use devices for sports participants at all levels" - HITIQ Chief Executive, Mike Vegar
AuMEGA Metals (ASX:AAM, TSXV:AUM, OTCQB:AUMMF) has commenced the second phase of diamond drilling on the Cape Ray Shear Zone located in Newfoundland, Canada.
🚜 The primary focus of this diamond drilling is on Greenfield targets at Malachite.
⛏️ Drill targets at Malachite focused on large, mineralised zones identified through the highly successful winter Reverse Circulation drill program.
⚒️ Phase one of diamond drilling completed at the end of July with assays expected over the next couple of weeks.

AuMEGA Metals (ASX:AAM, TSXV:AUM, OTCQB:AUMMF) has commenced the second phase of diamond drilling on the Cape Ray Shear Zone located in Newfoundland, Canada.
🚜 The primary focus of this diamond drilling is on Greenfield targets at Malachite.
⛏️ Drill targets at Malachite focused on large, mineralised zones identified through the highly successful winter Reverse Circulation drill program.
⚒️ Phase one of diamond drilling completed at the end of July with assays expected over the next couple of weeks.
Frontier Energy (ASX:FHE; OTCQB: FRHYF) has appointed the former Western Australian Premier, Mark McGowan AC, the 30th Premier of Western Australia, as Non-Executive Chairman.
🌬️ Frontier’s Waroona Renewable Energy Project, located near the town of Waroona in the South West of Western Australia, is ideally positioned to support Australia’s clean energy transition
🌬️ McGowan AC will be appointed as Non-Executive Chairman as Frontier transitions from renewable electricity developer to major renewable energy producer
🌬️ McGowan brings strong knowledge of Federal Government processes

Frontier Energy (ASX:FHE; OTCQB: FRHYF) has appointed the former Western Australian Premier, Mark McGowan AC, the 30th Premier of Western Australia, as Non-Executive Chairman.
🌬️ Frontier’s Waroona Renewable Energy Project, located near the town of Waroona in the South West of Western Australia, is ideally positioned to support Australia’s clean energy transition
🌬️ McGowan AC will be appointed as Non-Executive Chairman as Frontier transitions from renewable electricity developer to major renewable energy producer
🌬️ McGowan brings strong knowledge of Federal Government processes
Globe Metals & Mining (ASX: GBE) has signed the Community Development Agreement (CDA) with the representatives of the qualified communities surrounding the Company’s Kanyika Niobium Project.
🖊️Signed a Community Development Agreement (CDA) with representatives of communities surrounding the Kanyika Project
🤝The signing ceremony was attended by various senior dignitaries.
📍The CDA sets out the guidelines for the management of the 0.45% of turnover Globe must spend on projects to advance these communities’ interests
🏛️The CDA mandates the formation of the Kanyika Development Trust

Globe Metals & Mining (ASX: GBE) has signed the Community Development Agreement (CDA) with the representatives of the qualified communities surrounding the Company’s Kanyika Niobium Project.
🖊️Signed a Community Development Agreement (CDA) with representatives of communities surrounding the Kanyika Project
🤝The signing ceremony was attended by various senior dignitaries.
📍The CDA sets out the guidelines for the management of the 0.45% of turnover Globe must spend on projects to advance these communities’ interests
🏛️The CDA mandates the formation of the Kanyika Development Trust
Noxopharm (ASX:NOX) has released new data regarding its CRO-67 preclinical drug for pancreatic cancer.
💊 Reduced pancreatic tumours & barrier cells in complex model
💊 Metastatic cancer spread decreased
💊 Safe and well tolerated pre-clinically

Noxopharm (ASX:NOX) has released new data regarding its CRO-67 preclinical drug for pancreatic cancer.
💊 Reduced pancreatic tumours & barrier cells in complex model
💊 Metastatic cancer spread decreased
💊 Safe and well tolerated pre-clinically
QMines (ASX:QML) has revealed that the drilling program at the Company`s Develin Creek project is now underway.
🚜 Drill rig arrives onsite with drilling expected to commence imminently
🪨 Phase one program designed to bring the high-grade Scorpion open-pit resource into the Mt Chalmers mine plan
⛏️ Drilling program planned to infill the existing resource at Develin Creek and test for potential extensions
⚒️ Drilling program expected to deliver seventh resource upgrade in Q4-2024

QMines (ASX:QML) has revealed that the drilling program at the Company`s Develin Creek project is now underway.
🚜 Drill rig arrives onsite with drilling expected to commence imminently
🪨 Phase one program designed to bring the high-grade Scorpion open-pit resource into the Mt Chalmers mine plan
⛏️ Drilling program planned to infill the existing resource at Develin Creek and test for potential extensions
⚒️ Drilling program expected to deliver seventh resource upgrade in Q4-2024
Everest Metals Corporation (ASX:EMC) has provided an update on the bulk sampling program at the Revere Gold and Base Metal Project in Western Australia, located just off the Great Northern Highway approximately 90km to the northeast of Meekatharra in the Murchison Region, 900km north of Perth.
👉 Bulk sampling continues to reveal a high grade and well developed saddle reef system carrying gold from surface
👉 Geological interpretation confirms strong structural and mineralised system similarities to the world class Bendigo Gold Province of Victoria, which includes the legendary Fosterville Gold Mine
👉 Bulk sampling primary and secondary ore crushing commenced

Everest Metals Corporation (ASX:EMC) has provided an update on the bulk sampling program at the Revere Gold and Base Metal Project in Western Australia, located just off the Great Northern Highway approximately 90km to the northeast of Meekatharra in the Murchison Region, 900km north of Perth.
👉 Bulk sampling continues to reveal a high grade and well developed saddle reef system carrying gold from surface
👉 Geological interpretation confirms strong structural and mineralised system similarities to the world class Bendigo Gold Province of Victoria, which includes the legendary Fosterville Gold Mine
👉 Bulk sampling primary and secondary ore crushing commenced
PYC Therapeutics (ASX:PYC) has developed the only clinical-stage investigational drug candidate designed specifically for patients with the blinding eye disease Retinitis Pigmentosa type 11 (RP11).
👁️ PYC recently reported an improvement in vision in 2 patients with RP11
📣 PYC will announce further results from the ongoing multiple dose studies of VP-001 in Q4 2024
🧪 PYC is now preparing for a registrational trial that will be designed to support a new drug application and commercial launch of this drug candidate 4

PYC Therapeutics (ASX:PYC) has developed the only clinical-stage investigational drug candidate designed specifically for patients with the blinding eye disease Retinitis Pigmentosa type 11 (RP11).
👁️ PYC recently reported an improvement in vision in 2 patients with RP11
📣 PYC will announce further results from the ongoing multiple dose studies of VP-001 in Q4 2024
🧪 PYC is now preparing for a registrational trial that will be designed to support a new drug application and commercial launch of this drug candidate 4
Pan Asia Metals (ASX:PAM) has reported that field work at the KT East Lithium Prospect continues to yield strong results.
⛏️ Soil sampling strengthens potential, increasing the anomalous zone by 2.8x to 2.1km long and 1.0km wide.
⛏️ Pegmatites are stacked and dip moderately suggesting KT East is likely amenable to open pit mining.

Pan Asia Metals (ASX:PAM) has reported that field work at the KT East Lithium Prospect continues to yield strong results.
⛏️ Soil sampling strengthens potential, increasing the anomalous zone by 2.8x to 2.1km long and 1.0km wide.
⛏️ Pegmatites are stacked and dip moderately suggesting KT East is likely amenable to open pit mining.
San Francisco based Life360, Inc. (NASDAQ:LIF) (ASX:360) has updated its agreements with partners Arity and Placer.ai.
🤝 These partnerships support Life360`s pursuit of delivering increasing value to its members
📱 Through Life360 mobile applications on iOS and Android devices, and also creating and developing new revenue streams.

San Francisco based Life360, Inc. (NASDAQ:LIF) (ASX:360) has updated its agreements with partners Arity and Placer.ai.
🤝 These partnerships support Life360`s pursuit of delivering increasing value to its members
📱 Through Life360 mobile applications on iOS and Android devices, and also creating and developing new revenue streams.
Neuren Pharmaceuticals (ASX: NEU) has reported top-line results from its Phase 2 clinical trial of NNZ-2591 in children with Angelman syndrome.
🩺 Clinician and caregiver global efficacy measures specifically designed for Angelman syndrome showed a level of improvement
💊 NNZ-2591 was safe and well tolerated as an oral liquid dose, with no serious adverse events
⚕️Results further strengthen confidence in potential of NNZ-2591 for multiple neurodevelopmental
disorders

Neuren Pharmaceuticals (ASX: NEU) has reported top-line results from its Phase 2 clinical trial of NNZ-2591 in children with Angelman syndrome.
🩺 Clinician and caregiver global efficacy measures specifically designed for Angelman syndrome showed a level of improvement
💊 NNZ-2591 was safe and well tolerated as an oral liquid dose, with no serious adverse events
⚕️Results further strengthen confidence in potential of NNZ-2591 for multiple neurodevelopmental
disorders
Codeifai (ASX: CDE) has reported a potentially high-value strategic integration of its QR code generation and management platform, ConnectQR, into the Canva App Marketplace.
🎨 Canva’s 180m monthly active users now have access to ConnectQR through the Canva App Marketplace
🖼️ Users can now seamlessly integrate our dynamic, static and AI QR codes
🖍️ ConnectQR is now the only Canva integration for QR codes with serialisation
🖌️ Valuable route to market for CDE’s key ProtectCodetm & BrandReportertm
🖋️ Firm commitments received for A$600,000 placement

Codeifai (ASX: CDE) has reported a potentially high-value strategic integration of its QR code generation and management platform, ConnectQR, into the Canva App Marketplace.
🎨 Canva’s 180m monthly active users now have access to ConnectQR through the Canva App Marketplace
🖼️ Users can now seamlessly integrate our dynamic, static and AI QR codes
🖍️ ConnectQR is now the only Canva integration for QR codes with serialisation
🖌️ Valuable route to market for CDE’s key ProtectCodetm & BrandReportertm
🖋️ Firm commitments received for A$600,000 placement
LTR Pharma (ASX:LTP) has jumped up 8% after announcing that a second medical practitioner has been authorised to prescribe SPONTAN under the Therapeutic Goods Administration.
👃 SPONTAN is a nasal spray treatment for Erectile Dysfunction
👃 LTR Pharma is supporting strategic engagement with a network of healthcare providers familiar with SPONTAN and its clinical benefits

LTR Pharma (ASX:LTP) has jumped up 8% after announcing that a second medical practitioner has been authorised to prescribe SPONTAN under the Therapeutic Goods Administration.
👃 SPONTAN is a nasal spray treatment for Erectile Dysfunction
👃 LTR Pharma is supporting strategic engagement with a network of healthcare providers familiar with SPONTAN and its clinical benefits
Nuren Group Limited (NSX:NRN) has listed on the National Stock Exchange of Australia with a ticker code of NRN, achieving an initial market value of $30.9 million. Nuren Group is the holding company of Enlinea who operates an e-commerce platform in Malaysia called motherhood.com.my. The platform generates revenue by purchasing products from suppliers at a discount and reselling the products to its customers on its platform, in addition to advertising revenue, sponsored content placements and marketing programmes
Visit Nuren Group website

Nuren Group Limited (NSX:NRN) has listed on the National Stock Exchange of Australia with a ticker code of NRN, achieving an initial market value of $30.9 million. Nuren Group is the holding company of Enlinea who operates an e-commerce platform in Malaysia called motherhood.com.my. The platform generates revenue by purchasing products from suppliers at a discount and reselling the products to its customers on its platform, in addition to advertising revenue, sponsored content placements and marketing programmes
Visit Nuren Group website
Gold Mountain (ASX:GMN) has received a batch of 54 stream sediment samples from the Irajuba tenements in the Down Under Project area in Brazil
🪨 Very high grade results in stream sediment samples demonstrate
👉 Jiquiriçá tenements in Down Under have excellent REE potential.

Gold Mountain (ASX:GMN) has received a batch of 54 stream sediment samples from the Irajuba tenements in the Down Under Project area in Brazil
🪨 Very high grade results in stream sediment samples demonstrate
👉 Jiquiriçá tenements in Down Under have excellent REE potential.
Nyrada (ASX:NYR) has made progress on developing NYR-BI03, a first in class neuroprotection treatment for both traumatic brain injury (TBI) and stroke.
- Additional study provided further data to support safety and tolerability of Nyrada’s lead Brain Injury drug candidate.
- Rat CNS testing satisfactorily completed under Good Laboratory Practice (GLP) conditions for NYR-BI03.
- Nyrada will continue to report on remaining GLP study results and remains on track to commence first in-human Phase I clinical trial for NYR-BI03 in late CY2024

Nyrada (ASX:NYR) has made progress on developing NYR-BI03, a first in class neuroprotection treatment for both traumatic brain injury (TBI) and stroke.
- Additional study provided further data to support safety and tolerability of Nyrada’s lead Brain Injury drug candidate.
- Rat CNS testing satisfactorily completed under Good Laboratory Practice (GLP) conditions for NYR-BI03.
- Nyrada will continue to report on remaining GLP study results and remains on track to commence first in-human Phase I clinical trial for NYR-BI03 in late CY2024
LTR Pharma (ASX:LTP) has revealed that first patients have received SPONTAN, a nasal spray treatment for Erectile Dysfunction, under the Therapeutic Goods Administration Special Access Scheme

LTR Pharma (ASX:LTP) has revealed that first patients have received SPONTAN, a nasal spray treatment for Erectile Dysfunction, under the Therapeutic Goods Administration Special Access Scheme
Tryptamine Therapeutics Limited (ASX:TYP) is a clinical-stage biotech and its current primary focus is the development of an innovative and scalable intravenous-infused psilocin formulation which can be used in conjunction with psychotherapy to address significant unmet medical needs. Tryptamine Therapeutics CEO and Executive Director Jason Carroll speaks with The Stock Network’s Lel Smits.
🧬 Phase 2a clinical trial now underway - investigating the treatment of Irritable Bowel Syndrome, or IBS
🏥 Recently dosed the first patient at Massachusetts General Hospital, U.S.A
🍄 First time this prestigious hospital has administered psilocybin in a clinical setting
Watch the full interview on our youtube channel ⚡

Tryptamine Therapeutics Limited (ASX:TYP) is a clinical-stage biotech and its current primary focus is the development of an innovative and scalable intravenous-infused psilocin formulation which can be used in conjunction with psychotherapy to address significant unmet medical needs. Tryptamine Therapeutics CEO and Executive Director Jason Carroll speaks with The Stock Network’s Lel Smits.
🧬 Phase 2a clinical trial now underway - investigating the treatment of Irritable Bowel Syndrome, or IBS
🏥 Recently dosed the first patient at Massachusetts General Hospital, U.S.A
🍄 First time this prestigious hospital has administered psilocybin in a clinical setting
Watch the full interview on our youtube channel ⚡
AML3D (ASX:AL3) announces Arcemy® ‘X-Edition’ Commissioned at US Navy supplier cogitic corp
➡️ The A$2.5 million ARCEMY® `X-Edition 6700` ordered by US Defence contractor, Cogitic Corporation, is now commissioned and operational.
➡️ Cogitic is positioned to supply ARCEMY® metal 3D printed’, ‘cannot fail’, components to the US Navy and other defence applications.

AML3D (ASX:AL3) announces Arcemy® ‘X-Edition’ Commissioned at US Navy supplier cogitic corp
➡️ The A$2.5 million ARCEMY® `X-Edition 6700` ordered by US Defence contractor, Cogitic Corporation, is now commissioned and operational.
➡️ Cogitic is positioned to supply ARCEMY® metal 3D printed’, ‘cannot fail’, components to the US Navy and other defence applications.
Western Gold Resources (ASX: WGR) has completed a mining-level Aboriginal heritage survey at the Company’s 100% owned Gold Duke Project in the north-eastern goldfields of Western Australia.
- Aboriginal heritage clearance secured
- Additional surveys planned for Q3 to expand gold production
- Scoping study underway to determine best processing method for 4.57Mt gold resource

Western Gold Resources (ASX: WGR) has completed a mining-level Aboriginal heritage survey at the Company’s 100% owned Gold Duke Project in the north-eastern goldfields of Western Australia.
- Aboriginal heritage clearance secured
- Additional surveys planned for Q3 to expand gold production
- Scoping study underway to determine best processing method for 4.57Mt gold resource
Globe Metals & Mining (ASX:GBE) has released its Quarterly Activities Report – June 2024 Quarter.
🌏 Funding update confirms the Phase 1 development plan for Globe’s Malawi-based Kanyika Niobium Project and provides a clear path to its construction
🌏 Globe received a non-binding letter of intent from Ecobank Malawi Limited to provide the Company with a USD15 million loan facility
🌏 Cash at bank at the end of the quarter was $1.144 million

Globe Metals & Mining (ASX:GBE) has released its Quarterly Activities Report – June 2024 Quarter.
🌏 Funding update confirms the Phase 1 development plan for Globe’s Malawi-based Kanyika Niobium Project and provides a clear path to its construction
🌏 Globe received a non-binding letter of intent from Ecobank Malawi Limited to provide the Company with a USD15 million loan facility
🌏 Cash at bank at the end of the quarter was $1.144 million
Sabre Resources (ASX:SBR) has released its quarterly report highlighting how it advanced the exploration and development of nickel sulphide, lithium and gold assets in Western Australia, and uranium-vanadium prospects in the Northern Territory. Sabre’s flagship project is the Sherlock Bay (nickel-copper-cobalt) Project in the Pilbara Region of Western Australia and the company also holds assets in the Eastern Goldfields and Northern Territory.
➡️ High-grade uranium targets in Ngalia Basin project in Northern Territory, using drone magnetic survey where its plan to do drilling
➡️ Outstanding lithium and gold targets in the Northwest Pilbara
➡️ Large lithium and gold soil anomalies at Cave Hill project
Watch full interview on our Youtube channel ⚡

Sabre Resources (ASX:SBR) has released its quarterly report highlighting how it advanced the exploration and development of nickel sulphide, lithium and gold assets in Western Australia, and uranium-vanadium prospects in the Northern Territory. Sabre’s flagship project is the Sherlock Bay (nickel-copper-cobalt) Project in the Pilbara Region of Western Australia and the company also holds assets in the Eastern Goldfields and Northern Territory.
➡️ High-grade uranium targets in Ngalia Basin project in Northern Territory, using drone magnetic survey where its plan to do drilling
➡️ Outstanding lithium and gold targets in the Northwest Pilbara
➡️ Large lithium and gold soil anomalies at Cave Hill project
Watch full interview on our Youtube channel ⚡
Golden Deeps (ASX:GED) has released its quarterly report highlighting how it advanced the Otavi Mountain Land Copper District of Namibia and copper-gold projects in the Lachlan Fold Belt of New South Wales Australia where the company recently expanded its footprint.
➡️ Commencement of drilling at Havilah copper, gold and silver project
➡️ Acquired over nearly 300sqkm of extensions of the perspective ground through entering a joint venture with Acros and Crown tenements
➡️ Resource upgrade on Namibia projects,the polymetallic projects, vanadium, copper, lead zinc and silver.
Watch full interview on our Youtube channel ⚡

Golden Deeps (ASX:GED) has released its quarterly report highlighting how it advanced the Otavi Mountain Land Copper District of Namibia and copper-gold projects in the Lachlan Fold Belt of New South Wales Australia where the company recently expanded its footprint.
➡️ Commencement of drilling at Havilah copper, gold and silver project
➡️ Acquired over nearly 300sqkm of extensions of the perspective ground through entering a joint venture with Acros and Crown tenements
➡️ Resource upgrade on Namibia projects,the polymetallic projects, vanadium, copper, lead zinc and silver.
Watch full interview on our Youtube channel ⚡
ClearVue Technologies (ASX:CPV) has entered the Middle East, North Africa & Indian markets with a Manufacturing and Distribution agreement with Aluminium Technology Auxiliary Industries.
☀️ Aluminium Technology Auxiliary Industries façade is an engineering, contracting and manufacturing company in Qatar
☀️ Five-year agreement consists of manufacturing and distribution partnership for ClearVuePV unique Solar Glazing and Insulated Glass Units in Alutec’s key markets

ClearVue Technologies (ASX:CPV) has entered the Middle East, North Africa & Indian markets with a Manufacturing and Distribution agreement with Aluminium Technology Auxiliary Industries.
☀️ Aluminium Technology Auxiliary Industries façade is an engineering, contracting and manufacturing company in Qatar
☀️ Five-year agreement consists of manufacturing and distribution partnership for ClearVuePV unique Solar Glazing and Insulated Glass Units in Alutec’s key markets
Tennant Minerals (ASX:TMS) has released its quarterly report highlighting how it remained focused on its 100%-owned Barkly Project in the Northern Territory and the high-grade Bluebird Copper Gold discovery. Tennant CEO, Vincent Algar says Bluebird is considered to be one of the most significant discoveries of Tennant Creek style iron-oxide hosted copper-gold mineralisation in over 20 years and joins Lel Smits to discuss:
🔍 Discovery of high-grade copper-gold mineralization at the Bluebird project
🏆 First drilling program of 24 field season completed. Assay anticipated soon.
🪨 Positive metallurgical test results demonstrating high recovery rates
🖋️ Securing of $4.78m in capital for exploration
“This year’s drilling and field programs will be transformational for the Company as we progress towards defining a maiden Mineral Resource and commencement of development studies. All metallurgical test work has exceeded expectations. These activities will continue to define Tennant Minerals as a key player in the rejuvenated Tennant Creek Mineral Field – a field that has already produced over 5.5Moz of gold and 700kt of copper.” - Tennant Minerals CEO, Vincent Algar

Tennant Minerals (ASX:TMS) has released its quarterly report highlighting how it remained focused on its 100%-owned Barkly Project in the Northern Territory and the high-grade Bluebird Copper Gold discovery. Tennant CEO, Vincent Algar says Bluebird is considered to be one of the most significant discoveries of Tennant Creek style iron-oxide hosted copper-gold mineralisation in over 20 years and joins Lel Smits to discuss:
🔍 Discovery of high-grade copper-gold mineralization at the Bluebird project
🏆 First drilling program of 24 field season completed. Assay anticipated soon.
🪨 Positive metallurgical test results demonstrating high recovery rates
🖋️ Securing of $4.78m in capital for exploration
“This year’s drilling and field programs will be transformational for the Company as we progress towards defining a maiden Mineral Resource and commencement of development studies. All metallurgical test work has exceeded expectations. These activities will continue to define Tennant Minerals as a key player in the rejuvenated Tennant Creek Mineral Field – a field that has already produced over 5.5Moz of gold and 700kt of copper.” - Tennant Minerals CEO, Vincent Algar
BCAL Diagnostics (ASX:BDX) is dedicated to the early diagnosis of breast cancer, aiming to facilitate early intervention and enhance outcomes for women. Over the past decade, BCAL has engaged in the research and development of non-invasive diagnostic technologies designed to complement existing imaging technologies, such as the mammogram. BCAL is currently focused on improved screening for breast cancer in women via its innovative blood test BREASTEST ®. BCAL Diagnostics Co-Founder and Executive Chair Jayne Shaw joins The Stock Network`s Lel Smits to discuss:
🧪 Advancing efforts to improve breast cancer diagnostics
🩺 Launching BREASTEST ® into the market
👉 Making it available for all women alongside mammogram
Watch the full interview on our Youtubw channel ⚡

BCAL Diagnostics (ASX:BDX) is dedicated to the early diagnosis of breast cancer, aiming to facilitate early intervention and enhance outcomes for women. Over the past decade, BCAL has engaged in the research and development of non-invasive diagnostic technologies designed to complement existing imaging technologies, such as the mammogram. BCAL is currently focused on improved screening for breast cancer in women via its innovative blood test BREASTEST ®. BCAL Diagnostics Co-Founder and Executive Chair Jayne Shaw joins The Stock Network`s Lel Smits to discuss:
🧪 Advancing efforts to improve breast cancer diagnostics
🩺 Launching BREASTEST ® into the market
👉 Making it available for all women alongside mammogram
Watch the full interview on our Youtubw channel ⚡
The Stock Network is thrilled to announce our partnership with the World Business Forum
🌏 Organised by the World Business Forum in major cities across the globe, the World Business Forum gathers thousands of senior executives to learn from world-class business thought leaders.
🌏 The Forum focuses on the most relevant management topics for today’s business leaders as they face the challenge of steering their teams and organisations.
📍 ICC Sydney
🕐 13 & 14 November 2024

The Stock Network is thrilled to announce our partnership with the World Business Forum
🌏 Organised by the World Business Forum in major cities across the globe, the World Business Forum gathers thousands of senior executives to learn from world-class business thought leaders.
🌏 The Forum focuses on the most relevant management topics for today’s business leaders as they face the challenge of steering their teams and organisations.
📍 ICC Sydney
🕐 13 & 14 November 2024
Globe Metals & Mining has welcomed news of Mine Development Agreements from Lotus Resources (ASX:LOT - Uranium) and Mkango Resources (LSE:MKA.L - Rare Earths) with the Government of Malawi.
"This is a major step forward for both companies and ensures that the enviable momentum behind the development of Malawi’s young mining sector is maintained. Together with the positive operational trajectories of Globe itself, Sovereign Metals (ASX:SVM - rutile/graphite), and Lindian Resources (ASX:LIN - rare earths) Malawi is rapidly establishing itself as a world-class investor-friendly mining destination."
- Chief Executive Officer, Paul Smith

Globe Metals & Mining has welcomed news of Mine Development Agreements from Lotus Resources (ASX:LOT - Uranium) and Mkango Resources (LSE:MKA.L - Rare Earths) with the Government of Malawi.
"This is a major step forward for both companies and ensures that the enviable momentum behind the development of Malawi’s young mining sector is maintained. Together with the positive operational trajectories of Globe itself, Sovereign Metals (ASX:SVM - rutile/graphite), and Lindian Resources (ASX:LIN - rare earths) Malawi is rapidly establishing itself as a world-class investor-friendly mining destination."
- Chief Executive Officer, Paul Smith
Tennant Minerals (ASX:TSM) has released its quarterly report highlighting how it remained focused on its 100%-owned Barkly Project in the Northern Territory and the high-grade Bluebird Copper Gold discovery
Tennant says Bluebird is considered to be one of the most significant discoveries of Tennant Creek style iron-oxide hosted copper-gold mineralisation in over 20 years.
🔍 Discovery of high-grade copper-gold mineralization at the Bluebird project
🏆 First drilling program of 24 field season completed. Assay anticipated soon.
🪨 Positive metallurgical test results demonstrating high recovery rates
🖋️ Securing of $4.78m in capital for exploration
“This year’s drilling and field programs will be transformational for the Company as we progress towards defining a maiden Mineral Resource and commencement of development studies. All metallurgical test work has exceeded expectations.
These activities will continue to define Tennant Minerals as a key player in the rejuvenated Tennant Creek Mineral Field – a field that has already produced over 5.5Moz of gold and 700kt of copper.”
Tennant Minerals CEO, Vincent Algar

Tennant Minerals (ASX:TSM) has released its quarterly report highlighting how it remained focused on its 100%-owned Barkly Project in the Northern Territory and the high-grade Bluebird Copper Gold discovery
Tennant says Bluebird is considered to be one of the most significant discoveries of Tennant Creek style iron-oxide hosted copper-gold mineralisation in over 20 years.
🔍 Discovery of high-grade copper-gold mineralization at the Bluebird project
🏆 First drilling program of 24 field season completed. Assay anticipated soon.
🪨 Positive metallurgical test results demonstrating high recovery rates
🖋️ Securing of $4.78m in capital for exploration
“This year’s drilling and field programs will be transformational for the Company as we progress towards defining a maiden Mineral Resource and commencement of development studies. All metallurgical test work has exceeded expectations.
These activities will continue to define Tennant Minerals as a key player in the rejuvenated Tennant Creek Mineral Field – a field that has already produced over 5.5Moz of gold and 700kt of copper.”
Tennant Minerals CEO, Vincent Algar
Power Minerals (ASX:PNN) is a diversified explorer now validating the prospectivity of projects located in Argentina, Brazil and Australia. Its flagship assets are the Salta Lithium Brine Project in Argentina`s prolific lithium triangle, and the Lĺtio Niobium Project in Brazil. While exploration work occurs at these South American projects, the Company is also working to derive value from some non-core Australian assets currently on its books and its Managing Director Mena Habib and Exploration Manager Steven Cooper speak with The Stock Network’s Lel Smits about:
⛏️ Power Minerals’ Salta Lithium Project milestones, located in a recognised lithium triangle in Argentina
⛏️ Lĺtio Project exploration activities at the Brazil-based niobium, tantalum and rare earth element project
⛏️ Planned exploration and development milestones over the coming 12 months
Watch the full interview on our Youtube channel ⚡

Power Minerals (ASX:PNN) is a diversified explorer now validating the prospectivity of projects located in Argentina, Brazil and Australia. Its flagship assets are the Salta Lithium Brine Project in Argentina`s prolific lithium triangle, and the Lĺtio Niobium Project in Brazil. While exploration work occurs at these South American projects, the Company is also working to derive value from some non-core Australian assets currently on its books and its Managing Director Mena Habib and Exploration Manager Steven Cooper speak with The Stock Network’s Lel Smits about:
⛏️ Power Minerals’ Salta Lithium Project milestones, located in a recognised lithium triangle in Argentina
⛏️ Lĺtio Project exploration activities at the Brazil-based niobium, tantalum and rare earth element project
⛏️ Planned exploration and development milestones over the coming 12 months
Watch the full interview on our Youtube channel ⚡
HITIQ (ASX:HIQ) has received approval for a US Patent relating to impact processing technology for its Nexus™ technology.
🧠 The Company provides software and hardware designed to monitor concussive impacts in the brain incurred by sports players
🧠 HITIQ technology is now supported by foundational IP protection in key jurisdiction

HITIQ (ASX:HIQ) has received approval for a US Patent relating to impact processing technology for its Nexus™ technology.
🧠 The Company provides software and hardware designed to monitor concussive impacts in the brain incurred by sports players
🧠 HITIQ technology is now supported by foundational IP protection in key jurisdiction
Bhagwan Marine (ASX:BWN) has listed on the ASX with a ticker code of BWN. The marine services company is one of the largest marine vessel operators and service providers in Australia and has operations focused on sectors including oil and gas, resources, renewables, civil construction, marine lodgings and defence. Bhagwan Marine`s more than 900 employees service a broad client base including oil and gas, mining and construction companies, port authorities and Government organisations

Bhagwan Marine (ASX:BWN) has listed on the ASX with a ticker code of BWN. The marine services company is one of the largest marine vessel operators and service providers in Australia and has operations focused on sectors including oil and gas, resources, renewables, civil construction, marine lodgings and defence. Bhagwan Marine`s more than 900 employees service a broad client base including oil and gas, mining and construction companies, port authorities and Government organisations
Adore Beauty Group (ASX:ABY) has appointed former David Jones executive, Sacha Laing, as Chief Executive Officer, effective 1 October 2024.
💄Laing was noted as having 25 years’ experience in physical, online and wholesale retail with executive roles across a variety of Australian businesses
💄Previously, Laing was CEO of General Pants Co and CEO of Colette by Colette Hayman
"We will continue to focus on accelerating our strategic growth pillars, including stand-alone Adore Beauty physical stores, further expansion of our own private label brands, and the integration and expansion of the iKOU business, expected to complete later this month.” Sacha Laing commented.

Adore Beauty Group (ASX:ABY) has appointed former David Jones executive, Sacha Laing, as Chief Executive Officer, effective 1 October 2024.
💄Laing was noted as having 25 years’ experience in physical, online and wholesale retail with executive roles across a variety of Australian businesses
💄Previously, Laing was CEO of General Pants Co and CEO of Colette by Colette Hayman
"We will continue to focus on accelerating our strategic growth pillars, including stand-alone Adore Beauty physical stores, further expansion of our own private label brands, and the integration and expansion of the iKOU business, expected to complete later this month.” Sacha Laing commented.
Raiz Invest (ASX:RZI) has reported strong Q4 FY24 results for its Australian operations, showcasing growth and performance across key metrics including:
📲 Revenue Growth: Q4 FY24 revenue increased by 28.1% YOY to $5.5m, up 3.1% QOQ.
📲 Active Customers: Grew by 3.7% YOY to 306,776 as of 30 June 2024; 308,653 by 25 July 2024.
📲 Funds Under Management (FUM): Total FUM reached $1.4bn, up 23.4% YOY. Retail FUM increased by 22.2% YOY to $1.1bn, and Superannuation FUM by 28.1% YOY to $288m.
In FY25, we will continue to expand our product suite, with new additions to the Plus portfolio, incorporating Plus into the Super offering, launching automatic Raiz Rewards, and improving our marketing processes through AI tools to boost awareness, engagement, and retention.
We have a scalable platform for growth with a low marginal cost of trading and we continue to pursue both organic and inorganic growth opportunities to accelerate our growth trajectory.” Brendan Malone, Raiz Invest Managing Director and CEO

Raiz Invest (ASX:RZI) has reported strong Q4 FY24 results for its Australian operations, showcasing growth and performance across key metrics including:
📲 Revenue Growth: Q4 FY24 revenue increased by 28.1% YOY to $5.5m, up 3.1% QOQ.
📲 Active Customers: Grew by 3.7% YOY to 306,776 as of 30 June 2024; 308,653 by 25 July 2024.
📲 Funds Under Management (FUM): Total FUM reached $1.4bn, up 23.4% YOY. Retail FUM increased by 22.2% YOY to $1.1bn, and Superannuation FUM by 28.1% YOY to $288m.
In FY25, we will continue to expand our product suite, with new additions to the Plus portfolio, incorporating Plus into the Super offering, launching automatic Raiz Rewards, and improving our marketing processes through AI tools to boost awareness, engagement, and retention.
We have a scalable platform for growth with a low marginal cost of trading and we continue to pursue both organic and inorganic growth opportunities to accelerate our growth trajectory.” Brendan Malone, Raiz Invest Managing Director and CEO
Globe Metals & Mining (ASX:GBE) is an African-focused resources company focused on the Kanyika Niobium Project in Malawi. The Kanyika Niobium Project will produce niobium and tantalum products, which are key additives in high strength-low alloy (HSLA) steels and electronics and a JORC Mineral Resource Estimate indicates Kanyika could support a 20 year mine life.
🇲🇼 The Kanyika Niobium Project in Malawi
🏗️ Development milestones
📝 Development plan
⛏️ Infrastructure requirements
🪨 Niobium oxide
⚙️ Niobium demand dynamics
🌱 ESG impact
🚀 Expansion plans

Globe Metals & Mining (ASX:GBE) is an African-focused resources company focused on the Kanyika Niobium Project in Malawi. The Kanyika Niobium Project will produce niobium and tantalum products, which are key additives in high strength-low alloy (HSLA) steels and electronics and a JORC Mineral Resource Estimate indicates Kanyika could support a 20 year mine life.
🇲🇼 The Kanyika Niobium Project in Malawi
🏗️ Development milestones
📝 Development plan
⛏️ Infrastructure requirements
🪨 Niobium oxide
⚙️ Niobium demand dynamics
🌱 ESG impact
🚀 Expansion plans
Tissue Repair (ASX:TRP) has secured a TGA approval for TR Pro+, the Company`s first advanced wound healing gel product containing the proprietary active ingredient derived from yeast

Tissue Repair (ASX:TRP) has secured a TGA approval for TR Pro+, the Company`s first advanced wound healing gel product containing the proprietary active ingredient derived from yeast
Barton Gold (ASX:BGD): Accelerating gold development at Tunkillia project, Gawler Craton, SA